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Abstract 
The anterior surface of the eye is composed of the clear cornea centrally and the conjunctival 
and white sclera peripherally. The clarity of the cornea is of crucial importance for the 
transmission and focusing of light to the retina for visual perception. The limbus harbours 
the stem cells for corneal regeneration, the so-called limbal stem cells, and acts as a physical 
barrier preventing the conjunctiva and its blood vessels from encroaching onto the corneal 
surface. Upon injury or other inherited causes, the ocular surface homeostasis is impaired 
resulting in a migration of conjunctival epithelium onto the corneal surface, in a process 
called conjunctivalisation. Upon conjunctivalisation, which results in loss of corneal clarity 
and visual impairment, the conjunctival migrating cells can undergo a process of 
transdifferentiation towards cornea epithelial-like cells. This process of transdifferentiation 
seems to be incomplete, with the differentiated cells showing differences in glycogen 
metabolism, keratin profiling and tensile strength when compared to the native corneal 
epithelial cells. Limbal epithelial transplantation forms the mainstay of treatment in severe 
cases of such deficiency. However, two main hurdles stand for this treatment, including the 
requirement of large amounts of healthy tissue and the need of immunosuppression 
therapies in the case of allografts. Therefore, the emergence of cell-based therapies that 
potentially promote the complete transdifferentiation of conjunctival cells into corneal 
epithelial cells would overcome these two hurdles. This study aims to understand ocular 
surface and epithelial cell differentiation in response to the composition and morphogenic 
properties of the extracellular matrix (ECM). Cell cultures were treated with strong alkali 
solutions, by a process called “de-roofing”, resulting in systems devoid of any cell and cell 
debris with only the respective ECM proteins attached to the cultureware. For the first-time, 
cells were driven to differentiate towards the lineage of the ECM depositing-cell. This process 
of differentiation required an intermediate step of cell dedifferentiation as suggested by the 
increased expression of early progenitor epithelial cell markers ΔNp63 and ABCB5. The ECM 
composition and protein deposition profiles were extensively characterized to narrow the 
possible cues involved in the process of cell differentiation. Laminin-511 coated surface was 
shown to be a potential candidate to promote epithelial cell differentiation, with cell 
response shown to be concentration and time-dependent. Furthermore, the 
phosphorylation or cleavage levels of 18 different proteins, mainly involved in cell growth 
and differentiation, were assessed to understand the mechanisms behind this process. 
Additionally, and for the first-time, microvesicles were extracted from epithelial cells derived 
from human ocular epithelial cells. These microvesicles showed cargo containing several 
mRNA and miRNA molecules. Furthermore, the microvesicles were used to drive cell 
differentiation towards the lineage of the exosome-originating cells. Lastly, by replicating 
factors within the conjunctival and corneal epithelium environment, human embryonic stem 
cells were partially differentiated into conjunctival and corneal epithelial-like cells, 
respectively.   
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Chapter 1 - Introduction 
1.1. Structure and functions of the cornea, limbus, and conjunctiva 
The anterior surface of the eye is composed of the clear cornea centrally and the conjunctiva 
and white sclera peripherally. The limbus forms the transition zone between the cornea and 
the sclera and conjunctiva, Figure 1.  
Figure 1 – Schematic anterior view and sagittal cross-section of the human eye (not to scale). (A) 
The limbus forms the transition zone between the cornea located centrally and the sclera and 
conjunctiva located peripherally. (B) Sagittal cross-section of the human eye.  
The cornea is a specialized transparent avascular structure, composed of five main layers, 
Figure 2. The first layer, which forms the outer surface, is made up of approximately five to 
seven cell layers of non-keratinized, stratified, and squamous epithelium. The second layer, 
called the Bowman’s layer, is formed by a thin acellular collagenous layer and serves as a 
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basement membrane (BM) for the epithelial layer. The third layer is the avascular stroma 
and comprises about 90% of the corneal thickness. The corneal stroma is composed of 
aligned arrays of collagen fibrils interspersed with specialised fibroblasts, called keratocytes. 
The fourth layer, called the Descemet’s membrane, serves as the BM of the fifth layer - the 
corneal endothelium. The endothelial cells transport nutrients and water to and from the 
stroma preventing corneal oedema and therefore maintaining optimal hydration [8]. The 
main function of the cornea is to enable the transmission and focusing of the light into the 
retina by providing two-thirds of the eye’s refractive power. It also acts as a first line of 
defence against injury, infection and desiccation [8].  
Figure 2 – Cross section of the human cornea (not to scale). The cornea is composed of five main 
layers: the epithelium on the outer surface, the Bowman’s layer, the collagenous stroma, the 
Descemet’s membrane and the endothelium on the inner surface. Adapted from [9]. 
The superficial layers of the cornea (the stratified epithelium and the Bowman’s layer) are 
continuous with the peripheral conjunctiva. The conjunctiva is a thin loose mucous 
membrane that covers and bridges the anterior surface of the globe and the posterior 
surface of the eyelids [8]. The conjunctiva is composed of two to ten cell layers of non-
keratinized, stratified squamous and columnar epithelium with scattered mucin (MUC)-
producing goblet cells and an underlying highly vascularised substantia propria, Figure 3. The 
conjunctiva is of crucial importance to: (i) support the structure of the corneal epithelial tear 
film, (ii) enable the independent motion of the eyeball and eyelids, and (iii) protection of the 
cornea and the interior of the eye from the external environment by secreting mucins, 
Epithelium 
Bowman’s layer 
Stroma 
Descemet’s  
membrane 
Endothelium 
- Basal cell 
- Wing cell 
- Squamous cell 
 
- Keratocyte  
 
- Endothelial cell 
- Collagen fibril 
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antibacterial proteins, and water to form the inner mucous layer of the tear film [10]. Besides 
its nonspecific defence mechanisms, the conjunctiva provides with a system of specific 
immune response in the form of mucosa-associated lymphoid tissue (MALT) [11, 12]. This 
tissue consists of an arrangement of lymphatic cells situated underneath the epithelium [13]. 
MALT detects antigens and induces an immune response through direct action of the 
lymphatic cells or secretion of soluble antibodies [14]. In human conjunctiva the presence of 
an associated lymphoid tissue has been shown elsewhere [15], suggesting the term 
conjunctiva-associated lymphoid tissue (CALT).  
The conjunctiva is divided into three main regions, as follows:  
i. Palpebral conjunctiva. The palpebral conjunctiva lines the posterior surface of the eyelid 
and is divided into marginal, tarsal, and orbital regions. The marginal region starts at the 
intermarginal strips of the eyelid as a continuation of the skin and continues into the 
posterior surface of the eyelid up to a shallow groove, named sub tarsal sulcus, where it 
merges with the orbital region. The tarsal region is a highly vascular structure and very 
adherent to the tarsal plates. The orbital region is a looser entity covering between the 
tarsal plate and the fornix [16].  
ii. Forniceal conjunctiva. The forniceal conjunctiva covers the posterior surface of the 
eyelids up to the anterior surface of the globe. This structure is thicker and loosely 
attached to allow free movement of the eye globe. It is divided into superior, inferior, 
lateral, and medial fornix regions [16, 17]. 
Figure 3 - Cross-section of the human conjunctiva (not to scale). The conjunctiva is composed of 
three main layers: the outer epithelium containing scattered goblet cells, the basement membrane, 
and a substantia propria containing blood vessels. 
Epithelium 
Substantia  
propria 
Basement membrane 
- Goblet cell 
 
- Conjunctival  
  epithelial cell 
- Collagen fibril 
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iii. Bulbar conjunctiva. The bulbar conjunctiva is the thinnest and the clearest of all parts of 
the conjunctiva, allowing the white sclera and its blood vessels to be seen easily. It is 
loosely attached, exception made for the zone near the limbus. Belonging to the bulbar 
conjunctiva is the limbus conjunctiva that covers the limbal region and fuses with the 
corneal epithelium [16, 18].  
Table 1 – Characteristics of conjunctival epithelium. Adapted from [19]. 
Conjunctival regions Number of layers Cells in layers 
Marginal 
5 layers of non-
keratinized stratified 
squamous epithelium 
Superficial layer: squamous cells 
Middle three layers: polyhedral cells 
Deepest layer: cylindrical cells 
Tarsal 2 layers of stratified cuboidal epithelium 
Superficial layer: cylindrical cells 
Deepest layer: cuboidal cells 
Fornix and bulbar 3 layers of stratified squamous epithelium 
Superficial layer: cylindrical cells 
Middle three layers: polyhedral cells 
Deepest layer: cuboidal cells 
Limbal 10 layers of stratified squamous epithelium 
Superficial layer: squamous cells 
Middle three layers: polygonal cells 
Basal layer: cuboidal cells 
  
Physically separating the cornea and the conjunctiva is a narrow band known as limbus that 
encircles the cornea. It starts at the termination of Bowman’s layer and is approximately 
1.5mm wide. The limbus’ main function is twofold in maintaining the corneal clarity. Firstly, 
the limbal epithelium acts as a physical barrier, preventing the phenotypically different 
conjunctival epithelium and its stromal blood vessels from encroaching onto the cornea, 
thereby impairing its clarity [20]. Secondly, the limbal epithelium harbours the stem cells 
(SCs) that renew the corneal epithelium, the so called limbal stem cells (LSCs) [21, 22]. Unlike 
the transparent cornea, both the limbus and the conjunctiva are vascularised.  
1.2. Embryology  
The major development of the human eye occurs between the 3rd and 10th week of gestation 
and mainly involves the ectoderm, the neural crest cells, and the mesenchyme. The eye 
begins to develop as a pair of two small optic grooves on each side of the forebrain at the 
end of the 3rd week of gestation. These grooves will eventually close becoming the optic 
vesicles which will then invaginate to form a double-layered structure called the optic cup. 
The optic vesicles will contact the surface ectoderm triggering the necessary changes for 
further eye development, initiated by the master control gene PAX6. The PAX6 gene product 
is a transcription factor playing a key role in the regulation of eye development. Further 
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differentiation and mechanical rearrangement of cells gives rise to the fully developed eye 
[23, 24]. 
Different germ layers form different areas of the eye: the neural tube ectoderm gives rise to 
the retina, iris, ciliary body epithelia, optic nerve, smooth muscles of the iris, and some of 
the vitreous humour. Surface ectoderm gives rise to the lens, the corneal and conjunctival 
epithelium, the eyelids, and the lacrimal apparatus. The remaining ocular structures are 
formed from the mesenchyme.  
The developing corneal epithelium is first apparent at 6 weeks post-ovulation [25] when the 
mesenchyme that surrounds the external surface of the optic cup condenses into two 
different layers. The inner layer is pigmented and vascular, known as choroid. The outer layer 
is fibrous and is called the sclera. The mesenchyme, anterior to the developing lens, splits 
into two layers that surrounds the newly formed anterior chamber of the eye. The outer 
layer, continuous with the sclera, will form the corneal stroma. The corneal endothelium 
develops from the surface ectoderm and the inner endothelium from migrating neural crests 
cells from the optic cup. The primitive corneal epithelium is initially composed of two cell 
layers (as compared to the five to seven layers in the adult). This primitive epithelium is also 
responsible for forming a prominent primary acellular corneal stroma and the Bowman’s 
layer. Sometime between the 8th week of gestation (when the eyelids fuse together) and the 
26th week (when eyelids open), the corneal epithelium stratifies into a structure of four to 
five cell layers thick. Adhesion complexes only become detectable by 19 weeks of gestation. 
Further development in utero leads to an increase in the number of hemidesmosomes (HDs), 
increase in fibril penetration into the Bowman’s layer, and an increase in the Bowman’s layer 
thickness. Maturation of the corneal epithelium is therefore related to eyelid development 
[25].  
The conjunctival epithelium is derived from the surface ectoderm and becomes 
distinguishable from the limbal-corneal epithelium at the 7th week of gestation [26]. At the 
8th week of gestation the conjunctival epithelium develops within the lid folds from surface 
ectoderm along the posterior surface of the lids and around the developing cornea. Budding 
of the epithelium in the forniceal region at the 12th week leads to the formation of the 
lacrimal and accessory lacrimal glands [27]. Contrarily to corneal epithelium, the conjunctival 
epithelium does not stratify until the eyelids re-open (26th week of gestation) [28]. The 
normal eye development results therefore, from a sequential interaction of the various 
tissues, with some being the inducers for the development of other tissues. 
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Despite their closeness, the corneal epithelial cells (ECs) and the conjunctival ECs belong to 
distinct lineages [29, 30] arising from different cell populations [31]. In vivo studies in rabbit 
models have shown that limbal and corneal EC-derived cysts contained only stratified 
squamous-type cells. In contrast, conjunctival EC-derived cysts contained stratified 
columnar-type cells interspersed with periodic acid-Schiff (PAS) staining cells (PAS test is 
widely used as MUC staining method) with a goblet-like structure (the goblet cells) [31]. This 
supports the hypothesis that corneal and limbal ECs originate along a different embryonic 
lineage to conjunctival ECs, with the goblet cells originating from the conjunctival 
compartment. 
1.3. Basic stem cell biology   
The classical definition of a SC is ‘an undifferentiated cell that is both capable of self-renewing 
and has the ability to generate one or more differentiated cell types (cell potency). Broadly, 
two main groups of SCs can be distinguished: 
 Embryonic SCs (ESCs). ESCs are derived from the undifferentiated inner cell mass (ICM) 
of the blastocyst. They were firstly established from human in 1998 [32]. Like their 
counterparts in the inner cell mass, they are pluripotent, i.e. they can give rise to all 
derivatives of the three primary germ layers: ectoderm, endoderm, and mesoderm. ESCs 
are distinguished from other SCs by two distinctive properties: their pluripotency and by 
their indefinite ability to replicate.  
 Adult SCs. Adult SCs are undifferentiated cells found among differentiated cells within a 
tissue or organ. These cells can renew themselves and can differentiate into the major 
specialized cell types of the tissue or organ of origin. They have, however, a more limited 
ability to generate differentiated cells compared to ESCs. Their main role is to maintain 
and repair the tissue where they reside [33]. 
The ability of ESCs to maintain the self-renewal and pluripotency is associated with their 
ability to remain in a proliferative state. ESCs cell divide rapidly [34] and undergo successive 
symmetrical cell divisions to generate new progeny structurally and functionally equivalent 
to the mother cells [35]. Their cell cycle progression is controlled by accurate mechanisms to 
ensure the rapid replication and accurate transmission of the genetic material to the 
daughter cells. The cell cycle is divided into four phases; the S phase (chromosome 
replication, M phase (chromosome transmission), and two gap phases (G1 and G2) that 
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temporally separates the S and M phase [35]. ESCs have an unusual cell cycle, consisting 
mainly of S phase and truncated G1 phase [36]. In human, ESCs reside 65% of the time in S 
phase and 15% of the time in G1 phase (on the other hand, somatic cells reside 40% of the 
time in G1 phase and 25 to 30% in S phase) [34]. Both tritiated thymidine and 
bromodeoxyuridine (BrdU), an analogue of thymidine, have been used in the detection of 
cells in S phase [37, 38] as it has been postulated that they can retain these markers for 
longer periods of time [39, 40]. More differentiated cells however, cycle much more rapidly 
therefore retaining these markers for shorter periods of time. This so-called ‘label retaining 
property’ has been used to distinguish SCs from other differentiated cells in the ocular 
surface [40-42]. 
1.4. Stem cell niche 
Schofield suggested in the “Stem Cell Niche hypothesis” that SCs are located in a specialized 
microenvironment, known as a niche [43]. The niche varies depending on the tissue type, 
although it generally consists of a group of SCs and their transient amplifying cells (TACs), 
which are anchored together by specific junctions surrounded by a specialized extracellular 
matrix (ECM), Figure 4. The niche regulates cell cycle quiescence, maintenance, self-renewal, 
activation, and proliferation providing external signals [44, 45]. Besides their differences, all 
SCs niches share common features, such as an enriched blood supply and well protected 
areas with specialized ECM [46]. 
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Figure 4 – Schematic illustration of a stem cell niche. The SC niche consists of a group of SCs and 
transient amplifying cells, anchored together by specific adhesion complexes. Surrounding these cells 
is a very specialized ECM which drives SCs to (A) self-renew or (B) to differentiate into its transient 
amplifying cell. Abbreviations used SC: stem cell, ECM: extracellular matrix. Adapted from [47]. 
1.5. Limbal stem cell niche 
Differences in the microenvironments of limbus and cornea epithelium allow LSCs to 
maintain their relatively undifferentiated state in the limbus. These include the presence of 
palisades of Vogt [41, 48, 49], crypts [50, 51], and adhesion complexes [52, 53], as well as 
differences in the BM composition [46, 52]. 
1.5.1. Palisades of Vogt 
Anatomically the LSCs reside within the palisades of Vogt, firstly proposed by Davanger and 
Evenson [48] and subsequently supported by in vivo evidence [49, 51]. This region is 
characterized by numerous undulations of richly vascularized stroma projected into the 
limbal epithelium. The function of these stromal projections is two-fold. Firstly, these 
invaginations allow basal limbal cells to interact with the underlying richly vascularized 
stroma, which provides nutrients and other soluble factors [41, 54]. Closeness to vascular 
networks has been postulated as being a prerequisite for the SC state [41, 52]. Secondly, 
these undulations also provide an increased surface area, allowing a higher concentration of 
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LSCs within a small area [41, 49, 52]. The deep limbal ridges also protect LSCs from trauma. 
Scattered amongst LSCs and ECs are melanocytes that offer additional protective 
mechanisms against ultraviolet radiation [55]. In addition, it has also been suggested that 
the LSC niche may be enriched in epithelial crypts associated with palisades of Vogt [50, 51]. 
These are formed by epithelial projections from the periphery of the palisade which extend 
either radially from the limbus into the conjunctival stroma or circumferentially within the 
limbus. These crypts are sparsely distributed, with only 6-7 per human eye [50, 51]. 
1.5.2. Basement membrane 
The BM is a thin, fibrous layer that separates the epithelium and endothelium from the 
underlying connective tissue. Together with all other niche features, the BM plays a critical 
role in the maintenance of SC properties [43, 56]. Individual components of the BM regulate 
cell growth, proliferation, differentiation, and migration through interactions with cell 
surface receptors. BM provides structural support, and in addition stores and traps growth 
factors and cytokines, functioning as a reservoir of soluble factors that can be released in 
response to changes in physiological conditions [46]. It is mainly composed of collagen type 
IV, various types of laminin isoforms and fibronectin. A detailed comparison of limbus, 
cornea, and conjunctiva BM can be found in Section 3.1.2. 
1.5.3. Fibroblasts 
Fibroblasts are classically defined as fusiform mesenchymatous cells possessing an elongated 
nucleus parallel to the long axis of the cell, a cytoplasm rich in organelles, and a rough 
endoplasmic reticulum. Upon injury to the cornea, fibroblasts can transit into various 
phenotypes dependent on specific extracellular cues [57]. Stromal fibroblasts played an 
important role in the regulation of progenitor EC differentiation both in vitro and in vivo, 
providing cytokines and soluble factors that mediate their paracrine interactions [47]. Briefly, 
Li et al. found that:  
i. Type I cytokines, such as interleukin (IL)-1β, are released by injured corneal ECs and their 
receptors expressed by fibroblasts. IL-1β results in type III cytokine production by both 
limbal and corneal fibroblasts [58, 59].  
ii. Type II cytokines, such as transforming growth factor (TGF)-β1, are released by healing 
corneal ECs and their receptors are expressed by both ECs and fibroblasts [58, 59]. TGF-
β1 inhibits type III cytokine production by both limbal and corneal fibroblasts [58]. 
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iii. Type III cytokines, such as keratinocyte growth factor (KGF) and hepatocyte growth factor 
(HGF), are expressed by fibroblasts, but their receptors are predominantly expressed by 
ECs [58, 59]. KGF causes the proliferation of limbal ECs, and HGF causes the migration of 
ECs over the surface of the cornea [60].  
1.5.4. Adhesion structures 
Epithelial attachment to the underlying stroma is aided by three adhesion structures – 
hemidesmosome, anchoring fibrils, and adhesion plaques, Figure 5 [52].  
i. Hemidesmosomes. HDs help the adhesion of basal cell membranes to the underlying BM 
[52]. 
ii. Anchoring fibrils. Anchoring fibrils, mainly composed of collagen type VII, link the BM to 
adhesion plaques in the underlying stroma [52]. 
iii. Adhesion plaques. Adhesion plaques are small patches of BM within the stroma itself, 
and are attached to the BM by anchoring fibrils [52].  
The limbal area shows a smaller number of HDs, anchoring fibrils and adhesion plaques, a 
discontinuous basement membrane, and a more irregular surface when compared to the 
corneal BM [52, 53]. 
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Figure 5 - The basement membrane of the limbal and corneal epithelia. The basement membrane 
zone ensures adherence of the overlying epithelium to the underlying stroma, through four main 
components: the hemidesmosomes, the basement membrane, the anchoring fibrils, and the elastic 
fibres. The cell-cell adhesion is mediated by desmosomes and transmembrane proteins. Adapted from 
[7]. 
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1.6. Conjunctival stem cell niche 
1.6.1. Common features 
1.6.1.1. Fibroblasts  
Fibroblasts are responsible for secreting fibres and other ECM proteins that form the 
conjunctival stroma. The fibroblasts play an important role in the regulation of progenitor EC 
differentiation both in vitro and in vivo providing cytokines and other soluble factors which 
mediate the paracrine interactions between themselves and ECs [58, 59].  
1.6.1.2. Nutrients supply 
The medial canthal and the inferior areas of the conjunctiva, two of the suggested areas for 
conjunctival SC location, are densely vascularized providing a plentiful supply of nutrients, 
blood-borne growth factors and other survival factors [61]. 
1.6.1.3. Protection  
Solari et al. have suggested the presence of melanocytes interspaced in the plica semilunaris 
and caruncle [62]. These melanocytes offer protection against the carcinogenic insults from 
the ultraviolet light and subsequent formation of reactive oxygen species. The plica 
semilunaris is particularly enriched in both specific and non-specific immune cells. The intra-
epithelial mucous crypts, abundant on the medial canthal and inferior forniceal regions, 
provide an increased surface area and protective locations allowing higher concentrations of 
conjunctival SCs within a small area. 
1.7. The X, Y, Z model of the corneal epithelial renewal 
Our understanding about the location and biological properties of the SCs has come primarily 
from investigations on the hematopoietic system [63] and intestinal epithelium [64]. In all 
these tissues three different cell populations can be distinguished: (i) the SCs, (ii) the TACs, 
and (iii) the terminally differentiated cells (TDCs), Figure 6 .Their main properties are 
explained below:  
i. SCs. SCs are fewer in number and have a high capacity for self-renewal and high 
proliferative potential. In health they remain relatively quiescent. They give rise to TACs 
during normal tissue homeostasis and become more active during episodes of significant 
wound healing [65], although small wounds may be healed without upregulating SCs. 
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ii. TACs. TACs are larger in number and have limited proliferative potential capacity and 
limited capacity for self-renewal, and in healthy tissue they proliferate quickly. They give 
rise to TDCs. 
iii. TDCs. TDCs are the main functioning cells in a given tissue. They have no capacity for self-
renewal and no proliferative potential. In healthy tissue, they are continuously replaced 
due to their limited life-span.  
The advantage of having a TAC population in a self-renewing tissue is considerable. The TACs 
amplify each SC division and therefore minimize the number of SC divisions. This conserves 
SCs energy and load, providing additional genetic protection by reducing the accumulations 
of mutations.  
Figure 6 – The hierarchy of the cells in the adult stem cells system. The SCs have the greatest 
capability to self-renew. The TACs are larger in number and have reduced ability to self-renew. The 
TDCs form most cells in adult tissues and have no ability to self-renew. Abbreviations used SC: Stem 
cell, TAC: transient amplifying cells, TDC: terminally differentiated cell.  
Besides the evidence for the preferred location of LSCs, others have also showed that TACs 
for the corneal epithelium are preferentially localized to the basal layers of the limbal and 
peripheral corneal epithelia. These include: 
i. Wound healing studies. Matsuda et al. have shown in rabbits that corneal epithelial 
wounds that involved the peripheral cornea heal faster than those involving central 
corneal epithelial [66]. 
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ii. Cell culture studies. In vitro studies have suggested that human peripheral corneal 
cultures grow better than central corneal epithelium cultures. Thus, these findings 
indicated that peripheral cornea contains cells with higher proliferative potential than the 
central cornea [65, 67]. 
iii. Radio-labelling studies. in vivo studies have identified cells actively dividing in the basal 
layers of the limbal and peripheral corneal epithelium in mice and rabbit [65, 68]. 
Collectively these studies show that certain cells in the basal layers of the limbal epithelium 
and the peripheral corneal epithelium exhibited properties of TACs, which are cells with high 
proliferative potential and actively proliferating in health. This contrasts with the LSCs at the 
limbus which have higher proliferative potential but remain relatively quiescent in healthy 
tissues. 
LSCs can undergo asymmetric division whereby one daughter cell is retained in the SC niche, 
while the other detaches from its BM and loses its ‘stemness’ as it migrates centripetally 
towards the cornea. The differentiated cell is now termed a TAC. Following multiple rounds 
of replication, it becomes a post-mitotic TDC that is shed from the corneal surface. This 
homeostasis in which the corneal epithelium is renewed was summed up by Thoft and Friend 
in the “X, Y, Z hypothesis of corneal epithelial maintenance” [69]. This hypothesis predicts 
that the balance between cell proliferation and cell loss is directed by the following equation: 
𝑋 + 𝑌 = 𝑍 
Equation 1 – X, Y, Z hypothesis of corneal epithelium maintenance. 
The X component represents the proliferation of basal ECs [68, 70], the component Y 
represents the contribution to the cell mass by centripetal movement of peripheral cells [71, 
72], and component Z represents the loss of ECs shed from the cornea surface [73, 74], Figure 
7. 
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Figure 7 – The X, Y, Z hypothesis of corneal epithelium maintenance. X component is the migration 
of cells from the basal layers of the corneal epithelium to the epithelial surface. Y component is the 
migration of epithelial cells from the periphery of the cornea to the central cornea. Z component is 
the loss of corneal epithelial cells from shedding. Abbreviations used BL: Bowman’s layer. Adapted 
from [75, 76]. 
1.7.1. Challenging the XYZ hypothesis 
Recently, the XYZ hypothesis has been challenged by observations made in other mammals. 
These new evidences suggested that uninjured cells in the central cornea can generate 
holoclones (SC colonies with proliferative potential) with regenerative epithelial capabilities, 
which may also be responsible for the maintenance of the corneal epithelium [77, 78]. 
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Supporting these controversial findings, central islands of normal corneal ECs have been 
described in patients with apparently complete clinical absence of LSCs [79].  
1.8. Conjunctival epithelial stem cell location 
Whilst it is commonly accepted that the SCs for the corneal epithelium, the LSCs, are located 
within the basal layers of the limbal epithelium, the location of SCs for the conjunctival 
epithelium is less well defined. In the human, conjunctival SCs have been identified 
throughout the whole tissue, especially in the bulbar and forniceal regions [61, 80-82]. 
Studies elucidating conjunctival stem cell location in various animal species are conflicting 
but may support this [83, 84]. 
Three main approaches have identified the bulbar and forniceal regions as the areas with 
highest concentrations of the SCs in the human conjunctiva: 
i. Stem cell markers expression. Although there are no specific markers for conjunctival 
SCs, ATP-binding cassette subfamily G member 2 (ABCB2) and ΔNp63 have long been 
described as putative epithelial SC markers, described in detail in section 1.9. Stewart et 
al., using the expression of these two putative SCs markers, showed that SCs are 
distributed throughout the conjunctiva but with greatest concentration in the medial 
canthal and the inferior forniceal areas. Other studies also suggest the presence of 
conjunctival SCs on the bulbar conjunctival surface [81]. 
ii. Clonogenic activity. Another important property of the epithelial SCs is their ability to 
initiate clonal growth in vitro and form colonies consisting of small cells that have a long 
survival time, the holoclones. Stewart et al also performed in vitro clonogenic analysis of 
epithelial colonies from all the different regions of the conjunctiva confirming the findings 
found with SC marker expression [61]. Others have found similar observations, however 
only the bulbar and forniceal regions were assessed [80]. 
iii. Circumstantial evidences. Clinical observations also indicate that the conjunctival SCs are 
located in the fornix and/or in the bulbar conjunctiva [82]. 
The medial bulbar and inferior forniceal areas may provide greater physical protection, but 
more importantly are especially rich in goblet cells, intra-epithelial mucous crypts, blood 
vessels, melanocytes, and immune cells, common features shared with other SC niches [61].  
  Chapter 1 - Introduction 
16 
 
In the other mammalian species, three approaches have identified different regions as the 
locations of SCs for conjunctival epithelium which would support the findings above: 
i. Label retention studies. Similarly to what was performed on mouse corneas and limbus 
by Cotsarelis et al. [41]; Nagasaki et al. using BrdU retention (a property of quiescent SCs) 
in GFP-labelled mice cells, suggested that epithelial SCs are uniformly distributed 
throughout the whole conjunctiva [85].  
ii. Slow cell-cycling and proliferative potential. Wei et al. showed, by analysing slow cell-
cycling (by continuous administration of 3H-TdR to detect cells in S phase) and the 
proliferative potential (by single administration of 3H-TdR ), that the forniceal region of 
the conjunctiva contains the largest proportions of cells with high proliferative potential 
[30] and a higher percentage of slow cycling cells (14% of ECs) when compared to the 
bulbar (5%) and palpebral conjunctiva (1%) [83].  
iii. Stem cell markers expression. ABCG2-positive cells have been found in palpebral and 
forniceal conjunctiva regions of rabbits and these cells shared features consistent with 
the epithelial SC phenotype, including slow cycling [84]. 
Conjunctival SCs are thought to be bipotent in health giving rise not only to ECs, but also to 
mucin-producing goblet cells, which are scattered throughout the conjunctival epithelium 
[80, 86].  
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Figure 8 – Schematic anterior view of the human conjunctiva. Several regions have been proposed 
as possible regions for conjunctival stem cells, although the medial canthal and the inferior forniceal 
regions have been suggested as the preferred regions. These regions provide greater protection and 
share many features with other SCs niches. Adapted from [87]. 
1.9. Corneal epithelial stem cell location 
Six main studies have identified the basal layer of the limbal epithelium as the preferred 
location of the SCs for the corneal epithelium: 
i. Pigment migration studies. Davanger and Evensen were the first to propose the basal 
epithelial layer of the limbus as the “generative organ for corneal epithelial cells” [48]. 
Using guinea-pig eyes, where the basal layer of the limbal epithelium was pigmented, 
they demonstrated that the cornea healed with pigmented epithelium when the normally 
non-pigmented central cornea epithelium was removed [48]. These results suggested 
that cells located at limbal basal layer have proliferative potential for corneal 
regeneration.  
ii. High proliferative capacity of limbal epithelial culture. Using in vitro cultures, Ebato et 
al. showed that human limbal epithelium has higher proliferative potential when 
compared to either corneal or conjunctival ECs [88]. Since the potential for proliferation 
is one of the hallmarks of SCs, this provides further evidence for the limbal location of 
SCs. 
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iii. Radiolabelled thymidine studies. Cotsarelis et al. used tritiated thymidine to radio-label 
cells in S phase of the cell cycle in mouse cornea and limbus models [41]. They showed 
that the basal cells of the limbal epithelium are slow cycling in nature (an important 
property of SCs), but in central corneal wounds they can be made to cycle much more 
rapidly [41]. Being this an important property of SCs, they concluded that the “corneal 
epithelial SCs are located preferentially, if not exclusively, in the limbal area”.  
iv. Corneal epithelial regeneration with limbal grafts. Kenyon and Tseng showed that, in 
patients who have a LSCs deficiency (LSCD), normal corneal epithelium can be restored 
by transplanting large healthy grafts of limbal epithelium [89]. 
v. Corneal conjunctivalisation with limbal epithelial removal. Several authors, using 
corneal wound healing studies in rabbits, showed that removal of the basal layers of the 
limbal epithelium prevents normal regeneration of the corneal epithelium. In such 
studies, the adjacent conjunctival epithelium and its blood vessels was seen to encroach 
over the corneal surface [20, 29, 90]. 
vi. Circumstantial evidence. Tumours of the ocular surface normally involve the limbus and 
it is well known for other tissue/organ systems that tumour cells may preferentially arise 
from SCs enriched systems [91, 92].  
Collectively, the stated studies show that SCs for corneal epithelium exist in the basal layer 
of the limbus and have high proliferative potential, remaining relatively quiescent in vivo in 
health (important properties of SCs). Furthermore, studies have shown that LSCs are not 
evenly distributed throughout the limbus but are more abundant in the superior and inferior 
zones when compared to the nasal and temporal limbal zones [93, 94]. This uneven 
distribution may be explained by the higher protection offered by the upper and lower 
eyelids.  
Recent studies in animal models however suggested that there is also a reservoir of SCs 
within the corneal epithelium itself in addition to the LSCs. A number of nonhuman studies 
have shown corneal epithelial maintenance without limbal input, and survival and self-
maintenance of SCs outside the limbal SC niche [95]. Successful corneal epithelial 
regeneration by sequential corneal epithelial transplantation in a murine model was first 
proposed as evidence for this [96]. Recently, again in a murine model, lineage-tracing 
experiments have shown that although the limbus is the prime source for corneal epithelial 
  Chapter 1 - Introduction 
19 
 
maintenance, there is also a reservoir of cells with colonies forming potential (properties of 
SCs) within the corneal epithelium itself [97]. In addition to these studies, 48-week follow-
up rabbit studies have shown that although normal corneal epithelium cannot initially be 
maintained following the removal of limbal epithelium, there is evidence of corneal epithelial 
normalization at 48 weeks [98]. Further research is required particularly in human studies, 
to provide strength and consistency to this theory.  
1.10. Epithelial stem cells markers 
Despite decades of research, no definitive marker for ocular SCs has been identified. One of 
the reasons for this elusive task is the very few LSCs present, probably as few as 100 in the 
mouse limbus [99]. Comprehensive reviews of suggested putative LSC markers have been 
extensively published [56, 100]. These include transcription factors and ATP-binding cassette 
(ABC) family members as positive SC markers and keratins as negative markers.  
1.10.1. Markers for corneal stem cells  
In brief, putative positive markers include the transcription factor ΔNp63α [101-103], the 
ATP-binding cassette transporter ABCG2 [84, 104, 105], whilst negative markers include 
keratin (KRT)3 and KRT12, the structural proteins found in the corneal epithelium [106-108]. 
TP63. This gene encodes a transcription factor that belongs to a family of tumour suppressor 
proteins which includes p53 and p73 [109]. Alternative splicing of this gene results in 
transcript variants encoding different isoforms that vary in their functional properties, which 
include adult/SC progenitor cell regulation [109]. Pellegrini et al., using 
immunohistochemistry and in vitro studies, localised the ΔNp63α isoform (one of the six p63 
isoforms) within the LSCs holoclones, which are thought to be generated by SCs, but not in 
the paraclones (comparable to more differentiated cells) [101]. More recently Di Iorio et al., 
using Western blotting, real time PCR, and quantitative fluorescence immunohistochemistry 
have shown that the ΔNp63α isoform is specific to LSCs [102, 103], challenging other studies 
where ΔNp63α was also expressed by early TACs [110-112]. 
ABC transporters. ABC transporters are a family of surface transmembrane proteins whose 
functions are related with the transport of potentially harmful metabolic products out of the 
cells [113]. Conceptually, ABC transporters may form a component of the molecular 
mechanisms by which long-lived cells reduce the potential for genomic damage over their 
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extended lives, and their expression has been associated with SC activity [114]. Two ABC 
transporters have been suggested as markers for LSCs: 
 ABCG2. Using Fluorescence-Activated Cell Sorting ABCG2-positive limbal ECs were 
isolated as a side population (SP). This SP contained cells exhibiting properties associated 
with LSCs, including slow-cycling nature, higher clonogenic capacity and p63 expression 
[104]. It has recently been demonstrated that ABCG2 expression can be localized to basal 
cells of the human limbal epithelium [84, 105]. However, some of the ABCG2-positive cells 
with high nucleus:cytoplasma ratio (striking feature of progenitor cells) in the rat limbus 
have later been identified as Langerhans cells rather than epithelial SCs [115].  
 ABC sub family C member 5 (ABCB5). More recently, murine and human studies have 
shown that cells expressing ABCB5 are required for corneal epithelial homeostasis and 
repair [116]. Those studies showed that ABCB5-positive cells were localized to the limbus 
and co-expressed ΔNp63α but not KRT12.  
Integrins. Integrins belong to a family of cell membrane glycoproteins involved in cell-cell 
and cell-matrix adhesion, they are obligate heterodimers composed of a α and β subunit 
[117]. The α9β1 integrin has been localized to the basal cells of healthy adult limbal 
epithelium, similarly to LSCs [118]. The expression of tenascin-C, a ligand for the α9β1 
integrin, is limited to the extracellular space in the limbal region [119] and its upregulation 
in wounded murine corneas has suggested that this integrin is associated with TACs [120].  
Other proteins have too been used as positive markers to distinguish cells present in human 
basal limbal but not in basal corneal epithelium. These include the type III intermediate 
filament, vimentin [56], the mediator for cell-cell adhesion, N-cadherin [121], the proto-
oncogene, Bmi1 [122], and the self-renewal regulator, C/EBPδ [122]. 
1.10.2. Markers for conjunctival epithelial stem cells 
Similar to LSCs, no specific marker for conjunctival SCs has yet been reported. Positive 
putative markers ΔNp63α and ABCG2 are nevertheless the most widely used [61, 81, 110-
112]. 
ΔNp63. p63 is a transcription factor known to be expressed by LSCs and early TACs [110-
112]. Stewart et al. using cytochemistry analysis, showed a preferred location of this 
transcription factor in the inferior forniceal and medial canthal regions– the preferred 
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location for conjunctival SCs. The cells in those areas also exhibited properties associated 
with SCs, including higher clonogenic capacity [61].  
ABCG2. In human beings, ABCG2-positive cells have been found in biopsies from basal [84], 
medial canthal and inferior forniceal areas of the conjunctiva [61]. Those cells display many 
features that are consistent with the epithelial SC phenotype including slow cycling, 
clonogenic capacity, and resistance to phorbol-induced differentiation [61].  
Heat shock protein (Hsp) 70. The Hsp70 belongs to a protein family that assists a wide range 
of folding processes, including protein folding and assembly of newly synthesized proteins 
and refolding of misfolded and aggregated proteins [123]. Besides their important role in the 
cell’s machinery for protein folding, Hsp70 is known to aid to protect cells from thermal and 
oxidative stress [124, 125]. Hsp70 also inhibits apoptosis [126]. Because of their role in 
protecting cell against harmful metabolites, Hsps have been used as markers for SCs (an 
extensive review can be found at Fan et al. [127]). Interestingly, its expression was found 
higher in the inferior forniceal and medial canthal areas of the conjunctiva [61], which are 
believed to be the preferred location for the human conjunctival SC [61, 82]. 
KRT15. Initially proposed as a marker for hair follicle progenitor cells [128], it was recently 
proposed as a potential marker for progenitor conjunctival ECs [129]. Two studies revealed 
that KRT15 is expressed in the basal layers of the limbal and conjunctival epithelia but absent 
in the corneal epithelium [108, 129]. One in vitro study has shown that KRT15 is not 
expressed only by conjunctival epithelial progenitor cells, but more differentiated 
conjunctival cells may also express this protein, limiting their usefulness as a marker for 
progenitor cells [10].  
1.11. Differentiated epithelial cell markers  
The identification of a distinguishable marker that is expressed in the conjunctival epithelium 
but not in the corneal epithelium and vice-versa has been a growing need and is of crucial 
importance for the herein studies. Thereafter, the degree of cell plasticity in response to the 
extracellular cues will be based on the expression of such markers. Currently the two main 
markers to distinguish these two epithelia are the KRTs and the MUCs, as follows:  
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1.11.1. Keratins 
KRTs are a heterogeneous class of structurally related proteins that comprise the 
intermediate filament-forming system and, together with microfilaments and microtubules, 
are responsible for the structural integrity and function of ECs [130]. The KRT gene family 
consists of the highest number in humans with 54 distinct functional genes (37 encoding for 
epithelial KRTs and 17 for hair KRTs) [130]. Based on their isoelectric charge, they are divided 
into type I (acidic) and type two (basic or neutral) subfamilies [106]. The type I subfamily 
include KRT9 to KRT20 and the type II include KRT1 to KRT8. In vivo, the intermediate filament 
unit is made up of a type I KRT subunit that dimers with a type II KRT subunit to form specific 
pairs. Because of their different patterns of expression, KRTs have widely been used to 
distinguish the different populations of ECs from the ocular surface [131], Table 2.  
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Table 2 - The distribution of different keratins across the ocular surface epithelia adapted from 
[106-108, 131]. – negative, -/+ weak, + moderate, ++ strong labelling. 
Keratin Cornea Limbus Conjunctiva 
1 -/+ -/+ -/+ 
2 - - - 
3 + (basal) ++ (suprabasal and superficial) 
- (basal) -/+ (suprabasal 
and superficial) - 
4 -/+ (basal) + (suprabasal and superficial) 
- (basal) + (suprabasal 
and superficial) 
- (basal) + (suprabasal 
and superficial) 
5 + -/+ (basal) + (suprabasal and superficial) 
-/+ (basal) + (suprabasal 
and superficial) 
6 - (basal) -/+ (suprabasal and superficial) 
- (basal) -/+ (suprabasal 
and superficial) 
- (basal and suprabasal) 
-/+ (superficial) 
7 - - - (basal and suprabasal) -/+ (superficial) 
8 -/+ (basal) + (suprabasal and superficial) ++ 
-/+ (basal and 
suprabasal) + superficial 
9 - - - 
10 - - - 
12 All layers + peripheral (superficial)  - 
13 -  + peripheral (suprabasal and superficial) 
++ (suprabasal and 
superficial) 
14 
++ (basal and 
suprabasal) + 
(superficial) 
++ (basal) + (suprabasal 
and superficial) 
++ (basal) + (suprabasal 
and superficial) 
15 - 
+ (basal) -/+ 
(suprabasal) - 
(superficial) 
+ (basal) -/+ (suprabasal 
and superficial) 
16 
-/+ (basal and 
superficial) ++ 
(suprabasal) 
- (basal and superficial) 
-/+(suprabasal) 
- (basal and superficial) 
-/+suprabasal 
17 - - - 
18 + -/+ + (basal and suprabasal) -/+ (superficial) 
19 + (central and peripheral) 
+ (basal suprabasal) ++ 
(superficial) 
++ (basal and 
superficial) + 
(suprabasal) 
20 - - - 
1.11.2. Mucins  
MUCs are a heterogeneous group of highly glycosylated glycoproteins found in all mucous 
secretions on wet-surfaced epithelia. At the ocular surface they act as lubricants, stabilizers 
of the preocular tear film to prevent desiccation of the underlying epithelium, and as a 
barrier to pathogens [132]. 20 human MUC genes have been identified [133]. MUCs can be 
categorized into secreted or membrane-spanning. Secreted MUCs can be further sub-
classified as gel-forming (responsible for the rheological properties of the mucous) or soluble 
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[134]. In the epithelia of the ocular surface, the gel-forming MUC5AC is expressed in 
conjunctival goblet cells, Figure 9, and the membrane-spanning mucins MUC1 and MUC4 are 
primarily expressed by the stratified cells [132]. The limbal and corneal epithelia express 
transmembrane-type MUC1. MUC4 is also present at the peripheral corneal and limbal 
epithelia (at lower levels when compared to conjunctival epithelium). MUC16 (another 
membrane-associated mucin) has also been shown to be present on human stratified cells 
of corneal and conjunctival epithelium [135]. Human lacrimal gland has also been suggested 
as other sources of soluble mucins (MUC7). In the healthy tear film, membrane-spanning 
mucins provide a negatively charged, hydrated EC surface, which supports the spreading of 
the hydrated tear film [132]. 
Figure 9 - Schematic illustration of a goblet cell.  The goblet cells are highly polarized cells with 
organelles mainly located at the base of the cells. The remaining cytoplasm is occupied by secretory 
vesicles which contain the mucins. The microvilli increase the surface area for secretion. Adapted from 
[136]. 
1.11.3. Markers for differentiated corneal epithelial cells 
KRT3/12. Schermer et al. were the first to propose that the “acidic 55KDa (KRT3) and basic 
64KDa (KRT12) keratins represent markers for an advanced stage of corneal epithelial 
differentiation” [107]. KRT3/12 is the most widely accepted dimer marker for corneal ECs 
with countless studies showing its presence in all layers of the corneal epithelium and the 
Microvilli 
Rough Endoplasmic Reticulum  
Secretory Vesicles 
Mitochondria 
Golgi Apparatus 
Nucleus 
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suprabasal layers of the limbus, but not in the conjunctival epithelium. These include 
microarrays, qRT-PCR and immunocytochemistry studies [106-108].  
Missense mutations within KRT12 gene, one of the causes for Meesmann epithelial corneal 
dystrophy [137, 138], led to a significant increase in expression of KRT4 and KRT13 (amongst 
others) [139], two suggested markers for conjunctival ECs (see section below). These 
observations may be interpreted as a loss of corneal phenotype associated with the gain of 
other epithelial-like phenotypes, including conjunctival-like.  
Besides the KRT3/12 dimer, other proteins have been used to identify cells present only in 
basal cornea but not in basal limbal epithelium. These include nerve growth factor receptor 
(p75NTR) [54], involucrin [54], the gap junction protein connexin 43 [54, 56], the cell-cell 
adhesion protein E-cadherin [54], and the type IV intermediate filament nestin [56]. Because 
of their expression pattern, these markers are commonly used as negative markers for the 
presence of limbal SCs [54, 56, 75, 140]. 
1.11.4. Markers for differentiated conjunctival epithelial cells 
Whilst it is commonly regarded that KRT3/12 dimer is the most widely accepted marker for 
corneal ECs, a specific marker for conjunctival ECs is still not established with confounding 
results arising from different investigations. KRT19 was firstly proposed by Donisi et al. [141] 
as a specific marker for conjunctival ECs, however, others have found its expression also in 
corneal ECs [129, 142, 143]. Amongst all the candidates, KRT4/13 dimer has been shown to 
be the more specific for conjunctival ECs [10, 106, 144].  
KRT4. KRT4 has been shown to be expressed in all the epithelial layers in conjunctival mice 
however, its expression in the basal layers is reported as weaker and more focal. Moreover, 
KRT4 expression has also been detected in the superficial layers of the mouse and rabbit 
corneal epithelium [145, 146]. In vitro studies have also shown that both human adult 
conjunctival and corneal ECs express KRT4 in the suprabasal and superficial cells, but few 
KRT4-positive cells are observed in the basal layer [108]. 
KRT7. KRT7 pairs with KRT19 and its expression is characteristic of glandular epithelia [147]. 
Its expression has been found in goblet cells from human conjunctiva and trachea, but not 
in the mucosa of the intestinal tract nor in the stratified epithelia of the skin [147]. This may 
suggest that goblet cells from conjunctival epithelium are related more closely to those 
present in the respiratory epithelium than those present in the intestine [148, 149]. Its 
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expression has been shown to be highly specific of conjunctival differentiation, being positive 
in all the tissues derived from 12 eyes evaluated in one study [150].  
KRT13 and KRT19. Ramirez-Miranda et al. have shown that KRT13 and KRT19 transcript 
expression is significantly upregulated in the human conjunctiva in comparison to the human 
cornea [106]. Using immunostaining they found a complete absence of KRT13-positive cells 
in the cornea, with their expression being only detected in the suprabasal limbal epithelium 
and in all layers of the conjunctival epithelium [106]. KRT19 is reported to be present at 
substantial levels in the peripheral corneal epithelium, and in all layers of the conjunctiva 
epithelium and limbus (either at transcript and protein expression levels) [54, 106, 129, 142]. 
None of the KRT12-positive cells in the central cornea were found to express KRT13. Limbal 
ECs expressed either KRT12 or KRT13 with KRT12 and KRT19 positive cells co-located 
throughout the limbus and the peripheral cornea [106]. These results suggest a higher 
specificity of KRT13 for differentiated conjunctival ECs than KRT19. The same conclusions 
have been made more recently by Poli et. al [150].  
MUC1 and MUC5AC. Both MUC1 and MUC5AC have been postulated as being markers for 
conjunctival ECs and/or goblet cells. The exclusivity of MUC1 to conjunctival ECs is debated 
with some proposing it as a conjunctival epithelial specific marker [143] and others showing 
its expression throughout the entire ocular surface [151, 152]. MUC5AC, on the other hand, 
has long been postulated as being specific to the conjunctival goblet cells [153]. Although 
not detected in the ECs of the conjunctiva, it is the best surrogate marker for the presence 
of conjunctival epithelium by identifying its interspaced goblet cells.  
1.12. Limbal stem cell deficiency  
The loss or dysfunction of LSCs results in a condition known as limbal stem cell deficiency 
(LSCD). The imbalance of corneal-conjunctival homeostasis leads frequently to a process of 
re-epithelisation of the corneal surface by the conjunctival epithelial cells, a process called 
conjunctivalisation [154]. The cornea becomes covered by conjunctival epithelium and in 
more severe cases by the conjunctival substantia propria [155], Figure 10. This is 
accompanied by chronic inflammation, corneal scarring, vascularisation [156], resulting in 
vision loss and severe discomfort [157].  
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Various causes and diseases, grouped into inherited or acquired, can lead to LSCD, Table 3. 
This condition can affect the corneal epithelium to various degrees depending on the extent 
of limbal involvement [158, 159]. The case where only a portion of the limbus and cornea is 
defective and possibly covered by conjunctival epithelium it is known as partial or focal LSCD. 
When the whole circumference of the limbus and corneal epithelium is affected it is known 
as total or diffuse LSCD [155].  
Table 3 – Main ethiologies and pathological conditions for inherited and acquired limbal stem cell 
deficiency. 
Heritable Acquired 
Hereditary Injury Iatrogenic Inflammatory 
disease 
Aniridia Mechanical trauma Extensive limbal 
surgery 
Stevens-Johnson 
syndrome 
 Chemical or thermal 
burns 
Therapeutic 
radiation 
Cicatricial 
pemphigoid 
  Cytotoxic agents  
  
Impression cytology of the corneal surface may support a clinical diagnosis of LSCD [141, 160, 
161]. In this technique, a cellulose acetate filter is pressed onto the corneal surface under 
topical anaesthesia. The loose superficial corneal ECs are removed and subjected to 
histological and immunohistological analysis [160]. Healthy corneal epithelium is devoid of 
goblet cells and its differentiated cells lack KRT19, unlike those from the conjunctiva 
epithelium. Thus, the presence of goblet cells or KRT19 on impressions of the central cornea 
are indicators of conjunctivalisation, which may represent LSCD [161]. Although the presence 
of goblet cells is suggestive of LSCD, their absence does not exclude LSCD as one third of the 
Figure 10 - Clinical image of a patient with limbal stem cell deficiency. The cornea loses its clarity, 
becoming covered by conjunctival epithelium and blood vessels. 
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patients with clinical diagnosis of LSCD were not found to have goblet cells in their cornea 
[162].  
In vivo confocal microscopy, has emerged as a promising tool for LSCD diagnosis [79]. This 
technique does not require the removal of corneal ECs but requires physical contact between 
the imaging probe and the ocular surface. This technique can distinguish the bright well-
defined membrane corneal ECs from the hyper-reflective conjunctival ECs and goblet cells 
[79]. 
Mann and Pullinger [163] and later Friedenwald et al. [164] were the first to show that 
conjunctival ECs can migrate into the corneal region upon limbal injury. Later on, studies 
showed that the migrating cells can acquire an incomplete corneal-like phenotype being 
trapped in an incomplete metaplastic transition (later designated conjunctival 
transdifferentiation) between corneal and conjunctival type [165]. More recently, others 
have supported this hypothesis, showing that the migrating conjunctival cells differ from the 
normal corneal epithelium in glycogen metabolism and protein profiling [166-169]. Kurpakus 
et al. have suggested that conjunctival transdifferentiation is a result of environmental 
modulation, with the corneal BM playing a key role in such a process [170]. The 
environmental modulation of the corneal BM in the process of conjunctival 
transdifferentiation may have been ruled out in most of the previous studies as a total 
debridement of corneal epithelium and/or stroma may have occurred as a consequence of 
the mechanical or chemical corneal debridement prior the migration of conjunctival 
epithelium. The studies in this thesis will surpass this issue by recreating conjunctival or 
cornea microenvironments in vitro. Numerous studies have already addressed the 
importance of external cues, particularly ECM proteins, in cell fate modulation and 
differentiation utilizing a wide variety of cell types, including ECs from ocular surface [171-
175], epidermal ECs [176], and endometrial ECs [177]. Very well documented observations 
also arise from SC differentiation in response to specific ECM proteins, where SC of various 
origins are driven into corneal epithelial-like cells upon culture on collagen type IV [178] or 
laminin-5 [179] and supplemented with limbal fibroblasts conditioned medium. However, 
the process of conjunctival transdifferentiation in response to extracellular cues has never 
been studied in in vitro culture systems. The studies in this thesis examined the plasticity of 
corneal and conjunctival ECs in response to various extracellular cues. To be able to do so, a 
panel of established markers to distinguish each cell type is required. Therefore, KRT3 and 
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KRT12 were used as markers for corneal ECs, KRT7 and KRT13 as markers for conjunctival 
ECs, and ΔNp63 and ABCB5 as putative markers for epithelial SCs. 
1.12.1. Management of limbal stem cell deficiency  
Four main approaches can be used for LSCD treatment: (i) non-surgical approaches [157, 
180-182], (ii) whole tissue transplantation grafts [89, 183, 184], (iii) cell-based therapy [157, 
185-187], and (iv) non-cultured cell based therapy [188, 189]. 
i. Non-surgical approaches. Non-operative or more conservative approaches have been 
used to treat milder cases of LCSD. These include intensive lubrication of the ocular 
surface to aid healing and reduce the discomfort from persistent epithelial defects [181], 
contact lenses to provide symptomatic relief from the epithelial irregularity [180], and 
antibiotic eye drops to prevent infections of the corneal surface in cases of epithelial 
failure [182].  
ii. Whole tissue transplantation. Kenyon and Tseng were the first to propose the treatment 
of LSCD with healthy limbal tissue grafts [89]. They showed that limbal epithelial autograft 
from the healthy other eye of a patient could be used to treat unilateral LSCD with 
success. In cases of bilateral LSCD, the other eye cannot be used as a source of LSCs. 
Limbal epithelial allografts from a healthy matched living related or cadaveric donors have 
therefore been used with additional use of potent immune-suppression [183]. The main 
disadvantage of limbal epithelial grafting is the sizeable amount of healthy tissue required 
for the procedure. Animal studies have shown that the removal of large amounts of limbal 
epithelium from healthy eyes creates a considerable risk of LSCD in those eyes [184].  
iii. Cell-based therapy. This approach is based on in vitro expansion of limbal ECs as firstly 
reported by Pellegrini et al. [185]. In this therapy a small biopsy of healthy human limbal 
epithelium from the patient’s other eye (if healthy), a living related donor’s eye, or a 
cadaveric tissue is harvested and expanded ex vivo (12-19 days) to form epithelial sheets. 
These epithelial constructs have successfully been used to restore the corneal epithelium 
of patients suffering LSCD [185]. The culture of limbal epithelium, and more importantly 
the LSCs, can be performed using co-culture with inactivated 3T3 mouse fibroblasts [185], 
AM alone [189, 190], or a combination of these two methods [191]. These methods 
enable the reconstruction of the ocular surface from a small biopsy of the donor eye 
minimizing the risk of SC failure in the healthy eye. However, the associated costs of a SC 
laboratory increase the price of this transplantation to €12000. Several studies have 
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addressed the success rate of ex vivo expansion of LSC all pointing to a success rate 
varying from around 75% to 100% [157, 186]. However, the follow-up time of the current 
clinical studies is usually less than one year and, as suggested by Sangwan et al., all the 
failures occurred within 20 months which may raise the need to extend the follow-up 
times [187]. The mechanisms by which the transplanted cells restore the ocular surface 
are still unknown. However, two main possibilities have been postulated: the 
transplanted LSC (i) replace the lost SCs or (ii) revitalize the dormant SCs [79]. Other 
sources of ECs have been used with varying rates of success. These include mucosal ECs 
[192], ESCs [193], bone-marrow-derived mesenchymal SCs [194, 195], and of bigger 
relevance for this study conjunctival ECs [196-198].  
iv. Non-cultured cell-based therapy. A recent technique created by Sangwan et al. named 
Simple Limbal Epithelial Transplantation (SLET) has been shown to effectively treat 
unilateral LSCD in six human patients, with visual acuity improved from worse than 
20/200 in all recipient eyes to 20/60, or even better in four eyes [188]. This method 
involves: (i) the removal of the fibrovascular tissue from the diseased cornea, (ii) the 
harvest of a biopsy of the limbal tissue from the contralateral eye, and (iii) the cutting of 
this biopsy in smaller pieces and their placement on amniotic membrane (AM) around 
the centre of the cornea. AM has long been used as a surrogate niche for LSC [189]. This 
substrate promotes epithelial healing, has low immunogenicity, anti-inflammatory, anti-
angiogenic, and anti-scarring properties [199]. It also produces various growth factors, 
which have been shown to promote corneal epithelial wound healing. As there is no need 
for laboratory cell expansion, the SLET costs and time are reduced. In some severe cases 
of partial LSCD the above-mentioned approach may not be sufficient, and it is necessary 
to pursue with treatment options reserved for total LSCD. 
v. Potential new approaches. Based on the relatively low efficiency of the aforementioned 
approaches [157, 186, 188], on the plasticity of conjunctival cells to differentiate into 
cornea epithelial-like cells [29, 30], and in the rationale that cells can respond to the 
extracellular cues [171-175], the studies in this thesis will assess a new method for 
conjunctival transdifferentiation based on cell response to extracellular cues (ECM 
proteins on Chapter 2 and 3 and extracellular vesicles on Chapter 4). This approach would 
lead to the implementation of a culture system to promote conjunctival differentiation 
into cornea epithelial-like cells that would have clinical potential. Additionally, bilateral 
cases of LSCD require the identification of alternative SC sources, other than autologous 
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limbal epithelium, for treatment. For this reason, the differentiation potential of human 
ESCs towards the conjunctival and corneal epithelial lineage was also investigated 
(Chapter 2). 
1.13. Hypothesis 
“The plasticity of the human ocular epithelial cells is modulated by extracellular cues” 
1.14. Aims and objectives 
The main aim of this work was to modulate the plasticity of ECs from human cornea and 
conjunctiva using extracellular cues. To achieve this, this thesis is broken down into 4 specific 
objectives: 
i. To determine if the differentation of human ECs from the conjunctiva and cornea can 
be modulated in response to ECM cues in vitro. This was investigated in both established 
human conjunctival and corneal EC lines and primary cells, by culturing cells on ECM 
proteins previously deposited by alternative ECs. This is of importance due to its clinical 
significance. The studies in Chapter 2 investigate this aim.  
ii. To investigate the differentiation of human ESCs towards the conjunctival and corneal 
epithelial-like lineage. hESCs were cultured on ECM proteins deposited by ECs to 
promote their differentiation towards conjunctiva epithelial-like or corneal epithelial-like 
cells. The studies in Chapter 2 also investigate this aim. 
iii. To assess the composition of the ECM that modulates the differentiation of the ECs from 
the human ocular surface. This was investigated by analysing the differences in ECM 
composition produced by the two different cell lines (conjunctival and corneal ECs). The 
studies in Chapter 3 investigate this aim. 
a. To identify the role played by several laminin isoforms in the modulation of cell 
differentiation. This was achieved by culturing ECs on surfaces coated with all the 
commercially available human recombinant laminins. 
b. To identify which signalling pathways are activated in response to the process of 
cell differentiation. This was achieved by analysing the phosphorylation and 
  Chapter 1 - Introduction 
32 
 
cleavage levels of 18 proteins known to play a role on cell differentation and/or 
growth.  
iv. To determine if the differentiation of human ECs from the conjunctiva and cornea can 
be modulated in response to extracellular vesicles in vitro. Exosomes extracted from the 
above-mentioned cells lines were used to cross-modulate the differentiation of the two 
cell lines. The studies in Chapter 4 investigate this aim. 
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Chapter 2  
Specific decellularized ECM promotes the plasticity of human ocular 
epithelial cells  
2.1 Introduction 
2.1.1. Cellular reprogramming 
Since development is mainly dictated by genetic and epigenetic events, the process of cell 
differentiation is, in principle, reversible. Two main events in the history of genetics have 
confirmed this hypothesis. Firstly, the concept of nuclear transfer. Nuclear transfer is a two-
step approach that requires the nuclei withdrawn from an egg cell and replacing it with a 
nucleus from an older donor cell [200] that induces the change in the gene expression 
pattern to that of an embryo state in response to the factors present in the transfected cell 
[201]. These studies demonstrated the feasibility of somatic nuclear reprogramming, 
although with low efficiency and better results by using nuclei from less differentiated cells, 
suggesting the involvement of epigenetic modifications [202]. Secondly, four transcription 
factors (Oct4, Sox2, Klf4, and c-myc) were shown to reprogram mouse fibroblasts into 
pluripotent SCs, the so-called induced pluripotent SCs (iPS) [203].  
Three different approaches to address the process of cell reprogramming have been raised: 
i. Transdifferentiation. The differentiated cells first dedifferentiate into an intermediate 
state with limited potency, prior re-differentiation into the second cell type [204], Figure 
11A. 
ii. Direct reprogramming. In this approach the differentiated cells directly differentiate from 
one cell type to another with no intermediate state of cell de-differentiation [205, 206], 
Figure 11B.  
iii. iPS technology. In this approach a mature adult cell is reprogrammed to became 
pluripotent [203]. 
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2.1.1.1. Transdifferentiation  
The irreversible switch mechanism from one differentiated cell into another is called 
transdifferentiation [207]. The term “transdifferentiation” was first used by Selman and 
Kafatos to describe the conversion of cuticle-producing cells into salt-secreting cells, using 
the silk moth during metamorphosis from the larval to the adult moth [208]. In the eye it was 
firstly reported by Wolff upon the finding that dorsal iris pigmented ECs transdifferentiated 
into crystalline lens during the regeneration of the crystalline lens cells of newts [209]. The 
first successful studies of ex vivo transdifferentiation were reported by Taylor and Jones in 
1979. By inhibiting DNA methylation using 5-azacytidine, they converted cultured fibroblast 
cell lines into myocytes, chondrocytes, and adipocytes, suggesting a transdifferentiation 
under epigenetic control [210]. One decade later a transcription factor, called MyoD, was 
identified by its ability in transforming cultured fibroblasts into myoblasts by activating 
muscle-specific genes [211]. Dedifferentiation and cell division are intermediate processes 
in the switch in phenotype, but not obligatory in all cases [212]. At molecular levels, the cause 
of transdifferentiation has been associated with a change in the expression of a master 
switch gene, whose normal function is to distinguish the two cell types in normal 
development. Almost all studies on transdifferentiation required in vitro cell culture 
approaches prior to the transplantation of the transdifferentiated cells into the body. More 
recently, in situ induced transdifferentiation has shown promising results with cells within 
the tissue driven to transdifferentiate into the desired target cells [213-216]. Other instances 
Ancestor 
Intermediate  
cell type Descendant 
Dedifferentiation  
+ cell division 
A 
B 
Figure 11 - Modes of cell reprogramming. Cell reprogramming can occur via two main mechanisms: 
(A) by requiring cell division and dedifferentiation as intermediate steps prior full re-differentiation 
into a different phenotype, a mechanism called transdifferentiation, (e.g. conversion of pigmented 
epithelial cells of the dorsal iris to lens fibers) or (B) alternatively it can occur without the requirement 
for cell division and dedifferentiation as intermediate steps, a process named direct reprogramming 
(e.g. conversion of pancreatic AR42J-B13 cells into hepatocytes).  
  Chapter 2 
35 
 
of transdifferentiation that involve the intermediate process of cell dedifferentiation include 
the conversion of pancreatic cells to hepatocytes [217] and vascular endothelium to smooth 
muscle [218].  
2.1.1.2. Direct reprogramming  
Direct reprogramming is generally accomplished through forced expression of lineage-
specific transcription factors. These have been used successfully in reprogramming 
fibroblasts into various cell types in vitro, including skeletal muscle cells [211], hepatocytes 
[219], neurons [220], pancreatic islet cells [213], endothelial cells [221], smooth muscle cells 
[222], and cardiac muscle [223]. This technique is conceptually attractive as it does not 
require the reversion into a pluripotent state prior differentiation, avoiding any risks of 
teratoma formation [213]. This process involves the activation of target genes, within hours 
to days [220], does not require cell division and it is stable after removal of reprogramming 
factors [213, 219]. Direct reprogramming occurs at varying efficiency, however it is usually 
low and requires high expression of reprogramming factors [202]. Another drawback of this 
process is the epigenetic memory, also well documented in iPS cells [224, 225]. Despite 
induction of gene expression to another cell type, frequently some residual gene expression 
specific to the original cell type persists [226, 227]. The cell reprogramming works better 
when the progenitor and descendant cells share similar embryogenic germ layer origins. The 
mechanisms of direct reprogramming are poorly understood. While it is well established that 
transcription factors are the driving force with the contribution of microRNAs, it is less clear 
how cells maintain their descendant lineage. Direct reprogramming of patient-derived cells 
would facilitate the generation of clinically relevant cell therapies for regenerative medicine. 
2.1.1.3. Metaplasia  
Metaplasia is a wider class of cell transformation, which includes transdifferentiation and 
cases in which cells switch to a completely different cell type [228]. The term metaplasia was 
coined by Slack to describe anatomical and histological observations of unexpected 
appearance of foreign tissues in ectopic sites [229]. In some cases, metaplasia may be due 
to the presence of minor cell types within the given tissue, whose damage or regeneration 
triggers their outgrowth [230]. In human beings, one of the best studied examples of 
metaplasia is Barrett’s metaplasia of the oesophagus. In this disease, the continuous damage 
due to reflux of the acid contents of the stomach causes the lower end of oesophagus, 
composed by stratified squamous epithelium, to become intestinal-type tissue. 
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2.1.1.4. Plasticity  
The term plasticity has been suggested as an alternative to transdifferentiation and 
metaplasia. However, others have postulated that this new term is particularly applied to 
examples involving nuclear reprogramming [231]. One of the best studied cases of plasticity 
is the ectoderm to mesoderm lineage switch during tail regeneration of the axolotl upon 
injury [232]. Echeverri and Tanaka followed individual spinal cords during tail regeneration 
in the axolotl showing that they can generate muscle cells, chondrocytes and neurons, 
suggesting a switch in cell lineage in response to foreign environments [232]. 
2.1.2. Conjunctival transdifferentiation - early studies 
Based on the notion that conjunctival epithelium can differentiate into a cornea epithelial-
like phenotype by a process of transdifferentiation [233, 234], it was hypothesized that 
conjunctival epithelial grafts could be used as an approach to treat LSCD [235, 236]. However, 
it was later shown that conjunctival epithelial grafts are largely ineffective for the treatment 
of LSCD as the transdifferentiation to corneal epithelium appears to be incomplete [237]. 
The process of conjunctival transdifferentiation was first described by Mann and Pullinger 
[163] and Friedenwald [238]. By scraping off the corneal epithelium of six rabbits, 
Friedenwald showed a complete coverage of the corneal defect after 5-7 days. The 
appearance of the animals’ eyes was entirely normal up to 2-3 weeks after injury, when the 
eyes acquire a roughened and more opaque appearance (conjunctiva-like) with the presence 
of typical goblet configuration cells. Four to five weeks after the abrasion, the corneal 
epithelium begins to assume a more normal appearance with still the persistence of some 
mucin-producing cells. Of significance is the presence of glycogen in the goblet cells’ 
cytoplasm (goblet cells cytoplasm lacks glycogen), which suggests that the cells are trapped 
in the “process of metaplastic transition between corneal and conjunctival type of 
morphology and metabolism” [238]. Additionally, several reports have later shown that the 
resultant epithelium after conjunctival transdifferentiation differs from the normal corneal 
epithelium in glycogen metabolism [166], keratin profiling [167], general protein profile 
[168] and tensile strength [169], suggesting that the transdifferentiated epithelium is not a 
genuine corneal epithelium. 
It has been suggested, in rabbits, that the retardation of conjunctival transdifferentiation 
into corneal epithelium-like is correlated with the corneal vascularization [239, 240]. 
Friedenwald observed that the conjunctival epithelium, which migrated onto the cornea 
after corneal abrasion, persisted in regions of superficial corneal vascularization and scar. 
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This was in contrast with the nearly complete process of conjunctival transdifferentiation 
observed in eyes with no signs of corneal vascularization or scar [238]. Kruse et al. explained 
this duality on corneal healing process based on the extent of limbal epithelium 
debridement: complete debridement would lead to corneal vascularization and 
conjunctivalisation and incomplete debridement (less than one third of the limbus [184]) 
would lead to non-vascularized corneas and conjunctival transdifferentiation [29]. Others 
have suggested that the limbus exerts an inhibitory growth pressure to prevent the migration 
of conjunctival ECs onto the cornea [234]. Tseng et al. showed, in rabbits whose corneas and 
limbus were totally removed, a rapid decline in goblet cell density accompanied by a 
complete transdifferentiation in non-vascularized corneas after 43 days of re-
epithelialisation by conjunctival epithelium. On the other hand, vascularized corneas 
maintained high levels of goblet cell density and an epithelium that possesses conjunctival 
features until day 167 [239]. This evidence supports the theory that corneal vascularization 
may be a causative factor in modulating conjunctival transdifferentiation, inhibiting or 
reversing this process. Some authors have speculated that the persistence of goblet cells may 
be supported by factors from the blood circulation, namely vitamin A or other retinoids 
[241]. Others have shown that the goblet cells do not migrate onto the cornea, being instead 
formed de novo from non-goblet ECs. Loss of goblet cells during transdifferentiation occurs 
by desquamation and in situ cell death [242]. 
Dua has shown on a group of ten patients with various eye diseases that even after several 
months, the corneal surface covered by conjunctival cells remained relatively thin and 
irregular with no evidences of transdifferentiation [243]. Interestingly and supported by 
other studies [159], buds of corneal epithelium were detected protruding into the migrating 
conjunctival epithelium, all along the contact line between the two epithelial phenotypes 
[243]. These findings suggest that the healthy corneal epithelium may replace the 
conjunctival epithelium, with incomplete conjunctival transdifferentiation. These authors 
recommended that in cases with partial damage to the limbal epithelium accompanied by 
cornea conjunctivalisation, the conjunctival epithelium could be removed. This can be 
achieved by mechanically scrapping the migrating conjunctival epithelial until the migrating 
sheets of limbal epithelium have met, re-establishing the limbal barrier. In more severe cases 
limbal transplants or keratoepithelioplasty are needed [159]. 
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2.1.3. Inhibitors of conjunctival transdifferentiation  
A possible candidate for inhibiting conjunctival transdifferentiation, by maintaining the 
presence of goblet cells, is retinoid (including vitamin A). Retinoids are lipid-soluble vitamins 
present primarily in serum and epithelial tissues, which contain higher concentrations of 
retinol-binding proteins. They are essential for epithelial growth and differentiation [244]. 
The scleral and the conjunctival blood vessels are the major source of vitamin A in healthy 
corneas [245-247], providing ten times more than tears [248] and lacrimal gland fluid [249]. 
Deficiency of vitamin A either in vitro or in vivo causes keratinization of mucous membranes, 
and vitamin A in excess inhibits keratinization of epithelium and induces mucous metaplasia 
[244, 250]. Using rabbits as models, Tseng et al. showed maintenance of the conjunctiva-like 
epithelium (containing goblet cells) either in vascularized or non-vascularized corneas upon 
applying topically two different retinoids (13-cis retinoic acid and etretinate). These 
observations suggest the retinoids as one of the factors that inhibit conjunctival 
transdifferentiation maintaining goblet cell differentiation and controlling mucin expression, 
and conversely transdifferentiation can be induced in vascularised corneas by systemic 
vitamin A deficiency [241].  
2.1.4. Conjunctival transdifferentiation - later studies 
Recent studies have shown that the process of conjunctival transdifferentiation is 
incomplete. Moyer et al. showed that, after total corneal epithelium debridement, the 
regenerated epithelium of conjunctival origin does not express the corneal EC marker KRT12. 
However, in other milder corneal defects, when areas of LSCs are preserved, the expression 
of KRT12 is also preserved [251]. Other studies have shown that conjunctival 
transdifferentiation is a result of environmental modulation, where the presence or absence 
of the corneal BM might play a key role in determining the cell’s fate [170]. Kurpakus et al. 
showed that conjunctival ECs cultured on top of intact corneal epithelial BM expressed 
KRT12 [170], suggesting a cell’s fate modulation in response to the extracellular 
environment. 
2.1.5. Microenvironment signalling cues in cells’ fate modulation 
Within the microenvironment, the ECM assumes to be the major support structure for the 
cells, providing dynamic signalling cues. Besides the support function, it also sequesters 
growth factors and other cytokines that can be released in response to a physiological 
alteration. In response to the ECM factors, the cells activate their biochemical and/or 
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mechanotransduction pathways that modulate their growth, survival, proliferation, 
migration, and differentiation [252]. Several studies have taken advantage of this to produce 
different types of matrices to modulate cell fate. These include the development of an 
acellular corneal matrix [171] to be used as a scaffold to induce the differentiation of 
mesenchymal SCs (MSCs) into cornea epithelial-like cells, which purely because of its physical 
and mechanical characteristics drive MSCs to express corneal epithelial markers KRT3 and 
KRT12 [253]. Others have differentiated amniotic ECs into conjunctiva epithelial-like cells 
(expressing KRT4 and KRT13) upon culture in decellularized conjunctival matrices [172]. 
Remarkably, Ang et. al have shown that AM sheets populated with human conjunctival ECs 
and transplanted into rabbit eyes with total LSCD have similar features to corneal epithelial 
tissues (including KRT3- and KRT12-positive events), suggesting these outcomes as possible 
clinical substitutes to corneal epithelial grafts [254]. 
Functionalized surfaces with major components of ECM, such as fibronectin, collagen, and 
laminins, are shown to either modulate ESCs to maintain their pluripotency or to 
differentiate into specific cell lineages [178, 255, 256]. The mechanism by which ECM 
modulates cell differentiation is attributed to integrins-cell cross-talk. Integrins are cell 
surface receptors that transduce a cascade of signals from the exterior to the intracellular 
space. When integrins bind to their ECM ligands they undergo conformational changes in 
both their extra and intracellular domains, which followed by the accumulation of 
cytoplasmic molecules and other adaptor proteins activates the downstream signalling 
pathways modulating their behaviour [257]. In addition to adhesion receptors, soluble 
growth factors can also bind to the ECM, which regulates their presentation, distribution, 
and activation.  
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2.1.6. Embryonic stem cells 
ESCs are pluripotent SCs derived from the ICM of the blastocyst, Figure 12. The ICM of 
developing embryos gives rise to all three germ layers of the embryo itself: the endoderm, 
mesoderm, and ectoderm. Isolation and culture of the ICM, after physical separation of the 
rest of the embryo (particularly the trophectoderm), results in the formation of ESCs. 
Thomson et al. in 1998 first derived human ESCs (hESCs) using discarded in vitro fertilisation 
embryos [32].  
Undifferentiated ESCs possess intrinsic properties which distinguish them from more 
differentiated cells, as follows: 
i. Pluripotency genes. Undifferentiated ESCs are known to express both the homeobox-
containing transcription factor, Nanog [258, 259], and the POU domain class 5 
transcription factor 1, POU5F1 (also known as octamer-binding transcription factor 4 
(Oct4)) [260].  
ii. Cell surface markers. The stage specific embryonic antigens (SSEA) 3 and 4 are glycolipids 
known to be expressed during the early stages of embryonic development and are down-
regulated during hESCs differentiation [261, 262]. The tumour rejection antigens (TRAs) 
160 and 181 are keratin sulphate associated antigens expressed by undifferentiated ESCs 
[261, 262]. 
iii. Teratoma formation. The pluripotency of ESCs can be confirmed by their injection into 
mice with severe combined immunodeficiency. This results in the formation of teratomas 
with cells and tissues from all three germ layers [263, 264]. 
Inner cell mass 
Blastocoel 
Trophectoderm  
Figure 12 - The blastocyst. It consists of an outer trophoblast layer (named trophectoderm after 
blastulation), an inner cell mass and a fluid-filled cavity (blastocoel). 
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2.1.6.1. The differentiation of embryonic stem cells 
The predominant signalling pathways involved in pluripotency and self-renewal of hESC are 
transforming growth factor (TGF)-β, through SMAD2/3/4, and fibroblast growth factor 
receptor (FGFR), which activates the MAPK and AKT pathways [265]. The Wnt pathway is also 
known to promote ESC pluripotency, through a non-canonical mechanism that involves a 
balance between the transcriptional activator, TCF1, and the repressor, TCF3. The regulation 
of these pathways maintains the pluripotent state [265], which depends predominantly on 
three major transcription factors - OCT4, SOX2, and NANOG. These transcription factors 
activate expression of ESC-specific genes, regulate their own expression, repress genes 
involved in cell differentiation, and act as hESCs markers [266-269]. hESCs differentiation in 
vitro can be directed toward derivatives of the three primary germ layers [32]. The primary 
signalling pathway responsible for this is the BMP (bone morphogenetic proteins) pathway 
[270], through SMAD1/5/9 to promote differentiation by inhibiting the expression of NANOG 
and activating the expression of specific genes involved in differentiation [270, 271]. SMADs 
are intracellular proteins that transduce extracellular signals from TGF-β ligands to the 
nucleus activating downstream gene transcription [272-274]. The well conserved Notch 
signalling pathway also plays a role in differentiation through the Notch intracellular domain 
[275]. As the differentiation proceeds, lineage-specific pathways are activated.  
Because of their potential to generate cells from the whole body, several studies have 
attempted to differentiate ESCs, including hESCs, into specific cell types with certain degrees 
of success. These include ESC differentiation towards skin and corneal epithelial-like cells 
using various methods [178, 193]. All the stated approaches have a transversal similarity; the 
mimicry of the extracellular environment where these differentiated cells reside. Amongst 
these are: 
i. Culture on fibroblast-deposited ECM proteins. Undifferentiated mESCs cultured on top 
of ECM proteins derived from either human fibroblasts or 3T3 mouse fibroblasts 
differentiate into skin epithelial-like cells. Upon exposure to these ECMs, the 
differentiated mESCs expressed characteristic skin epithelial proteins KRT10 and KRT14 
and showed formation of HDs [276]. Addition of either ascorbate or BMP4 to the culture 
further improved the formation of skin epithelial-like cells from mESCs [276]. Continued 
culture of the differentiating cells resulted in full thickness skin formation, including 
epithelial and sub-epithelial structures [276]. 
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ii. Culture on replicated limbal SC niche environment. The SC niche refers to the specialized 
microenvironment where SCs reside, which interacts with SCs to regulate their fate [44] 
as in the case of the LSC niche [56]. Limbal fibroblast conditioned medium together with 
several proteins known to be part of the limbal SC niche have been used to induce 
differentiation of ESCs towards corneal-like ECs. These include fibronectin, human 
placental laminin, and collagen IV [178]. Further studies with collagen IV demonstrated 
considerable differentiation towards corneal-like ECs through a transient increase in the 
expression of the terminally differentiated corneal epithelial markers, KRT3 and KRT12, 
and a diminution in expression of the markers for ESCs, OCT4, NANOG, and SSEA4 [178]. 
Intriguingly, at the transcript level, after 18-21 days in culture, where KRT3 and 12 levels 
had returned to starting levels, increased expression of the suprabasal epithelial keratin, 
KRT10, was reported indicating incomplete differentiation [178]. The same studies 
showed highest CFE values at times when KRT3 and KRT12 protein expression was the 
highest, these are accompanied by high values of ΔNp63 expression after 7 days in 
culture. The expression of ΔNp63 then dropped significantly while CFE values are still 
high, suggesting incomplete differentiation [178].  
iii. Culture of embryoid bodies on replicated limbal SC niche environment. Embryoid 
bodies, probably the most common method used to differentiate ESCs [277], are 3 
dimensional aggregates of pluripotent SCs that can differentiate toward the three germ 
layers [278]. Homma et al. have used collagen IV coated dishes to differentiate mESCs 
derived embryoid bodies into corneal-like ECs, which expressed the terminally 
differentiated corneal EC marker KRT12 [193]. Moreover, the transplantation of such 8-
day old differentiation cultures onto the surface of cornea denuded of its epithelium 
results in the formation of an epithelium showing morphological similarities to corneal 
epithelium 24 hours post-transplant [193]. 
2.1.6.2. Embryonic stem cell markers 
In addition to the established markers used to identify adult epithelial SCs from the ocular 
surface, (addressed in section 1.9), it is of importance to discuss in detail markers used to 
identify undifferentiated hESCs. These include the following: 
i. POU5F1. POU5F1 is a mammalian POU transcription factor expressed exclusively in 
pluripotent early embryo cells, blastomeres (type of cell produced by division of the 
zygote after fertilization), and in later germ cells [260, 279]. In vivo it is abundantly found 
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in the ICM of the early blastocyst but not in the trophectoderm, whereas nascent 
primitive endoderm in late blastocyst express Pou5f1 at even higher levels [266]. It 
regulates expression of several other transcription factors present in pluripotent cells, 
including Sox2 [280] and the E1A-like protein activity [281]. In the developing embryo, 
down-regulation of Pou5f1 expression is correlated with the loss of potential to form cells 
from the three germ layers, suggesting that Pou5f1 is a determinant of the germ line 
[267]. Niwa et al. suggest Pou5f1 to be the master regulator of pluripotency whose 
precise level governs 3 different distinct fates of ECs [282]. They found that when its 
expression was less than two-fold increase it caused differentiation of ESCs into primitive 
endoderm and mesoderm. On the other hand, the decreased expression of Pou5f1 
induced loss of pluripotency and dedifferentiation of cells to trophectoderm [282]. Thus, 
a precise amount of Pou5f1 is required to sustain SC self-renewal. 
ii. SOX2 (SRY-related HMG box). SOX2 is a member of the Sox gene family that encodes 
transcription factors with a single HMG (high motility group) DNA-binding domain [283]. 
It is associated with uncommitted dividing stem and precursor cells of the developing 
central nervous system [268]. It is also a marker for pluripotent lineage of the early mouse 
embryo, and similarly to Oct4 it is expressed in the ICM, epiblast, and in cells from the 
germinal layers. Unlike Oct4, Sox2 is also expressed by the multipotent cells of the 
extraembryonic ectoderm and in cells with limited developmental potential it is absent 
[283]. 
iii. NANOG. NANOG is a DNA binding homeobox transcription factor involved in the 
proliferation, self-renewal, and pluripotency of ESCs. During their differentiation, it is 
suppressed by p53 protein [269]. It also blocks ESCs differentiation and auto-represses its 
own expression in differentiating cells [258]. 
2.1.7. Aim 
i. To evaluate if the differentiation of ECs from the human cornea and conjunctiva can be 
modulated in response to ECM cues in vitro. This was investigated in both established 
human corneal and conjunctival ECs lines and primary cells, by culturing those on the ECM 
proteins meshwork deposited by ECs. This is of importance due to the clinical relevance 
of plasticity and reversibility of corneal conjunctivalisation.  
ii. To investigate if hESCs can be differentiated towards conjunctival and corneal 
epithelial-like lineage in response to specific ECM proteins. hESCs were cultured on 
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decellularized ECM proteins deposited by either conjunctival or corneal ECs to promote 
their differentiation accordingly. 
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2.2 Materials and Methods 
2.2.1. Preparation of Media 
Conjunctival medium consisted of Keratinocyte Serum-free medium without CaCl2 (KSFM, 
Gibco ™ ThermoFisher Scientific, cat. Number 37010-022), supplemented with: 0.2% (V/V) 
Bovine Pituitary Extract (BPE), and 0.2ng/ml of epithelial growth factor (EGF) (all supplied 
with the medium), 1% (V/V) penicillin/streptomycin (P/S, Sigma-Aldrich, cat. Number P0781), 
and 0.4mM of CaCl2 (Sigma-Aldrich, cat. Number 21114).  
Corneal medium consisted of KSFM with CaCl2 (Gibco ™ ThermoFisher Scientific, cat. Number 
17005-042), supplemented with: 0.2% (V/V) BPE, 0.23ng/ml EGF (all supplied with the 
medium), and 0.06mM (0.13mM final concentration) of CaCl2.  
Freezing medium consisted of DMEM/F12 medium supplemented with: (%V/V) 20% of foetal 
calf serum (FCS, Gibco ™ ThermoFisher Scientific, cat. Number 26140-079) and 20% of 
dimethyl sulfoxide (DMSO, Sigma-Aldrich cat. Number D2650). 
Basic medium consisted of high-glucose Dulbecco’s Modified Eagle’s Medium (DMEM, cat. 
Number 5671) without pyruvate, supplemented with: (%V/V) 10% FCS, 1% P/S, 1% fungizone 
(cat. Number A2942), and 8mM ʟ-glutamine (cat. Number G7513) (all provided by Sigma-
Aldrich, unless otherwise specified). 
Supplemental hormonal epithelial medium (SHEM) was made up of three parts of low-
glucose DMEM with pyruvate (Gibco Life Technologies, cat number 21885-025) and one part 
of Ham’s F12 medium (cat. Number N6658) supplemented with: (%V/V) 10% FCS, 1% P/S, 
0.4µg/mL hydrocortisone (cat. Number H2270), 5µg/mL insulin (cat. Number I9278), 
1.4µg/mL tri-iodothyronine (cat. Number T5516), 24µg/mL adenine (cat. Number A9795), 
and 10ng/mL EGF (cat. Number E9644) (all provided by Sigma-Aldrich, unless otherwise 
specified). 
The mTeSR™1 5X supplement was thawed overnight at 4°C, aliquoted, and kept at -20°C for 
a maximum of two months. The mTeSR™1 5X supplement was diluted accordingly in 
mTeSR™1 medium (cat. Number 05850, all provided by STEMCELL Technologies) and kept at 
4°C for a maximum of two weeks. 
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2.2.2. Human conjunctival epithelial cell line (HCjE-Gi) 
2.2.2.1. HCjE-Gi cell line 
This cell line was obtained from primary cultures of conjunctival ECs derived from a 
conjunctival biopsy of an 82-year-old male. Prior immortalization by expression of 
telomerase reverse transcriptase (hTERT), abrogation of p16 and p53 functions was 
preformed [284]. Its differentiation characteristics can be found at Gipson et. al [152]. This 
cell line was kindly gifted by Ilene Gipson (Harvard Medical School, United States).  
2.2.2.2. Maintenance of HCjE-Gi cultures  
A frozen vial of HCjE-Gi cells was thawed by incubation in a water bath at 37˚C. The cell 
suspension was slowly mixed with conjunctival KSFM. The resulting suspension was 
centrifuged for 3 minutes at 1000 revolutions per minute (rpm). The supernatant was 
removed, and the resulting pellet re-suspended in 5mL of conjunctival KSFM. The cell 
suspension was then plated in a T-25cm2 tissue culture flask at a density of 25000 cells/cm2 
and maintained at 37˚C, 5%CO2 in a tissue culture incubator (In-VitroCell ES NU-5800 Direct 
Heat, NuAire, United States). The medium was changed the next day and then every other 
day. Upon 70-80% confluence, the medium was removed, and the culture flask washed once 
with phosphate buffered saline (PBS, Gibco™ Life Technologies, cat. Number 10010-015). 
1.5mL of 1X trypsin-ethylene diaminetatraacetic (EDTA, Sigma-Aldrich cat. Number T4174) 
diluted in PBS was added and the flask placed in tissue culture incubator for 5-7 minutes. The 
trypsin inactivation was achieved by the addition of conjunctival KSFM. The resulting solution 
was centrifuged for 3 minutes at 1000 rpm. The supernatant was removed, and the resulting 
pellet re-suspended in 10mL of conjunctival KSFM. The cells plated in T-75cm2 tissue culture 
flask at a density of 25000 cells/cm2 were maintained at 37˚C, 5% CO2 in tissue culture 
incubator and fed with fresh conjunctival KSFM every other day until further experiments. 
2.2.2.3. Maintenance of HCjE-Gi frozen stocks 
To maintain frozen stocks at each early passage, the cells were detached from the culture 
flasks by trypsin method as previously stated. After centrifugation, the supernatant was 
removed, and the resulting pellet re-suspended in equal volume of conjunctival KSFM and 
freezing medium. The resulting suspension was placed in a cryogenic vial (at density of 1x106 
cells per vial) and the vial was stored at -80°C for 90 minutes and then stored in liquid 
nitrogen. 
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2.2.3. Human corneal epithelial cell line (hTCEpi) 
2.2.3.1. hTCEpi cell line 
This cell line was obtained from primary culture of ECs harvested individually from 21 donor 
eyes (ages ranging from 26-67 years). All corneas were obtained from the Tissue Transplant 
Services Lions’ Eye Bank (Dallas, Texas) [285]. A stable clone from a 62-year-old white male 
was selected and immortalized by infection with hTERT. This cell line was kindly gifted by 
James Jester (University of Southern California, United States). 
2.2.3.2. Maintenance of hTCEpi cultures  
A frozen vial of hTCEpi cells was thawed by incubation in a water bath at 37˚C. The cell 
suspension was slowly mixed with corneal KSFM. The resulting suspension was treated as 
described previously, section 2.2.2.2. 
2.2.3.3. Maintenance of hTCEpi frozen stocks 
To maintain frozen stocks at each early passage, the cells were detached from the culture 
flasks by trypsin method as previously stated. After centrifugation, the supernatant was 
removed, and the resulting pellet re-suspended in corneal freezing medium consisting of 
corneal KSFM supplemented with 10% (V/V) DMSO. The resulting suspension was placed in 
a cryogenic vial (at density of 1x106 cells per vial) and the vial stored in liquid nitrogen. 
2.2.4. Mouse 3T3 fibroblasts cultures and preparation as feeder layers 
2.2.4.1. 3T3 J2 cell line 
3T3 cell line was firstly prepared from 17 to 19-day old Swiss mouse embryos. The whole 
embryo was minced and disaggregated using 0.25% trypsin. Upon confluence, the culture 
was put on a rigid transfer schedule (every 3 days). These cells were then plated at a density 
of 3*106 cells per plate [286]. 
2.2.4.2. Maintenance of mouse 3T3 fibroblasts cultures  
A frozen vial of mouse 3T3 J2 fibroblasts was thawed by incubation in a water bath at 37 ˚C. 
The cell suspension was slowly mixed with 1mL of basic medium. The resulting suspension 
was centrifuged for 3 minutes at 1000 rpm. The supernatant was removed, and the resulting 
pellet re-suspended in basic medium. The cell suspension was then plated in a T-25 cm2 
tissue culture flask and maintained at 37˚C, 5% CO2 in a tissue culture incubator. The medium 
was changed every other day. Upon 70-80% confluence, the medium was removed from the 
culture flask and the cultures washed once with PBS. 1.5mL of 1X trypsin-EDTA solution was 
added and the flask placed in tissue culture incubator for 5 minutes. The trypsin inactivation 
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was achieved by the addition of basic medium. The resulting solution was centrifuged for 3 
minutes at 1000 rpm. The supernatant was then removed, and the resulting pellet was re-
suspended in basic medium. The 3T3 fibroblasts were then plated in T-75 cm2 tissue culture 
flasks. The cells were maintained in a tissue culture incubator and fed with fresh basic 
medium every other day. 
2.2.4.3. Maintenance of mouse 3T3 fibroblasts frozen stocks 
To maintain frozen stocks at each early passage, the fibroblasts were detached from the 
culture flasks by trypsin method as previously stated. After the centrifugation step, the 
supernatant was removed, and the resulting pellet re-suspended in freezing medium 
consisting of basic medium supplemented with 5% (V/V) DMSO. The resulting suspension 
was placed in a cryogenic vial (1x106 cells per vial) and the vial was stored in liquid nitrogen. 
2.2.4.4. Preparation of mouse 3T3 fibroblasts feeder cells 
For this purpose, 3T3 fibroblasts cultures were maintained until confluence. Upon 
confluence, the cells were mitotically inactivated by incubation with 10µg/mL mitomycin C 
(Sigma-Aldrich, cat. Number M4287) in basic medium for 2 hours at 37˚C 5% CO2. The 
medium was then removed, and the culture washed thrice with PBS. The fibroblasts were 
detached from the culture flasks by trypsin method as previously described. After cell 
counting, 25000 cells/cm2 were seeded in tissue well plates in basic medium. The plates 
containing the inactivated cells were then placed back in the tissue incubator overnight.  
2.2.5. Human primary limbal epithelial cultures 
2.2.5.1. Suspension culture of human limbal epithelium  
Cadaveric limbal tissue, remaining after removal of the central cornea for transplantation 
purposes and composed of peripheral cornea and limbus, was obtained from The Liverpool 
Research Eye Bank. Complete information about the donor can be found in Table 4. The 
deeper layers of the limbal rings were dissected away, and the remaining limbal tissue 
containing limbal epithelium was cut into (roughly) 1mm2 pieces. The limbal pieces were 
incubated with 1X trypsin EDTA for 20 minutes in tissue culture incubator. The resulting cell 
suspension was removed and centrifuged for 5 minutes at 1000 rpm. The supernatant was 
removed, and the remaining cell pellet was re-suspended in SHEM medium. This 
trypsinization process was repeated four times using the same limbal tissue. The resulting 
limbal cell suspensions were then pooled together. The limbal ECs were added to tissue 
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culture well containing the previously mitotically inactivated 3T3 fibroblasts, Figure 13. This 
co-culture was placed in the incubator and the medium changed on the day after and then 
every other day.  
2.2.5.2. Sub-culturing 
The original primary cultures, prior to confluence of the colonies, were sub-cultured. The 
cells were detached using the trypsinization method as previously described. After the 
centrifugation step the supernatant was discarded and the resulting pellet re-suspended in 
KSFM corneal medium supplemented with 1% P/S. The subcultures were then treated as the 
already stated hTCEpi cultures. 
2.2.6. Human primary conjunctival epithelial cells 
2.2.6.1. Suspension culture of human conjunctival epithelium  
Cadaveric conjunctival tissue (bulbar and forniceal regions) was obtained from The Liverpool 
Research Eye Bank. Whenever possible the conjunctival and limbal tissues were retrieved 
from the same donor eye. Complete information about the donor can be found in Table 4. 
The adipose tissue layers and blood vessels of the conjunctival tissue were dissected away, 
and the remaining tissue containing conjunctival epithelium was cut into 1mm2 (roughly) 
pieces. The conjunctival pieces were incubated with 1X trypsin EDTA for 20 minutes in tissue 
culture incubator. The resulting cell suspension was removed and centrifuged for 5 minutes 
at 1000 rpm. The supernatant was removed, and the remaining cell pellet was re-suspended 
in SHEM medium. This trypsinization process was repeated four times using the same 
conjunctival tissue. The resulting cell suspensions were then pooled together. The 
conjunctival ECs were added to tissue culture wells containing the previously mitotically 
inactivated 3T3 fibroblasts, Figure 14. This co-culture was placed in the incubator and the 
medium changed on the day after and then every other day.  
SHEM 
medium 
Inactivated 3T3 J2 
fibroblast
Limbal epithelial cell 
Figure 13 - Schematic illustration of the co-culture of limbal epithelial cells with 3T3 J2 mitotically 
inactivated fibroblasts using direct co-culture method. Abbreviations used SHEM: supplemented 
hormonal epithelial medium. 
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2.2.6.2. Sub-culturing 
The original primary cultures, prior to confluence of the colonies, were sub-cultured. The 
cells were detached using the trypsinization method. After the centrifugation step the 
supernatant was discarded and the resulting pellet re-suspended in KSFM conjunctival 
medium. The trypsinization step was repeated twice to fully detach all cells from the culture 
well. The subcultures were then treated as the already stated HCjE-Gi cultures. 
Table 4 - Donor information. Age, gender and post mortem interval are shown. 
Donor Age (years) Gender Post Mortem interval (hours) 
14 84 Female 18 
16 85 Male 22 
17 76 Male 19.5 
18 87 Male 17 
20 62 Male 17 
36 95-100 Female 16 
37 80-85 Male 10 
 
2.2.7. Human embryonic stem cells  
HUES7 cells (obtained from Harvard University, HUES cells facility, Melton Laboratory, MA, 
USA) were kindly gifted by Professor Patricia Murray (Institute of Translational Medicine, 
University of Liverpool, UK). The full description on cell line preparation can be found at 
Baxter et al. [287]. Briefly, embryos were cultured in a series of sequential media, the zona 
pellucida and trophectoderm removed and the inner cell mass seeded onto mitotically 
inactivated mouse feeder layers for 8 days and the outgrowth passaged by manual dissection 
for the first 10 passages.  
2.2.7.1. Coating of tissue culture plates with Matrigel® 
Corning® Matrigel® hESC-qualified matrix (cat. Number 354277, lot number 5257004, 
Corning) was used for the coating of tissue culture plates. One aliquot (containing 263µL) 
SHEM  
medium 
Inactivated 3T3 J2 Conjunctiva epithelial cell 
Figure 14 - Schematic illustration of the co-culture of conjunctival epithelial cells with 3T3 J2 
mitotically inactivated fibroblasts using direct co-culture method. Abbreviations used SHEM: 
supplemented hormonal epithelial medium. 
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was thawed on ice and added to 24mL of cold DMEM/F12 (cat. Number 36254, STEMCELL 
Technologies). The resulting solution (1mL/well) was used to coat the 6 well plate 
cultureware (cat. number CLS3516-50EA, Corning® Costar® TC-Treated Multiple Well Plates). 
The cultureware was briefly swirled to evenly spread the Corning® Matrigel® across the 
surface. The resulting solution was incubated for one hour at RT, and the excess of Corning® 
Matrigel® solution removed. Specifications followed as per Technical Manual for 
Maintenance of human pluripotent stem cells in mTeSR™1 by STEMCELL™ Technologies.  
2.2.7.2. Thawing of human embryonic stem cells 
Complete mTeSR™1 and DMEM/F12 were brought to RT and Corning® Matrigel pre-coated 
cultureware was prepared beforehand. The cryovials containing hESCs were thawed in a 
37°C water bath, and a 1mL micropipette was used to slowly transfer the contents into a 
conical tube containing the DMEM/F12 solution. The resulting solution was centrifuged for 
5 minutes at 300xg. The supernatant was removed, the resultant pellet re-suspended in 
mTeSR™1 complete medium containing 10µM of Y-26632 (Dihydrochloride, cat. Number 
72302, STEMCELL Technologies) and the cells seeded accordingly. The tissue culture flask 
was maintained at 37˚C, 5% CO2 in tissue culture incubator and fed with fresh complete 
mTeSR™1 medium (without Y-26632) every day until further experiments. 
2.2.7.3. Passaging of human embryonic stem cells 
StemPro® Accutase® Cell Dissociation Reagent (cat. Number A1110501, ThermoFisher 
Scientific) was used. The culture well was washed with warmed PBS, the washing medium 
aspirated and cell dissociation reagent added. The cultureware was placed in a 37°C 5% CO2 
tissue incubator for approximately 5 minutes, when small gaps occurred between cells 
located on the edges of colonies. The resulting solution was harvested and the cultureware 
washed with DMEM/F12. The resulting solution was then centrifuged for 5 minutes at 300xg. 
The resultant pellet was re-suspended with complete mTeSR™1 supplemented with 10µM 
of Y-26632. The tissue culture flasks were maintained at 37˚C, 5% CO2 in tissue culture 
incubator for 24 hours and fed with fresh complete mTeSR™1 medium (without Y-26632) 
every day until further experiments. 
2.2.8. Cell doubling time 
The cell doubling time was obtained by cell counting (trypan blue exclusion) at day 0 and day 
6 and calculated as in Equation 2 
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DT=𝑇 ∗ ௅௡(ଶ)
௅௡( ೉೔೉೚
)
 
Equation 2 – Doubling time calculation. Abbreviations used DT: doubling time, T: time, Xi: 
cell number at i time, Xo: cell number at time 0.  
2.2.9. Cell seeding on ECM proteins 
At desired time-points the cells were ruptured using the method described by 
Gospodarowicz [288] and Todorovic et al. [289] with small modifications. Briefly, the culture 
medium was removed and the cultureware briefly washed using sterile PBS. Cells were then 
treated with 20mM NH4OH (cat. Number A669-212, Fisher Scientific) in sterile PBS for 5 
minutes. The resulting cells (‘de-roofed’ cells) were washed away several times in sterile PBS 
followed by one wash with double distilled water (ddH2O). This results in cultureware coated 
with ECM proteins. Viable cell count was performed using Trypan Blue exclusion (cat. 
Number T8154, Sigma-Aldrich). Briefly, 10µL of cell suspension were incubated with 10µL of 
Trypan blue for 1-2 minutes and then loaded into a Neubauer chamber. After counting, 
25000 viable cells/cm2 were seeded on top of ECM protein. The tissue culture flasks were 
maintained at 37˚C, 5% CO2 in tissue culture incubator and fed with fresh KSFM (conjunctival 
or corneal accordingly) every other day until further experiments (at least three independent 
experiments were conducted with three technical replicates).  
Scheme 1 – Cell seeding on ECM proteins experiment outlook. (A) hTCEpi cells were seeded for 9 
days on TCPS. At this point cells were removed using NH4OH leaving the hTCEPi ECM proteins still 
attached to the TCPS. On top of these proteins, fresh HCjE-Gi cells (or hTCEPi cells as control) were 
seeded and fed with corneal KSFM for 5 days until further experiments. (B) HCjE-Gi cells were seeded 
for 9 days on TCPS. At this point cells were removed using NH4OH leaving the HCjE-Gi ECM proteins 
still attached to the TCPS. On top of these proteins, fresh hTCEpi cells (or HCjE-Gi cells as control) were 
seeded and fed with conjunctival KSFM for 5 days until further experiments Abbreviations used ECM: 
extracellular matrix, TCPS: tissue culture polystyrene. 
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2.2.10. RNA extraction  
The tissue culture well was briefly washed with sterile PBS and incubated with 0.350mL of 
TRIzol® reagent (Invitrogen, cat. Number 15596-026) for 5 minutes at room temperature 
(RT). The resulting solution was collected into an Eppendorf and 200µL of chloroform (Sigma 
Chemicals, cat. Number C2432) was added. The tube was vortexed for few seconds, 
incubated at RT for 15 minutes and then centrifuged at 13000rpm for 15 minutes at 4˚C. The 
colourless aqueous (upper) phase of the centrifuged solution was transferred into a new 
collection Eppendorf and 500µL of 100% isopropyl alcohol (Sigma-Aldrich, cat. Number 
I9516) was added. The reaction was then incubated for 10 minutes at RT and then 
centrifuged at 13000 rpm for 10 minutes at 4˚C. The supernatant was discarded, and the 
resulting RNA pellet was washed with 75% (V/V) ethanol (Sigma-Aldrich, cat. Number E7023) 
in ddH2O and centrifuged at 13000 rpm for 5 minutes at 4˚C. The supernatant was discarded, 
and the pellet allowed to air-dry for 15 minutes at RT. The dried pellet was dissolved in 20µL 
of DNAse, RNAse-free water (Ambion, cat. Number AM9937). Either this RNA mixture was 
stored at - 80˚C or reverse transcription was performed. 
2.2.11. Reverse Transcription  
Before reverse transcription, the concentration of RNA was assessed by analysing 1.5µL of 
the RNA solution using Nanodrop (ND100, Nanodrop Technologies). Subsequent steps were 
performed in accordance with the manufacturer’s protocol by Primerdesign using Precision 
nanoScript™ Reverse Transcription kit. Briefly, for the annealing step the volume 
correspondent to 2µg of RNA template and 1µL of reverse transcription primer was added 
into a 200µL PCR tube (Appleton Woods, cat. Number BS191). The final volume, 10µL, was 
completed with RNAse/DNAse-free water. The resulting solution was heated at 65˚C for 5 
minutes. For the extension step, a mastermix containing 5µL of nanoScript 4X Buffer, 1µL 
dNTP mix 10mM, 4µL RNAse/DNAse-free water, and 1µL nanoScript2 enzyme was prepared 
and added into the resulting solution from the annealing step (all reagents were purchased 
from Primerdesign). The final solution was incubated at 42˚C for 20 minutes, and then at 
72˚C for 15 minutes. The cDNA samples were then store at -20˚C until further utilization.  
2.2.12. Reverse Transcriptase qPCR 
96-well PCR microplates (LightCycler-type white, cat. Number I1402-9909, StarLab) were 
placed in cooled blocks, and each well was filled with 2.5µL (5ng) of cDNA template, 5µL 
SYBR® green, 0.5µL (30nM) of specific forward and reverse primers, and 2µL of 
RNAse/DNAse-free water. The filled LightCycler plates were briefly centrifuged on a mini-
plate spinet (MPS1000, Labnet). The plates were then placed in a LightCycler 480 II (Roche). 
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qPCR was performed at 95˚C for 2 minutes for enzyme activation, followed by 45 cycles at 
95˚C for 15 seconds, 60˚C for 60 seconds 72˚C for 1 second. To assess the purity of the 
amplicon, the melting curves were performed by continuously acquired fluorescence data 
until the temperature of 95˚C was achieved (at a 0.03˚C/s ramp rate). As housekeeping gene 
glyceraldehydes-3-phosphate dehydrogenase (GAPDH) was used for each investigated gene. 
The fold increase was calculated using ΔΔCt method [290]. Primer sequences are shown in 
Table 5. 
Table 5 – List of primers used for Reverse Transcriptase quantitative PCR studies in Chapter 2. The 
primer sequences and the product size are included. Abbreviations used: GAPDH: glyceraldehyde-3-
phosphate dehydrogenase, KRT: keratin, MUC5AC: mucin 5AC, ABCB5: ATP-binding cassette sub-
family B member 5. # Sequences and product size of reference genes are not commercially provided 
by PrimerDesign. 
Primer Gene Sequence Product size (bp) 
GAPDH 
F - # 
 
R - # 
KRT1 
F - GTGGTGGTGGTGGTTTTGG 
110 
R-T GCTCTGGTTGATAGTGACTTCTT 
KRT3 
F – TTCCATCTCAGGCACAAACAA 
130 
R –CAGGTCCTCCATGTTCTTCAG 
KRT7 
F –CTCCCACCACTCCATCCT 
105 
R - ATCACTTTCCAGACTGTCTCACT 
KRT10 
F- AAGAAGAACCACGAGGAGGAA 
113 
R- ATGTTATTCAGAAGTTGAGTCAGATC 
KRT12 
F –CTCCAAATCACAAGCACAGTCA 
98 
R - CCACCTCACCATTCACCATCT 
KRT13 
F –ATGCTGCTGGACATCAAGAC 
113 
R -TCGTGGTAACAGAGGTGCTA 
MUC5AC 
F –CAGAGGGGTTGACAGTGAC 
113 
R - GAACCGCATTTGGGCATC 
ΔNp63 
F –GGAAGGCGGATGAAGATAGC 
96 
R - CATGTGTGTTCTGACGAAACG 
ABCB5 
F -GGAAAGAATTACCACTACCAAGAAGG 
R -TGGTAGCATCCAAATGGGCAAAC 
119 
SOX2 
F – GGAGAGTAAGAAACAGCATGGA 
128 
R -TTTGCGTGAGTGTGGATGG 
OCT4 
F - ATGTGGTCCGAGTGTGGTTC 
67 
R - TGTGCATAGTCGCTGCTTGA 
NANOG 
F –GCTGTGTGTACTCAATGATAGATTT 
85 
R -GAGGTTCAGGATGTTGGAGAG 
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2.2.13. Western Blot  
2.2.12.1. Reagents 
Running buffer was prepared by mixing 2L of methanol (cat. Number M/4000/PC17, Fisher 
Scientific UK), 300g of Tris (cat. Number T1503), 1440g of glycine (cat. Number G8898), and 
100g of sodium dodecyl sulphate (SDS, cat. Number L4509), all provided by Sigma-Aldrich 
unless otherwise specified, the pH was then set to 8.3-8.7. The final volume was completed 
to 10L with ddH2O. This stock solution was then diluted 10X in ddH2O prior utilization. 
Transfer buffer was prepared by mixing 2L of methanol with 30g of Tris and 144g of glycine. 
The final volume was completed to 10L with ddH2O and kept at 4°C until usage.  
Urea-SDS cell lysis buffer was prepared by mixing 40.08g of urea (cat. Number U5378), 1mL 
of 1M Tris/HCl (pH 6.8), 10mL of glycerol (cat. Number G8773), 5mL of 20% SDS in ddH2O, all 
provided by Sigma-Aldrich.  
Lower gel stock solution was prepared by mixing 90.8g of Tris (1.5M final concertation), 10mL 
of 20% SDS in ddH2O. The final volume was completed to 500mL with ddH2O. The resulting 
solution was stirred overnight at 4°C and the pH adjusted to 8.8. 
Upper gel stock solution was prepared by mixing 30.275g of Tris (0.5M final concentration) 
and 10mL of 20% SDS in ddH2O. The final volume was completed to 500mL with ddH2O. The 
resulting solution was stirred overnight at 4°C and the pH adjusted to 6.8. 
Buffer 1 consisted of (%V/V): 85% Urea-SDS buffer supplemented with 15% β-
mercaptoethanol (cat. Number M6250), 50µM phenylmethanesulfonyl fluoride (cat. 
Number P7626), and 50µM N-ethylmaleimide (cat. Number E3876), all provided by Sigma-
Aldrich.  
2.2.12.2. Cell extracts  
Cell preparations were extracted from a confluent T-25cm2 tissue culture flask. The medium 
was removed, and the flask washed twice with sterile PBS to remove the serum and any 
other medium remains. 1mL of buffer 1 was added and the cells vigorously removed with 
the aid of a cell scraper (cat. Number 83.1830, Sarstedt). 
2.2.12.3. SDS-PAGE 
The extracts were then processed for SDS-PAGE. Acrylamide lower and upper gels were 
prepared as described in Table 6. 5µL of Spectra ™ multicolour Broad Range protein ladder 
(cat. Number 26634 Thermo Scientific) and 20µL of each sample were loaded in different 
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lanes and the gel ran for approximately 2 hours at 80V (PowerPac Basic ™, BioRad) in running 
buffer. 
Table 6 – Western Blot 10% acrylamide gels recipe. Abbreviations used APS: ammonium persulfate, 
TEMED: N,N,N′,N′-Tetramethylethylenediamine. 
Reagent Lower gel Upper gel Cat. Number Supplier 
Stock 2mL 1.25mL --- --- 
30% Acrylamide 2.75mL 0.75mL A3699 Sigma-Aldrich 
ddH2O 3.25mL 3mL --- --- 
10% APS 100µL 100µL A/P470/46 Fisher Scientific 
TEMED 4µL 5µL T9281 Sigma-Aldrich 
2.2.12.4. Immunoblotting 
The Western immunoblotting was run for 2 hours at 110V in transfer buffer. The membranes 
(0.2µm cat. Number162-0112 BioRad) were then stained with Ponceau S solution (cat. 
number P7170, Sigma-Aldrich) for approximately 2 minutes and cut accordingly. Thereafter, 
the membranes were blocked in blocking solution containing 5% (W/V) skimmed milk diluted 
in 0.05% (V/V) PBSTween-20 (cat. number 9416, Sigma-Aldrich) solution for 30 minutes on 
the rocker and probed with primary antibody diluted in blocking solution overnight at 4˚C 
(Table 7). The membranes were then washed thrice using 0.05% (V/V) PBSTween-20 and 
incubated with the secondary antibody diluted in the blocking solution for one hour at RT 
(Table 8). The two horseradish peroxidase (HRP) chemicals SuperSignal® West Pico 
Chemiluminescent substrate (cat. Number 34080, Thermo Scientific) were mixed at ratio of 
1:1 and poured over the membrane. The immunoblots were scanned using a Chemidoc 
(chemiDoc ™ XRS+, BioRad) and quantified using ImageLab 5.0 Software.  
Table 7 - List of primary antibodies used for Western Blot studies in Chapter 2. Abbreviations used 
KRT: keratin, BS: blocking solution, ABCB5: ATP-binding cassette sub-family B member 5. # Kind gift 
from Professor Jonathan Jones (Northwestern University, Chicago, USA).  
Antibody Clone Host Blocking Manufacturer Dilution 
KRT1 Polyclonal Rabbit BS Abcam® 1:1000 
KRT3 AE5 Mouse BS Abcam® 1:1000 
KRT7 RCK105 Mouse BS Santa Cruz 1:1000 
KRT12 J6 Rabbit BS # 1:1000 
KRT13 Ks13.1 Mouse BS Santa Cruz 1:1000 
ABCB5 5H3C6 Mouse BS Abcam® 1:1000 
ΔNp63α Poly6190 Rabbit BS Biolegend 1:1000 
Β-Actin mAbcam 8224 Mouse BS Abcam® 1:5000 
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Table 8 - List of secondary antibodies used for Western Blot studies in Chapter 2. 
Antibody Host Reactivity Conjugate #Catalogue Manufacturer Dilution 
Anti-mouse Horse Human HRP 7076 Cell Signalling 1:1000 
Anti- rabbit Goat Human HRP 7074 Cell Signalling 1:1000 
2.2.14. Flow cytometry 
A cell suspension was obtained by trypsinization (as previously described) and then 
centrifuged (all centrifugation steps were performed for 3 minutes at 1000 rpm at RT). The 
supernatant was then removed, and the cell pellet re-suspended in 100 µl of 1X FACS 
Permeabilizing Solution 2 (cat. Number 347692, BD Biosciences) in ddH2O. The resultant 
suspension was incubated for 10 minutes at RT. After centrifugation, the supernatant was 
removed, and the remaining cell pellet re-suspended in 1ml of 5% (V/V) FCS in PBS. After 
centrifugation, the supernatant was discarded, and the cell pellet re-suspended in 100µL of 
primary antibody (Table 9) diluted in PBS. The resulting suspension was incubated in the dark 
for 30 minutes at 4°C. After adding 1ml of 5% (V/V) FCS in PBS to the cell suspension, 
centrifugation was performed, and the supernatant discarded. The resulting cell pellet was 
re-suspended in 100µL of appropriate secondary antibody (Table 10) diluted in PBS. This 
suspension was then incubated in the dark for 30 minutes at 4°C. 1ml of 5% (V/V) FCS in PBS 
was added to the cell suspension and centrifugation was performed. After discarding the 
supernatant, the cell pellet was re-suspended in 500µl of 5% (V/V) FCS in PBS. This final 
suspension was analysed using a BD Accuri C6 flow cytometer (BD Biosciences) and the 
results analysed using BD Accuri C6 software (BD Biosciences). 
Table 9 – List of primary antibodies used for flow cytometry studies in Chapter 2. Abbreviations used 
KRT: keratin, ABCB5: ATP-binding cassette sub-family B member 5. # Concentration dependent on 
primary antibody. 
Antibody Clone Host Isotype Manufacturer Dilution 
KRT3 AE5 Mouse IgG Abcam ® 1:1000 
KRT7 RCK105 Mouse IgG1 Santa Cruz 1:500 
KRT12 J6 Rabbit   1:500 
KRT13 Ks13.1 Mouse IgG1 Santa Cruz 1:500 
ABCB5 5H3C6 Mouse IgG1 Abcam ® 1:1000 
ΔNp63 Poly6190 Rabbit IgG Biolegend 1:1000 
IgG --- Mouse --- ThermoFisher Scientific # 
lgG --- Rabbit --- ThermoFisher Scientific # 
IgG1 --- Mouse --- ThermoFisher Scientific # 
IgG3 --- Mouse --- ThermoFisher Scientific # 
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Table 10 - List of secondary antibodies used for flow cytometry studies in Chapter 2. Abbreviations 
FITC: fluorescein isothiocyanate. 
Antibody Clone Host Reactivity Conjugate Manufacturer Dilution 
Anti-mouse A-11005 Goat Mouse FITC Life Technologies 1:1000 
Anti-rabbit F7512 Sheep Rabbit FITC Sigma-Aldrich 1:1000 
2.2.15. Statistical analysis 
Kruskal-Wallis and Mann-Whitney tests followed by according post hoc analysis were used 
to determine statistically significant differences (GraphPad Prism 5, *p<0.05, **p<0.01, 
***p<0.001). Data is expressed as median ± 5-95% percentile (unless otherwise specified). 
Non-parametric tests were chosen as these do not make the assumption about normally 
distributed data. Additionally, they are more robust when a small sample size is used and 
their outcome less affected by outliers. 
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2.3 Results  
A process called ‘de-roofing’, derived from a protocol established by Gospodarowicz and 
Todorovic et al. with few modifications, was used to remove cells leaving only the ECM 
proteins (and other soluble factors) attached to the tissue polystyrene cultureware [288, 
289]. On top of those ECM proteins, fresh cells were cultured, and the extent of 
differentiation assessed using various cell and molecular techniques. Six different markers 
were used for this purpose: KRT3 and KRT12 were used as markers for corneal ECs [106-108], 
KRT7 and KRT13 utilized as markers for conjunctival ECs [106], and ΔNp63 and ABCB5 as 
epithelial SCs markers [102, 103, 116]. The advantage of ABCB5 over ABCG2 (other marker 
for epithelial SCs) arises from the fact that ABCB5 is only expressed by the ΔNp63–positive 
cells [116]. MUC5AC was also investigated and used as a marker for the presence of goblet 
cells of conjunctival origin [132, 152]. This marker was only used at transcript levels as no 
suitable and reliable antibody can yet be found.  
2.3.1. Cell doubling time 
The doubling time showed non-significant differences between the two cell lines used, with 
cells needing approximately 2 days to go a full cell cycle, Figure 15. Since cell division is 
essential as an intermediate step for cell transdifferentiation, although not obligatory in all 
cases [212], cells were allowed in culture for 5 days (approximately two complete cell cycles). 
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Figure 15 - HCjE-Gi and hTCEpi cells doubling time. (Data is represented as median ± interquartile 
range, n=3. Mann-Whitney test). Abbreviations used NS: non-significant. 
 
2.3.2. hTCEpi ECM proteins drive higher expression of corneal and stem cell 
epithelial markers by HCjE-Gi cells than HCjE-Gi ECM proteins 
The aim of these experiments was to identify the day of cell culture associated with the 
optimum time of ECM production and deposition for the modulation of KRTs and ΔNp63 
expression. 
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hTCEpi cells were cultured over a desired period on TCPS. At each time-point the cultures 
were ‘de-roofed’ and HCjE-Gi cells cultured on hTCEpi ECM proteins for 5 days. HCjE-Gi cells 
cultured on their own ECM proteins were used as a control (dashed line). Day 9 appeared to 
be the only time-point whereupon KRT3 and was upregulated (1.4-fold increase, p<0.05) and 
KRT13 expression downregulated (6.2-fold decrease), Figure 16. No KRT12 expression was 
detected when HCjE-Gi cells were cultured on their own ECM proteins at day 9 (blue arrow) 
and as so no statistically analyses could be performed. 
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Figure 16 - The expression of epithelial cell markers by HCjE-Gi cells when cultured on hTCEpi ECM 
proteins compared to HCjE-Gi ECM deposited over time as assessed by Reverse Transcriptase qPCR. 
(Data is represented as median ± 5-95 percentile, n≥9, Mann-Whitney test, Bonferroni corrected p-
value, *p<0.05, **p<0.01, ***p<0.001). Dashed line represents the basal expression of the markers of 
interest when cells are cultured on their own ECM proteins. Blue arrow represents expression not 
detected. Abbreviations used GAPDH: glyceraldehyde 3-phosphate dehydrogenase, KRT: keratin, 
ECM: extracellular matrix. 
2.3.3. HCjE-Gi ECM proteins drives higher expression of conjunctival and 
stem cell epithelial markers by hTCEpi cells than hTCEpi ECM proteins 
In this section, HCjE-Gi cells were cultured over a desired period on TCPS and at each time-
point the cultures were ‘de-roofed’ and hTCEpi cells cultured on HCjE-Gi ECM proteins for 5 
days. hTCEpi cells cultured on their own ECM proteins were used as a control (dashed line). 
KRT13 expression by hTCEpi cells at day 7 was upregulated (87-fold increase, p<0.01). Day 9 
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appeared to be the only time-point where KRT3 expression was downregulated (25-fold 
decrease) and KRT12 expression not detected (blue arrow), Figure 17. 
KRT3
1 3 5 7 9 11 13
0.0001
0.001
0.01
0.1
1
10
100
1000
10000 *
*** ***
Time (days)
Fo
ld
 C
ha
ng
e
N
or
m
al
is
ed
 to
 G
AP
D
H
 
KRT12
1 3 5 7 9 11 13
0.01
0.1
1
10
100
1000
*** ***

*
Time (days)
Fo
ld
 C
ha
ng
e
N
or
m
al
is
ed
 to
 G
AP
D
H
 
KRT13
1 3 5 7 9 11 13
0.001
0.01
0.1
1
10
100
1000
***
Time (days)
Fo
ld
 C
ha
ng
e
No
rm
al
is
ed
 to
 G
AP
DH
 
Np63
1 3 5 7 9 11 13
0.001
0.01
0.1
1
10
100
**
**
***

Time (days)
Fo
ld
 C
ha
ng
e
N
or
m
al
is
ed
 to
 G
AP
D
H
 
Figure 17 - The expression of epithelial cell markers by hTCEpi cells when cultured on HCjE-Gi ECM 
proteins compared to hTCEpi ECM deposited over time as assessed by Reverse Transcriptase qPCR. 
(Data is represented as median ± 5-95 percentile, n≥9, Mann-Whitney test, Bonferroni corrected p-
value, *p<0.05, **p<0.01, ***p<0.001). Dashed line represents the basal expression of the markers of 
interest when cells are cultured on their own ECM proteins. Blue arrow represents expression not 
detected. Abbreviations used GAPDH: glyceraldehyde 3-phosphate dehydrogenase, KRT: keratin, 
ECM: extracellular matrix. 
ECM proteins produced and deposited for 9 days were chosen as the preferred condition to 
further investigate the process of EC differentiation. The potential for EC differentiation of 
this system was further investigated. To further investigate the degree of cell differentiation, 
the expression of KRT7 (marker for terminally differentiated conjunctival ECs) and ABCB5 
(marker for epithelial SC) will be addressed. 
2.3.4. hTCEpi ECM proteins drive higher expression of corneal and stem cell 
epithelial markers by HCjE-Gi cells than the HCjE-Gi ECM 
The results in this section were obtained by culturing HCjE-Gi cells on top of hTCEpi ECM 
proteins (produced and deposited by hTCEpi cells for 9 days) for 5 days. As internal control, 
the expression of the markers of interest by HCjE-Gi cells seeded on top of their own ECM 
proteins (deposited for 9 days) was used. 
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2.3.4.1. Reverse Transcriptase qPCR 
The differentiation of HCjE-Gi cells into a cornea epithelial-like lineage was assessed by 
Reverse Transcriptase qPCR. By culturing HCjE-Gi cells on top of hTCEpi ECM proteins three 
different outcomes were appreciated at transcript expression levels compared with HCjE-Gi 
cells cultured on HCjE-Gi ECM and normalised to GAPDH levels:  
i. significantly higher expression levels of the terminally differentiated corneal EC markers 
KRT3 (161-fold increase, p<0.05) and KRT12 (3.6-fold increase, p<0.01), Figure 18; 
ii. significantly lower expression of conjunctival EC markers KRT7 and KRT13 (respectively 
1.4 and 2.1-fold decrease, p<0.05), Figure 18;  
iii. significantly higher expression levels of ABCB5 (1.8-fold increase, p<0.05), Figure 18. 
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Figure 18 - The expression of epithelial cell markers by HCjE-Gi cells when cultured on top of hTCEpi 
ECM proteins compared with HCjE-Gi ECM as assessed by Reverse Transcriptase qPCR. Data 
normalised to GAPDH levels. (Data is represented as median ± 5-95 percentile, n≥6, Mann-Whitney 
test, *p<0.05, **p<0.01, ***p<0.001). Dashed line represents the basal expression of the markers of 
interest when cells are cultured on their own ECM proteins. Abbreviations used GAPDH: 
glyceraldehyde 3-phosphate dehydrogenase, KRT: keratin, MUC: mucin, ABCB5: ATP-binding cassette 
sub-family B member 5, ECM: extracellular matrix. 
2.3.4.2. Western Blot 
To further investigate the process of conjunctival differentiation into a corneal epithelial-like 
lineage, western blotting was performed. By seeding HCjE-Gi cells on top of deposited hTCEpi 
ECM proteins, and consistent with the transcript abundance data: 
i. significant higher expression of corneal EC markers KRT3 and KRT12 (p<0.05) was 
appreciated, Figure 19; 
ii. significant lower expression of KRT7 and KRT13 (p<0.05) was seen, Figure 19; 
  Chapter 2 
63 
 
iii. significant higher expression of ABCB5 and ΔNp63 (p<0.05) was observed, Figure 19. 
2.3.4.3. Flow Cytometry 
Flow cytometry corroborated the protein studies (Western blot) where the total protein 
content was assessed. The percentage of positive cells was defined by the subtraction of cells 
displaying expression for a given protein about a threshold given by its isotype control (see 
Appendix A.2 for details). By seeding HCjE-Gi cells on top of hTCEpi ECM proteins and 
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Figure 19 - The expression of epithelial cells markers by HCjE-Gi cells when cultured on top of hTCEpi 
ECM proteins compared with HCjE-Gi ECM as assessed by Western Blot. (A) Whiskers graphs 
showing the densitometry quantification of each protein, normalised against the expression of β-
actin. (B) Western blots representative of three independent experiments. (Data is represented as 
median ± 5-95 percentile, n≥3, Mann-Whitney test, *p<0.05, ** p<0.01, *** p<0.001). Abbreviations 
used A.U.: arbitrary units, KRT: keratin, ABCB5: ATP-binding cassette sub-family B member 5, ECM: 
extracellular matrix. 
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compared with HCjE-Gi cells cultured on their own ECM proteins, and consistent with 
Reverse Transcriptase qPCR and western blot data: 
i.  a significantly higher proportion of KRT12-positive cells was detected (30%, p<0.05), 
Figure 20.  
ii. a significantly lower proportion of KRT7-positive and of KRT13-positive cells was also 
shown (10% for each protein, p<0.05), Figure 21,  
iii. a significantly higher proportion of ΔNp63- and ABCB5-positive cells (nearly 25% for each 
marker, p<0.01) was observed, Figure 22. 
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Figure 20 - The expression of corneal epithelial cells markers keratin 3 and keratin 12 by HCjE-Gi 
cells when cultured on top of hTCEpi ECM proteins compared with HCjE-Gi ECM as assessed by flow 
cytometry. The percentage of positive events normalised against isotype control is shown (Mx). (Data 
is represented as median ± 5-95 percentile, n≥3, Mann-Whitney test, *p<0.05, **p<0.01, 
***p<0.001). Abbreviations used KRT: keratin, Ctrl: control, ECM: extracellular matrix. 
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Figure 21 - The expression of corneal epithelial cells markers keratin 7 and keratin 13 by HCjE-Gi 
cells when cultured on top of hTCEpi ECM proteins compared with HCjE-Gi ECM as assessed by flow 
cytometry. The percentage of positive events normalised against isotype control is shown (Mx). (Data 
is represented as median ± 5-95 percentile, n≥3, Mann-Whitney test, *p<0.05, **p<0.01, 
***p<0.001). Abbreviations used KRT: keratin, Ctrl: control, ECM: extracellular matrix. 
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2.3.4.4. Summary of results 1: 
To summarize these results, by culturing HCjE-Gi cells on top of hTCEpi ECM proteins and 
compared to HCjE-Gi cells cultured on their own ECM proteins, there was a: 
i. Higher expression of corneal EC markers. 
ii. Lower expression of conjunctival EC markers. 
iii. Higher expression of epithelial SC markers. 
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Figure 22 - The expression of epithelial stem cell markers ΔNp63 and ABCB5 by HCjE-Gi cells when 
cultured on top of hTCEpi ECM proteins compared with HCjE-Gi ECM as assessed by flow cytometry. 
The percentage of positive events normalised against isotype control is shown (Mx). (Data is 
represented as median ± 5-95 percentile, n≥3, Mann-Whitney test, *p<0.05, **p<0.01, ***p<0.001). 
Abbreviations used Ctrl: control, ABCB5: ATP-binding cassette sub-family B member 5, ECM: 
extracellular matrix.  
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2.3.5. HCjE-Gi ECM proteins drive higher expression of conjunctival and stem 
cell epithelial markers by hTCEpi cells than the hTCEpi ECM  
The results shown in this section were obtained by culturing hTCEpi cells on HCjE-Gi ECM 
proteins (produced and deposited by HCjE-Gi cells over 9 days) for 5 days. As internal control, 
the expression of the markers of interest by hTCEpi cells when seeded on top of their own 
ECM proteins (produced and deposited over 9 days) was used. 
2.3.5.1. Reverse Transcriptase qPCR 
By culturing hTCEpi cells on top of HCjE-Gi ECM proteins three different outcomes were 
appreciated at transcript expression levels compared with hTCEpi cells cultured on hTCEpi 
ECM and normalised to GAPDH levels: These are the opposite equivalent of the results shown 
in the previous sections:  
i. significantly lower KRT12 transcript expression levels (4.0-fold decrease, p<0.05), Figure 
23 
ii. significantly higher levels of KRT7 and KRT13 expression (1.9- and 8.4-fold increase, 
respectively, p<0.01), Figure 23 
iii. significant higher levels of ΔNp63 and ABCB5 expression (1.4-fold increase, p<0.05 and 
1.4- fold increase, p<0.001 respectively), Figure 23.  
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Figure 23 - The expression of epithelial cell markers by hTCEpi cells when cultured on top of HCjE-Gi 
ECM proteins compared with hTCEpi ECM as assessed by Reverse Transcriptase qPCR. Data 
normalised to GAPDH levels. (Data is represented as median ± 5-95 percentile, n≥4, Mann-Whitney 
test *p<0.05, **p<0.01, ***p<0.001). Dashed line represents the basal expression of the markers of 
interests when cells are cultured on their own ECM proteins. Abbreviations used GAPDH: 
glyceraldehyde 3-phosphate dehydrogenase, KRT: keratin, ABCB5: ATP-binding cassette sub-family B 
member 5, ECM: extracellular matrix. 
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2.3.5.2. Western Blot 
Consistent with the transcript abundance data, significant lower values of KRT3 and KRT12 
total protein expression (p<0.001 and p<0.01, respectively) accompanied by significant 
higher expression levels of KRT13 (p<0.001) and ABCB5 (p<0.05) were observed. Remarkably 
no KRT13 expression could be detected when hTCEpi cells were seeded on hTCEpi ECM 
proteins, Figure 24. 
Figure 24 - The expression of epithelial cell markers by hTCEpi cells when cultured on top of HCjE-Gi 
ECM proteins compared with hTCEpi ECM as assessed by Western Blot. (A) Whiskers graphs showing 
the densitometry quantification of each protein normalised against the expression of β-actin. (B) 
Western blots representative of three independent experiments. Green arrowheads show no KRT13 
expression when hTCEpi cells were seeded on hTCEpi ECM proteins. (Data is represented as median ± 
5-95 percentile, n≥3, Mann-Whitney test, *p<0.05, ** p<0.01, *** p<0.001). Abbreviations used A.U. 
arbitrary units, KRT: keratin, ABCB5: ATP-binding cassette sub-family B member 5, ECM: extracellular 
matrix. 
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2.3.5.3. Flow Cytometry 
Trends at protein levels assessed by flow cytometry are consistent with total protein data. 
By culturing hTCEpi cells on HCjE-Gi ECM proteins, and compared with hTCEpi cells cultured 
on hTCEpi ECM proteins, significant: 
i. lower proportion of KRT3-positive cells (nearly 30%, p<0.05) and of KRT12-positive cells 
(20%, p<0.05) were observed, Figure 25.  
ii. higher proportion of KRT7-positive cells was also appreciated (10%, p<0.05), Figure 26.  
iii.  higher proportion of ΔNp63-positive cells (25%, p<0.05) and of ABCB5-positive cells 
(nearly 40%, p<0.01) were observed, Figure 27.  
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Figure 25 - The expression of corneal epithelial markers keratin 3 and keratin 12 by hTCEpi cells 
when cultured on top of HCjE-Gi ECM proteins compared with hTCEpi ECM as assessed by flow 
cytometry. The percentage of positive events normalised against isotype control is shown (Mx). 
(Data is represented as median ± 5-95 percentile, n≥3 Mann-Whitney test, *p<0.05, **p<0.01, 
***p<0.001). Abbreviations used KRT: keratin, Ctrl: control, ECM: extracellular matrix. 
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Figure 26 - The expression of conjunctival epithelial cell markers keratin 7 and keratin 13 by hTCEpi 
cells when cultured on top of HCjE-Gi ECM proteins compared with hTCEpi ECM as assessed by flow 
cytometry. The percentage of positive events normalised against isotype control is shown (Mx). (Data 
is represented as median ± 5-95 percentile, n≥3 Mann-Whitney test, *p<0.05, **p<0.01, ***p<0.001). 
Abbreviations used KRT: keratin, Ctrl: control, ECM: extracellular matrix. 
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2.3.5.4. Summary of results 2:  
To summarize these results, by culturing hTCEpi cells on HCjE-Gi ECM proteins and compared 
to hTCEpi cells cultured on their own ECM proteins, there was a: 
i. Lower expression of corneal EC markers. 
ii. Higher expression of conjunctival EC markers. 
iii. Higher expression of epithelial SC markers. 
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Figure 27 - The expression of epithelial stem cells markers ΔNp63 and ABCB5 by hTCEpi cells when 
cultured on top of HCjE-Gi ECM proteins compared with hTCEpi ECM as assessed by flow cytometry. 
The percentage of positive events normalised against isotype control is shown (Mx). (Data is 
represented as median ± 5-95 percentile, n≥3, Mann-Whitney test, *p<0.05, **p<0.01, ***p<0.001). 
Abbreviations used Ctrl: control, ECM: extracellular matrix, ABCB5: ATP-binding cassette sub-family B 
member 5. 
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2.3.6. Corneal ECM proteins drive higher expression of corneal and stem cell 
epithelial markers by primary conjunctival cells than the conjunctival ECM 
The results obtained with immortalized cell lines were further confirmed using primary cells. 
The experimental design used was the same as for cell lines: primary cells were cultured on 
regular TCPS cultureware for 9 days, the resulting culture was then “de-roofed”. On top of 
the deposited ECM proteins, fresh cells (preferentially from the same donor) were cultured. 
2.3.6.1. Reverse Transcriptase qPCR 
Conjunctival primary cells from four different donors (six eyes called REBxx) cultured on 
corneal ECM proteins were used to assess the transcript expression profiles of the already 
stated markers of interest. All the comparisons were made against the expression of those 
markers by conjunctival cells cultured on conjunctival ECM proteins normalised to GAPDH 
levels. The results show:  
i. Significant higher values of KRT3 expression in all eyes (p≤0.05), although at lower levels 
when compared to the fold increase observed in HCjE-Gi cells cultured on top of hTCEpi 
ECM proteins. The expression of KRT12 was, in two of the donors (REB17R and REB18R), 
significantly higher (p<0.01), Figure 28.  
ii. Significant lower levels of KRT7 expression (p≤0.01, 3 out of 6 eyes) and of KRT13 
expression (p≤0.05, 4 out of 6 eyes). Relatively to the expression of MUC5AC, a significant 
higher expression of this transcript was observed (p≤0.05) in 5 out of 6 eyes, an exception 
is made for REB20L where lower values of its expression were observed (p<0.01), Figure 
28.  
iii. Significant higher expression of ΔNp63 (p≤0.05, 4 out of 6 eyes) and ABCB5 (p<0.01, 1 out 
of 6 eyes), Figure 28.  
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Figure 28 - The expression of epithelial cell markers by primary conjunctival cells when cultured on 
top of corneal ECM proteins compared with conjunctival ECM as assessed by Reverse Transcriptase 
qPCR. Data normalised to GAPDH levels (Data is represented as median ± interquartile range, n≥10). 
Dashed line represents the basal expression of the markers of interests when cells are cultured on 
their own ECM proteins. Abbreviations used GAPDH: glyceraldehyde 3-phosphate dehydrogenase, 
KRT: keratin, ABCB5: ATP-binding cassette sub-family B member 5, ECM: extracellular matrix. 
2.3.6.2. Western Blot 
Conjunctival primary cells extracted from six different donors (ten eyes) were used. 
Consistent with transcript abundance data, the total protein quantification results show: 
i.  Higher expression of KRT3 (8 out of 10 eyes) and KRT12 (9 out of 10 eyes). Noteworthy, 
no KRT12 expression was found when REB16R cells were seeded on conjunctival ECM 
proteins, Figure 29.  
ii. Lower values of KRT7 (9 out of 10 eyes) and KRT13 expression (7 out of 9 eyes), Figure 29.  
iii. Higher expression of ΔNp63 (7 out of 9 eyes) and ABCB5 (7 out of 10 eyes), Figure 29.  
Ocular primary cells are not abundant in number and, when in culture, they quickly start to 
differentiate. Thus, in vitro expansion is difficult and therefore only one sample from each 
donor was reliable for western blotting. Consequently, no statistical analysis could then be 
performed 
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Figure 29 - The expression of epithelial cells markers by primary conjunctival epithelial cells when 
cultured on top of corneal ECM proteins compared with conjunctival ECM as assessed by Western 
Blot. (A) Bar graphs showing the densitometry quantification of each protein, normalised to the 
expression of β-actin. (B) Western blots representative of nine independent experiments. 
Abbreviations used A.U. arbitrary units, KRT: keratin, ABCB5: ATP-binding cassette sub-family B 
member 5, ECM: extracellular matrix. 
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2.3.6.3. Summary of results 3: 
By culturing primary conjunctival ECs on top of deposited corneal ECM proteins and 
compared to conjunctival primary cells cultured on their own ECM proteins, there was a: 
i. Higher expression of corneal EC markers. 
ii. Lower expression of conjunctival EC markers. 
iii. Higher expression of epithelial SC markers. 
2.3.7. Conjunctival ECM proteins drive higher expression of conjunctival and 
stem cell epithelial markers by corneal primary cells than the corneal ECM 
This next section addresses the results obtained by culturing primary corneal ECs obtained 
from four different donors (six eyes) cultured on conjunctival ECM proteins when compared 
to those obtained by primary corneal cells seeded on corneal ECM proteins. 
2.3.7.1. Reverse Transcriptase qPCR 
By seeding primary corneal ECs on conjunctival ECM proteins three outcomes arise: 
i. Significantly lower levels of KRT3 expression were observed (p≤0.01, 4 out of 6 eyes). The 
expression of KRT12 was significantly lower (p≤0.01, 2 out of 6 eyes), Figure 30.  
ii. Significantly higher values of KRT7 expression (p≤0.01, 2 out of 6 eyes) and of KRT13 
expression values (p≤0.05, 6 out of 6 eyes) were also shown. Noteworthy, KRT13 
expression was not detected for REB17R and REB20L corneal primary cells when seeded 
on their own ECM proteins. In addition, MUC5AC expression was higher in 2 out of 6 eyes 
(p<0.001), Figure 30.  
iii. The expression of ΔNp63 was only significantly higher in 1 out of 6 eyes (p<0.001), this is 
accompanied by significant higher values in the expression of ABCB5 (p≤0.05, 4 out of 6 
eyes). Moreover, no ABCB5 expression was detected for REB17R and REB20L primary 
corneal cells seeded on their own ECM proteins, Figure 30.  
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Figure 30 - The expression of epithelial cell markers by primary corneal cells when cultured on top 
of conjunctival ECM proteins compared with corneal ECM as assessed by Reverse Transcriptase 
qPCR. Data normalised to GAPDH levels. (Data is represented as median ± interquartile range, n≥12). 
Dashed line represents the basal expression of the markers of interests when cells are cultured on 
their own ECM proteins. Abbreviations used GAPDH: glyceraldehyde 3-phosphate dehydrogenase, 
KRT: keratin, ECM: extracellular matrix, ABCB5: ATP-binding cassette sub-family B member 5. 
2.3.7.2. Western Blot 
Primary corneal cells extracted from five donors (eight eyes) were cultured on top of 
conjunctival ECM proteins and their lysates compared against those extracted from primary 
corneal cells cultured on corneal ECM proteins. The results, consistent with transcript 
abundance data, showed: 
i. Lower expression levels of KRT3 (6 out of 8 eyes) and KRT12 in all donors (8 out of 8 eyes), 
Figure 31.  
ii. Higher expression of KRT7 and KRT13 (7 out of 8 eyes), Figure 31.  
iii. Higher expression of ΔNp63 (4 out of 6 eyes) and ABCB5 (5 out of 8 eyes) when corneal 
primary cells were cultured on conjunctival ECM proteins, Figure 31 
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Figure 31 - The expression of epithelial cells markers by primary corneal epithelial cells when 
cultured on top of conjunctival ECM proteins compared with corneal ECM as assessed by Western 
Blot. (A) Bar graphs showing the densitometry quantification of each protein, normalised to the 
expression of β-actin. (B) Western blots representative of one independent experiments. 
Abbreviations used A.U. arbitrary units, KRT: keratin, ABCB5: ATP-binding cassette sub-family B 
member 5, ECM: extracellular matrix. 
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Yet again, no statistical analysis could here be performed because of the lack of cells 
necessary to run more than one reliable sample per donor.  
2.3.7.3. Summary of results 4: 
By culturing primary corneal ECs on top of deposited conjunctival ECM proteins and 
compared to corneal primary cells cultured on their own ECM proteins, there was a 
i. Lower expression of corneal EC markers. 
ii. Higher expression of conjunctival EC markers. 
iii. Higher expression of epithelial SC markers. 
2.3.8. The potential for cell differentiation of the “de-roofed” culture system 
was tested using other cell lines 
To further understand the potential of the hereby developed system for cell differentiation 
two additional cell lines were tested: HaCaT and hESC cell lines. 
2.3.8.1. HCjE-Gi ECM proteins drives higher expression of conjunctival 
epithelial markers by HaCaT cells than the HaCaT ECM 
Since skin cells from the eye lids are in close contact with the conjunctival ECs, a process of 
conversion of skin cells into a conjunctival-like epithelium was tried based on modulation by 
the external environment. KRT1 and KRT10 are widely accepted as differentiation-specific 
markers for ECs lines from human skin (particularly HaCaT cell line) [291]. 
The layout of the experiments was the same as used in the foregoing sections: HaCaT and 
HCjE-Gi cells were separately grown for 9 days, submitted to the process of “de-roofing”, and 
fresh cells cultured on the top of the deposited ECM proteins for 5 days. 
2.3.8.1.1. Reverse Transcriptase qPCR 
When HaCaT cells were cultured on top of conjunctival ECM proteins higher levels of KRT7 
and KRT13 expression were observed (2.6- and 64-fold increase respectively, p<0.01). 
Interestingly, no KRT10 expression was found in such conditions (blue arrow) despite its 
expression to be found when HaCaT cells were cultured on their own ECM proteins, Figure 
32.  
  Chapter 2 
81 
 
A 
KRT1 KRT7 KRT10 KRT13
0.001
0.01
0.1
1
10
100
1000
**
**
Fo
ld
 C
ha
ng
e
No
rm
al
is
ed
 to
 G
AP
D
H

 
Figure 32 - The expression of a panel of keratin by HaCaT cells when cultured on top of HCjE-Gi ECM 
proteins compared with HaCaT ECM as assessed by Reverse Transcriptase qPCR. Data normalised to 
GAPDH. (Data is represented as median ± 5-95 percentile, n≥6, Mann-Whitney test *p<0.05, **p<0.01, 
***p<0.001). Dashed line represents the basal expression of the markers of interests when cells are 
cultured on their own ECM proteins. Blue arrow denotes expression not detected. Abbreviations used 
GAPDH: glyceraldehyde 3-phosphate dehydrogenase, KRT: keratin, ECM: extracellular matrix. 
2.3.8.1.2. Western Blot 
Because KRT10 expression was not detected in Reverse Transcriptase qPCR, this marker was 
left out for western blotting. When HaCaT cells were cultured on HCjE-Gi ECM proteins, lower 
values of KRT1 expression and higher values of KRT13 expression were observed when 
compared to HaCaT cells cultured on their own ECM proteins (p<0.05 and p<0.01, 
respectively), Figure 33. 
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Figure 33 - The expression of a panel of keratins by HaCaT cells when cultured on top of HCjE-Gi ECM 
proteins as assessed by Western Blot. (A) Whiskers graphs showing the densitometry quantification 
of each protein, normalised to the expression of β-actin. (B) Western blots representative of three 
independent experiments. (Data is represented as median ± range, n≥3, Mann-Whitney test, *p<0.05, 
** p<0.01, ***p<0.001). Abbreviations used A.U. arbitrary units, KRT: keratin, ECM: extracellular 
matrix. 
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2.3.8.1.3. Summary of results 5: 
To summarize these results, by culturing HaCaT cells on HCjE-Gi ECM proteins and compared 
to HaCaT cells cultured on their own ECM proteins, there was a: 
i. Higher expression of conjunctival EC markers. 
ii. Lower expression of skin EC markers. 
2.3.8.2. Differentiation of human embryonic stem cells towards conjunctival 
epithelial cells in response to specific ECM proteins 
In the next section, the results obtained by culturing hESCs on ECM proteins produced and 
deposited by HCjE-Gi cells for 9 days will be addressed.  
2.3.8.2.1. Culturing hESCs on ECM deposited by conjunctival cells drives the 
expression of conjunctival transcripts 
The results in this section were obtained by comparing the expression of the genes of interest 
at a certain day of experiment against their expression at day 0 (RNA extracted from hESCs 
in suspension). 
2.3.8.2.1.1. Stem cell marker expression  
An up-regulation of ΔNp63 expression was only observed at day 1, 3, and 13 (nearly 10-fold 
increase, not statistically significant, NSS). An up-regulation of ABCB5 expression was seen 
at day 1 (2.8-fold increase, NSS) followed by a downregulation throughout the rest of the 
course of experiment (100 to 10-fold decrease, NSS). Moreover, the expression of 
undifferentiated hESCs markers, NANOG, SOX2, and OCT4 peaked at day 1 (9.6-, 2.6-, and 
1.9-fold increase, respectively, NSS) and at day 9 (3.4-, 12-, and 6.8-fold increase, 
respectively, NSS). At day 3 a minimum in their expression levels was observed (lower than 
10-fold decrease), Figure 34.  
2.3.8.2.1.2. Corneal epithelial cell markers expression 
A peak in expression of corneal epithelial marker KRT3 was observed at day 9 (9.7-fold 
increase, p<0.05 when compared to earlier time-points), while the expression of KRT12 was 
only detected in one sample at day 6 and day 9 (NSS), Figure 34.  
2.3.8.2.1.3. Conjunctival epithelial cell markers expression 
The expression of terminally differentiated conjunctival epithelial markers KRT7 and KRT13 
peaked at day 9 (11- and 12-fold increase, respectively, NSS), Figure 34.  
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The results shown in this section were not statistically different of those obtained when RNA 
is extracted from hESCs in suspension (dashed line), however, a trend toward the 
differentiation, although incomplete, into epithelial-like cells is appreciated accompanied by 
a decrease in expression of epithelial and embryonic SC markers.  
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Figure 34 - The expression of epithelial and stem cell markers by human embryonic stem cells when 
cultured on top of HCjE-Gi ECM proteins compared with hESC ECM as assessed by Reverse 
Transcriptase qPCR. (Data is represented as median ± 5-95 percentile, n≥3, Kruskal-Wallis test 
followed by a Dunn’s Multiple Comparison Test, Bonferroni corrected p-value, *p<0.05, **p<0.01, 
***p<0.001). Dashed line represents the basal expression of the markers of interests at day 0. Arrows 
represent expression not detected. Abbreviations used GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase, ABCB5: ATP-binding cassette sub-family B member 5, KRT: keratin, ECM: extracellular 
matrix. 
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2.3.8.3. Differentiation of human embryonic stem cells towards corneal 
epithelial cells in response to specific ECM proteins 
In the next section, the results obtained by culturing hESCs on ECM proteins produced and 
deposited by hTCEpi cells for 9 days will be addressed. 
2.3.8.3.1. Culturing hESCs on ECM deposited by corneal cells drives the expression of 
corneal transcripts 
The results in this section were obtained by comparing the expression of the genes of interest 
at a certain day of experiment against their expression at day 0 (RNA extracted from hESCs 
in suspension). 
2.3.8.3.1.1. Stem cell marker expression 
Various peaks of ΔNp63 expression were observed throughout the course of the experiment 
(day 1 and day 6-9, NSS) with no expression being detected at day 3. A downregulation of 
ABCB5 to negligible values was seen throughout the whole course of experiment (0.0039- to 
0.016-fold decrease, NSS). Moreover, the expression of undifferentiated hESC markers 
NANOG peaked at day 6-9 (13- 79-fold increase, respectively, NSS), SOX2 and OCT4 reached 
maximums of expression between day 6 and day 11 (NSS). Additionally, their expression 
showed minimums levels in the early time points (10-fold decrease, NSS), Figure 35.  
2.3.8.3.1.2. Corneal epithelial cell markers expression 
The expression of the differentiated corneal epithelial marker KRT3 peaked at day 9 (72-fold 
increase, NSS). Interestingly, no KRT12 expression was detected after day 1 (blue arrows), 
Figure 35.  
2.3.8.3.1.3. Conjunctival epithelial cell markers expression 
A peak in the expression of conjunctival epithelial marker KRT7 was observed at day 6-11 
with little variations in its expression throughout the rest of the course of experiment (NSS), 
while the expression of KRT13 was only increased at day 6 (NSS), Figure 35.  
The results shown in this section were not statistically different of those obtained when RNA 
was extracted from hESCs in suspension (dashed line), however, a trend towards the 
differentiation, although incomplete, into epithelial-like cells could be appreciated 
accompanied by a decrease in expression of epithelial SC markers. 
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Figure 35 - The expression of epithelial and stem cell markers by human embryonic stem cells when 
cultured on top of hTCEpi ECM proteins compared with hESC ECM as assessed by Reverse 
Transcriptase qPCR. (Data is represented as median ± 5-95 percentile, n≥3, Kruskal-Wallis test 
followed by a Dunn’s Multiple Comparison Test, Bonferroni corrected p-value, *p<0.05, **p<0.01, 
***p<0.001). Dashed line represents the basal expression of the markers of interests at day 0. Arrows 
represent expression not detected. Abbreviations used GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase, ABCB5: ATP-binding cassette sub-family B member 5, KRT: keratin, ECM: extracellular 
matrix. 
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2.3.9. Summary of results of Chapter 2: 
To summarize these results, by culturing HCjE-Gi cells on top of hTCEpi ECM proteins and 
compared to HCjE-Gi cells cultured on their own ECM proteins: 
i. The “de-roofed” culture system showed great potential in modulating the expression of 
several EC markers. 
ii. HCjE-Gi cells cultured on top of hTCEpi ECM proteins were found to express corneal EC 
markers. Similar trends were observed when primary conjunctival cells were used. 
iii. hTCEpi cells cultured on HCjE-Gi ECM proteins were found to express conjunctival EC 
markers. Similar trends were observed when primary corneal cells were used. 
iv. The cell re-differentiation is preceded by a process of cell de-differentiation. 
v. HaCaT cells cultured on HCjE-Gi ECM proteins were found to express conjunctival EC 
markers. 
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2.4 Discussion  
Since ECs are closely associated with the connective tissue in vivo, others have suggested the 
possibility of ECM to be involved in specifying their pattern of keratin expression and 
phenotype [170], governing also cell migration [173] and differentiation [172, 174, 175, 253, 
254]. The results outlined in this chapter highlight the role of ECM proteins for inducing the 
differentiation of ECs from the human ocular surface into a specific lineage, as assessed by 
various methods. 
2.4.1. hTCEpi ECM proteins drive higher expression of corneal and stem cell 
epithelial markers by HCjE-Gi cells than the HCjE-Gi ECM 
Reverse Transcriptase qPCR, total protein, and flow cytometry data show very consistent 
trends and results. Taken together the three data sets showed that when HCjE-Gi cells are 
cultured on hTCEpi proteins they show higher expression levels of corneal EC and epithelial 
SC markers (likely to indicate the emergence of early epithelial progenitor cells) and lower 
expression levels of conjunctival EC markers when compared to those obtained from HCjE-
Gi cells cultured on HCjE-Gi ECM proteins. These data sets suggested that the HCjE-Gi cells, 
a conjunctival cell line, start to show corneal epithelial-like characteristics, losing their 
conjunctival epithelial phenotype in a process that involves an intermediate step of cell de-
differentiation, an approach suggested by Kragl et al. in other organisms [204]. 
HCjE-Gi cells cultured on HCjE-Gi ECM proteins also expressed the ‘specific’ corneal 
epithelium-associated markers, although at lower levels when compared to those cultured 
on hTCEpi ECM proteins. Two different reasons help to explain these results. Firstly, the 
presence of ectopic clusters of KRT12-positive cells in human conjunctival tissue localized in 
the vicinity of SCs has been shown [292]. Secondly, KRT3 has also been shown to be 
expressed in bovine conjunctival epithelium in vitro but not in vivo [170]. These observations 
suggest that KRT3 may be antigenically masked in vivo and the detected expression may be 
a result of the KRT3 epitope “unmasking” in in vitro cultures, as seen in cells undergoing 
mitosis [293]. This would imply that KRT3 expression in conjunctiva is in situ inhibited by 
some sort of exogeneous factor and upon culture this exogenous factor is somehow lost. The 
source of this “negative” factor could be the vast blood vessel system present in the 
conjunctiva in vivo, which is absent in the cornea. However, the possibility that there may be 
an induction of KRT3 production in vitro by HCjE-Gi cells should not be ruled out.  
The residual expression of conjunctival markers KRT7 and KRT13 by HCjE-Gi cells cultured on 
hTCEpi ECM proteins suggested that, although the major differentiating lineage is that of 
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corneal epithelium, it may not be the only one, with other epithelial lineages likely to be 
formed. Other explanation for this arises from the notion that proliferation and 
differentiation are not mutually exclusive processes, i.e. the expression of a new gene 
product is not necessarily linked to functional irreversibility [64]. Suggesting that whilst some 
conjunctival cells are differentiating towards the corneal epithelial-like lineage, a pool of 
conjunctival cells may still be proliferating, exhibiting the conjunctival-like characteristics. 
Interestingly, Mackay et al. have compared the production of KRTs by cells seeded on 
Matrigel and on “de-roofed” matrices [294]. They have shown that cells seeded on Matrigel 
lack the production of several cytokeratins relative to the large amounts found on the “de-
roofed” systems. These observations suggest that the structural integrity, subtle biochemical 
features of the intact BM, and other growth factors produced by cells and trapped within the 
BM (see mass spectrometry results on Chapter 3) are of crucial importance to trigger cell 
differentiation. In this regard, the hereby study overcomes this issue since the ECM is 
produced by the specific cell type that populates each structure of the ocular surface, 
maintaining its structural integrity and the inherent pool of soluble factors trapped within 
the ECM proteins. Taken together, the structural and the biochemical cues provided by the 
ECM show to be important trigger signals to induce cell differentiation. Supporting this idea 
are the studies from Kurpakus et al. [170] and Moyer et al. [251], who showed that 
conjunctival cells cultured on intact corneal BM express KRT12 [170] and, on the other hand, 
cultures lacking an intact corneal BM failed to trigger KRT12 expression [170, 251]. 
Specific components of the BM, such as several laminin isoforms or collagen types, have been 
used to trigger the expression of KRT12 by conjunctival ECs with no success [295]. Others 
have also showed that conjunctival cells in organotypic cultures failed to express KRT12 when 
they are subjected to air-liquid interphase, a method to promote KRT12 expression by 
corneal ECs [296].  
2.4.2. HCjE-Gi ECM proteins drive higher expression of conjunctival and stem 
cell epithelial markers by hTCEpi cells than the hTCEpi ECM 
Taken together the Reverse Transcriptase qPCR, Western blot, and flow cytometry data show 
that hTCEpi cells cultured on HCjE-Gi ECM express higher levels of conjunctival and SCs 
epithelial markers and lower levels of corneal epithelial markers when compared to those 
cultured on hTCEpi ECM proteins. These results suggested that the hTCEpi cells, a corneal 
cell line, show conjunctival epithelial-like characteristics, losing its corneal epithelial 
phenotype in a process that involves an intermediate step of cell de-differentiation. 
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Conversely, these are the equivalent opposite results of those obtained by HCjE-Gi cells, 
suggesting that the cell plasticity can be modulated in both ways when cells are given the 
appropriate extracellular cues.  
The results obtained using cell lines as models were further confirmed using primary cells. 
Very similar trends were found, however, with greater variability, intrinsic to the utilization 
of primary (non-immortalized) cells. The variability of results can be consequence of several 
aspects including differences on post-mortem time of retrieval and other donor-to-donor 
variances (age, lifestyle, etc). However, primary cells retain normal cellular functions, 
signalling and genetic integrity, and are not genetically modified in any way beyond natural 
exposure to environmental insults typically encountered during the lifespan of the organism 
from which they were isolated. When compared, the results obtained by primary and cell 
lines showed an interesting trend. With exception of KRT3 (Figure 28) and ΔNp63 (Figure 30), 
the expression of all markers by the two cell lines showed to be close to an average value of 
the widespread values obtained by primary cells. This suggests that the used cells lines have 
a similar “average” behaviour when compared to the primary cells from the tissues that they 
were extracted from. 
Previous experiments have led to the suggestion that cells, upon injury, dedifferentiate not 
into a complete pluripotent state but rather to restricted progenitor cells [204]. Accordingly, 
Tata et al. have shown the de-differentiation of committed airway luminal secretory cells 
into stable and functional SCs in vivo [297]. Garcia-Arraras et al. have also shown a process 
of dedifferentiation of ECs to mesenchymal phenotypes during intestinal regeneration [298]. 
Similar to those observations, the studies in this thesis suggested that the process of re-
differentation may be preceded by an intermediate state of dedifferentiation as an increase 
in expression of putative epithelial SC markers was observed. However, the dedifferentiation 
and/or cell division are not obligatory processes in the conversion from one cell type into 
another [212]. 
The mechanisms involved in tissue-type cell differentation requires differential signal 
transduction from the ECM to the overlying cell layers [299, 300]. Proteins from the integrin 
family (reviewed in section 3.1.4) are the main candidates for the transduction of such signals 
[301, 302]. α6β4 and α3β1 integrins are two of the most common dimmers located along the 
region where ECs contact the BM [303]. Studies using conjunctival ECs have shown that by 
blocking β1 integrin chain, the focal adhesion kinase tyrosine (a protein involved in cell 
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adhesion) is phosphorylated, i.e. activated. The same results were not obtained when β4 
integrin chain was blocked, suggesting that different integrins have different effects on cell 
adhesion [304]. The same studies have also shown that the EC adhesion to different laminins 
isoforms activate different intracellular signalling pathways [304], suggesting that different 
ECM proteins activate different signalling pathways, which can modulate EC differentiation 
via alternate signalling pathways.  
The methods shown in this chapter open a new door for the possibility of promoting EC 
differentiation in in vitro culture models based on the cross-talk cell-ECM. The approach here 
applied showed that conjunctival ECs cultured in vitro can be triggered to express KRT3 and 
KRT12, although with no need for the presence of some sort of exogenous factor to trigger 
their expression as seen in in vivo systems [293].  
2.4.3. HCjE-Gi ECM proteins drive higher expression of conjunctival markers 
by HaCaT cells than the HaCaT ECM 
To further corroborate the ECM-driven differentiation, HaCaT cells were cultured on ECM 
proteins deposited by HCjE-Gi cells and the extent of differentiation assessed using specific 
markers for each epithelial population. Reverse Transcriptase qPCR and Western blot results 
confirmed this hypothesis. Both data sets showed a decrease in expression of skin epithelial 
markers KRT1 and KRT10 and a significant increase in expression of conjunctival markers 
KRT7 and KRT13 when HaCaT cells were cultured on HCjE-Gi ECM. These results suggest a 
differentiation toward the conjunctival epithelial-like lineage accompanied by a loss in skin 
epithelial-like features. Others have, however, showed that HaCaT cells express KRT13 [305] 
and low levels of KRT7 [306]. In the opposite direction, Wild et al. have yet shown that KRT1 
and KRT10 may be expressed in conjunctival epithelium in result of focal inflammatory 
responses to environmental stresses [307]. 
These results showed that regardless the origin of the differentiated cells they can be 
induced to differentiate towards the lineage of cells that deposited the ECM proteins.  
2.4.4. Potential of differentiating human epithelial cells towards a desired 
cell lineage 
The studies in this chapter describe a new approach for the differentiation of ECs in response 
to the ECM composition and morphogenic cues in in vitro systems. This provides a further 
step towards refinement of protocols to produce techniques with potential therapeutic 
purposes. Several improvements need to be carried out: 
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i. Functional studies to prove functionality of the differentiated cells need to be carried out 
to prove that the differentiated cells can function as the target cell type. 
ii. Full differentiation of the differentiating cells to prevent the risk of transplantation of 
early progenitor ECs that may led to the formation of tumours so that, either the process 
of differentiation must be refined or the cells expressing these markers selectively 
purified. 
iii. Double labelling of cells for KRT3/12 plus KRT7/KRT13 to assess if the same 
differentiating cell express both corneal and conjunctival markers. Additionally, double 
labelling for corneal or conjunctival markers plus putative epithelial SC markers would 
unveil the percentage of dedifferentiating cells.  
To conclude, two factors have been suggested to modulate the expression of corneal 
markers by conjunctival cells: (1) the morphological cues of the cornea BM and (2) and an 
exogenous factor that can trigger the expression of corneal epithelial markers when not in 
conjunctival environments. The hereby studies agreed with both these hypotheses, raising 
an approach suitable for cell culture and differentiation.  
2.4.5. Specific ECM proteins promote the partial differentation of human 
embryonic stem cells 
2.4.5.1. Expression of conjunctival epithelial associated markers by human 
embryonic stem cells 
The studies outlined in this section highlight the importance of the HCjE-Gi ECM composition 
for inducing the differentiation of hESCs into conjunctival epithelial-like lineage. This was 
partially achieved by replicating the environment present in human conjunctival epithelium 
within the in vitro system by “de-roofing” the cell cultures and leaving the conjunctival-
associated ECM proteins attached to the cultureware. The experiments suggested that the 
culture of hESCs on conjunctival ECM proteins results in an incomplete differentiation of 
these cells into conjunctival epithelial-like cells as assessed by Reverse Transcriptase qPCR. 
The observed peak in ΔNp63 and ABCB5 expression at earlier time-points (day 1 and day 1-
3, respectively), however not statistically different, is likely to indicate the emergence of 
early epithelial progenitor cells. This is accompanied by a downregulation in expression of 
undifferentiated hESCs markers NANOG, SOX2, and OCT4. Additionally, the expression of 
OCT4 decreased to values less than 2-fold decrease (NSS) suggested a differentiation of 
hESCs into trophectoderm lineage [282]. This was also followed by the appearance of 
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terminally differentiated conjunctival EC markers KRT7 and KRT13 at day 9 (NSS). 
Additionally, the expression of KRT3 (a marker for terminally differentiated corneal ECs) was 
an indication of an ESC incomplete differentiation towards the conjunctival epithelial-like 
lineage. The non-significance of results may be result of the small number of reliable samples 
used (n=3), therefore a larger number of samples and protein data (Western blotting and/or 
flow cytometry) are of the upmost need. The mass spectrometry results, addressed in 
Chapter 3, showed a specific ECM composition for each cell line herein used. The specificity 
in composition is not only shown at protein but also at soluble factors levels, the latter 
produced by cells and trapped within the protein meshwork. The morphogenic cues provided 
by such composition may trigger the process of hESC differentiation, which has long been 
associated with interactions with external cues [178, 179, 308], in response to the mimicked 
conjunctival environment. In accordance with these observations, Wang et al. have yet 
suggested that the in vitro strategies for the differentiation of ESC toward the derivatives of 
all three germ layers are a recapitulation of biochemical cues present during embryogenesis 
[309].  
2.4.5.2. Specific ECM proteins promote the expression of corneal epithelial 
associated markers by human embryonic stem cells 
The studies outlined in this chapter highlighted the importance of the corneal ECM 
composition for inducing the differentiation of hESCs into corneal epithelial-like lineage. This 
was partially achieved by replicating the environment present in human corneal epithelium 
within the in vitro culture system. The observed peak in ΔNp63 and ABCB5 expression at 
earlier time-points (day 1 and day 1-3, respectively) is likely to indicate the emergence of 
early epithelial progenitor cells. This is accompanied by a downregulation in expression of 
undifferentiated hESCs markers NANOG, SOX2 and OCT4 at day 6 suggesting an early 
differentiation, however, the expression of these markers is shown to be upregulated at later 
time-points. This was accompanied by the expression of the terminally differentiated corneal 
EC marker KRT3 and markers for other epithelial lineages (KRT7 and KRT13). Based on this 
data it appears that differentiation towards an epithelial-like lineage is occurring in response 
to the mimicked human corneal environment. Yet again the non-significance of results may 
be result of the little number of samples used (n=3), and therefore a larger number of 
samples and protein data are of the upmost need to confirm this data. 
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2.4.5.3. Differences exist between the potential of the two ECM proteins 
meshwork used herein for the hESC differentiation 
When the potential of the two decellularized ECM meshwork are compared, some 
differences in the magnitude of the fold changes are observed, despite the similar trends 
that were seen on gene expression profiling. Firstly, HCjE-Gi ECM appeared to promote a 
higher expression of ABCB5 by hESCs when compared to hTCEpi ECM suggesting an increased 
emergence of epithelial progenitor cells in the first condition. Secondly, the expression of 
undifferentiated ESC markers NANOG, SOX2, and OCT4 is higher at later time-points in 
hTCEpi ECM when compared to HCjE-Gi ECM, indicative of cells in less differentiated states. 
Thirdly, the expression of terminally differentiated ECs markers was lower in hTCEpi ECM, 
indicative of lower epithelial lineage commitment. The results in Chapter 3 showed a higher 
expression of laminin α5 by hTCEpi cells, as seen by the higher amount of protein detected 
in flow cytometry and ICC data and higher values of fold increase observed in Reverse 
Transcriptase qPCR data. Recent evidence has shown that this laminin isoform alone is 
sufficient to maintain the undifferentiated state and the pluripotency of ESC [310-313]. 
Taken together, these observations suggest a less differentiated state of hESCs and less 
commitment toward a differentiated epithelial-like lineage when cultured in hTCEpi ECM 
proteins possibly due to the higher amount of laminin α5 present in that condition. Further 
evaluation should then be performed in that regard.  
2.4.5.4. Potential of differentiating human embryonic stem cells towards a 
desired cell lineage 
The studies in this chapter assessed for the first time the differentiation of hESCs toward 
conjunctival and corneal epithelial-like lineages in response to the whole set of ECM proteins 
produced by two different EC lines – HCjE-Gi and hTCEpi. The non-significance of results and 
the expression of various hESC markers at later time-points may suggest that the ECM alone 
is not sufficient for hESCs differentiation toward the desired lineages. However, the 
combination with other external cues, such as conditioned medium and/or exosomes 
collected from differentiated conjunctival or corneal culture systems, may promote such 
process as shown by others with various degrees of success. These include, surface coating 
with collagen IV and use of limbal fibroblast medium [178], surface coating with laminin-332 
[179], and co-culture of murine ESC with conjunctival ECs using transwell techniques [314]. 
Further improvements need to be carried out to fully characterize the technique hereby 
used, as follows: 
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i. Studies at protein expression levels. The transcript expression data need to be 
corroborated at protein expression levels (Western blot and/or flow cytometry). 
ii. Complete differentiation. hESCs need to be fully differentiated toward the desired 
lineage, as the expression of some markers, such as KRT3 by hESCs cultured in HCjE-Gi 
ECM proteins, KRT7 and KRT13 by hESCs cultured in hTCEpi ECM are indicatives of 
incomplete differentiation. 
iii. Functional studies. The differentiated hESCs need to the proven functional in the same 
way as the targeted lineage.  
iv. Expression of hESCs markers. Some cells still expressed some of the undifferentiated 
hESCs markers. This can result in teratoma formation upon transplantation and therefore 
further purification and/or fully differentiation steps need to be carried out to eliminate 
this risk. 
v. Allogeneic source. The differentiated cells, being of an allogeneic source, remain 
immunogenic and will require the use of potent immunosuppression drugs [315]. 
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Chapter 3  
Differences exist in the response of conjunctival and corneal epithelial 
cells to extracellular matrix proteins 
3.1. Introduction  
The ECM is a crucial part of the extracellular microenvironment, providing signalling cues to 
regulate many aspects of cellular behaviour. These include cell migration, adhesion, 
morphology, and differentiation [316-323]. The ECM is composed of a complex meshwork of 
several collagen types, proteoglycans, laminins isoforms and many other proteins produced 
within the cells and eventually released to the extracellular environment via exocytosis [324]. 
Broadly, the ECM includes the interstitial matrix, which constitutes the intercellular spaces, 
and the BM, where the cells rest promoting cell polarity. In vivo all cells are in close contact 
with the surrounding ECM, however striking spatial differences exist in the way different cell 
types interact with their ECM. While most cells are surrounded by their ECM, ECs only 
contact their matrix at the basal side with no contact at their apical side.  
 Cell-ECM interactions  
Cell-ECM interactions are essential for many biological processes, including tissue 
development and repair, homeostasis, and response to injury [299]. The cell surface 
possesses two different groups of receptors that primarily mediate the interactions with the 
ECM: non-integrin and integrin receptors [325]. Non-integrin receptors include the syndecan 
family that may bind to collagens, fibronectin, thrombospondin, and bFGF [326]. Integrin-
based adhesive complexes include focal adhesions, which link the ECM (via fibronectin 
adhesion motives) to the actin cytoskeleton within the cell, and hemidesmosomes, that 
connect the ECM to intermediate filaments, such as keratins. The integrins are responsible 
for passing information about the chemical and mechanical composition of the ECM into the 
cell [327]. Downstream to ECM-integrin binding, several processes may be activated, these 
include clustering of the receptors, activation of intracellular protein kinases, 
phosphorylation of cytoskeleton and other associated proteins, and transmission of the 
signal generated by receptor occupancy to the transcriptional machinery in the nucleus 
[328]. In addition to providing instructive signals through direct ligand interactions, the ECM 
can signal in a more indirect approach by sequestering different types of growth factors and 
cytokines, acting as a local reservoir releasing its contents in response to changes in 
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physiological conditions [329-331]. These molecules can activate classic signal-transduction 
pathways that induce cell growth, proliferation, and gene expression [327, 332, 333] but also 
regulate the transcription, translation, and post-translational modifications of ECM 
macromolecules [334]. The binding of growth factors to the ECM is mainly regulated by the 
side chains of glycosaminoglycans [335]. An extensive review of association of growth factors 
with ECM proteins can be found at Adams and Watt [299].  
HDs are integrin-mediated adhesion complexes mainly found on the basal surface of 
specialized ECs, such as the intestine and skin [336]. They are responsible for firmly anchoring 
the ECs to the underlying BM, therefore increasing the overall rigidity of epithelial tissues. 
The cytoplasmic side of a HDs is composed of a plaque of adapter proteins attached to the 
end of a keratin filament [327, 337], Figure 36. Two types of HDs can be distinguished: type 
I present in the cornea and other epithelial tissues [4, 338] and type II present in intestinal 
epithelia [337]. The type I HDs correspond to the typical and conventional type of HDs, they 
are composed of 5 components (early named HD1-HD5): plectin, BP230, β4 integrin, collagen 
XVII, and α6 integrin, respectively. Type II HDs are negative for BP230 and collagen XVII and 
there is no direct evidence that type II HDs are involved in cell adhesion. 
Keratin filament 
Collagen XVII 
Plectin 
BP230 
Cell membrane Laminin 
ECM 
α6 integrin 
β4 integrin 
Figure 36 – Model for hemidesmosomes assembly. The association of the α6β4 integrin with the 
plectin plaque is essential for the formation of type II hemidesmosomes. When collagen XVII is 
present, it is incorporated into this complex through interactions with integrin and plectin. This is 
followed by the recruitment of additional plectin-collagen XVII complexes, resulting in further 
increase of size and stability of hemidesmosomes. The final step comprises the incorporation of 
BP230, and the hemidesmosomes containing α6β4 integrin, collagen XVII and plectin are turned into 
type I hemidesmosomes. Plectin and BP230 interact in the same site on collagen XVII, and it is likely 
they compete for this binding site. Abbreviations used ECM: extracellular matrix. Adapted from [3, 4]. 
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 ECM composition  
The ECM is composed of two biochemically and morphologically separate structures, the 
interstitial matrix and the BM [339, 340]. The interstitial matrix is mainly composed of 
proteoglycans, mostly chondroitin sulphate and heparan sulphate [341], fibronectin [342], 
elastin, and collagens types I, III, V, VI, VII, and XII [339]. BM is a sheet-like deposition located 
at the interface between the ECs and the connective tissue. Its composition is tissue-specific 
and varies with the state of differentiation and development [343, 344]. Broadly, it contains 
collagen type IV [340, 345], a wide variety of laminin isoforms [340], and heparan sulphate 
[346]. Some ECM constituents help to protect cells against compression and shear forces, 
whilst others regulate several cell functions [179, 347, 348]. As the proteoglycans are 
negatively charged they attract the positively charged ions which in turn attract water 
molecules via osmosis, keeping the cells hydrated [349]. Elastin, as the name suggests, gives 
elasticity to the tissues [350]. Collagens are by far the most abundant component of ECM, 
around 90% of ECM is composed by those. They are present as fibrillary proteins giving 
structural support to the resident cells [347]. Heparan sulphate binds to variety of protein 
ligands and regulates several biological processes, such as development and angiogenesis 
[347, 348].  
3.1.2.1. Basement membrane – cornea versus limbus 
The corneal and limbal BMs are mainly composed of type IV collagen and laminins (the most 
abundant non-collageneous glycoproteins in the BM). Immunohistochemistry studies have 
shown a corneal BM mainly composed of collagen type IV α3, α4, α5, and α6 chains, and 
laminin α1, α3, α5, β1, β3, γ1, and γ2 chains. Moreover, the limbal BM contain additional 
collagen type IV α1 and α2 chains, and laminin α2 and β2 chains, but no collagen IV α3 and 
α4 chains. More importantly, limbal BM shows unique features, such as an increased 
expression of laminin α1, α2, β1 chains and a specific expression of laminin γ3, BM40/SPARC 
(which function as a modulator of cellular interactions with the ECM), and tenascin-C (a 
glycoprotein regulator of cell-matrix interactions), when compared to both corneal and 
conjunctival BM [46].  
3.1.2.2. Basement membrane – limbus versus conjunctiva 
Type IV collagen is also the major structural component of the conjunctival BM. The main 
differences on collagen composition arise from higher amounts of α5 and α6 chain of 
collagen IV and collagen type XVI in limbus BM when compared to conjunctiva BM [46]. 
Regarding the laminin composition, the main differences are the presence of laminin α1 
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chain in limbus but not in the conjunctiva, and the higher expression of laminin α2 chain and 
laminin β1 chain in the limbus BM. Laminin γ3 chain is shown at the anterior limbal zone and 
is confined to the base of the epithelial rete ridges in the posterior limbal region and to few 
isolated locations in the anterior conjunctiva. Studies by Schlötzer-Schrehardt et al. 
suggested the laminin-211 and laminin-213 as the most specific laminins for the limbal BM 
[46]. Clusterin (a glycoprotein that protects cell membrane and stabilizes cell-matrix 
interactions) was found at higher intensities in conjunctiva, with decreasing intensities in 
posterior limbus, being absent in the anterior limbus. Thrombospondin-4 showed an 
augmented labelling intensity in the posterior conjunctiva, when compared with the limbus 
and the anterior conjunctiva [46].  
Besides these differences, there are features shared by the limbus and the conjunctiva BM, 
such as the pattern of collagen distribution (type IV chain α1, α2, α3, and α4 and type V, VI, 
and VII), the intensity of several glycoproteins, such as laminin-111, -322, α3, α5 chain, β2, 
β3, and γ2 chain, and thrombospondin -1. Regarding their composition in proteoglycans, the 
expression of type XV and XVIII collagen is also similar in both BMs [46]. Additionally, 
perlecan (the major BM heparin sulphate proteoglycan), fibronectin, nidogen-1 and -2 
(glycoproteins with crucial roles in BM assembly by connecting collagen IV and laminin 
networks), and type VII collagen are found throughout the whole ocular surface BM [29, 351, 
352]. A complete list of BM protein expression profile can be found in Table 11. 
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Table 11 - Localization of basement membrane components across the ocular surface. Abbreviations 
used: – no expression; -/+ weak expression; + moderate expression; ++ strong expression; BM: 
basement membrane. LAM: laminin. Adapted from [46].  
BM component Central cornea 
Peripheral 
cornea 
Anterior 
limbus 
Posterior 
limbus Conjunctiva 
Collagens      
Collagen IV + + + + + 
Collagen IV α1 chain - - + or ++ + or ++ + or ++ 
Collagen IV α2 chain -/+ -/+ ++ ++ ++ 
Collagen IV α3 chain + or ++ + - - - or -/+ 
Collagen IV α4 chain - or -/+ - or -/+ - - - or -/+ 
Collagen IV α5 chain ++ ++ ++ ++ ++→+→-/+ 
Collagen IV α6 chain ++ ++ ++ ++ +→-/+→- 
Collagen V + + - - - 
Collagen VI - - - - - 
Collagen VII ++ ++ ++ ++ ++ 
Collagen XVI - + (sub BM) ++ (sub BM) - - 
Collagen XVII + + + +(gaps) + 
Glycoproteins      
LAM-111 + + + + + 
LAM-332 ++ ++ ++ ++ ++ 
LAMα1 chain - or -/+ + + + - 
LAMα2 chain - - or -/+ + ++ + 
LAMα3 chain + + + + + 
LAMα4 chain - or -/+ - or -/+ - - - 
LAMα5 chain - or -/+ -/+ or + + + + 
LAMβ1 chain -/+ or + -/+ or + ++ ++ + 
LAMβ2 chain - - + + + 
LAMβ3 chain + + + + + 
LAMγ1 chain -/+ or + + ++ ++ ++ 
LAMγ2 chain ++ ++ ++ ++ ++ 
LAMγ3 chain - - + ++ (focal) + (focal) or - 
Fibronectin + + ++ ++ + 
Nidogen-1 + + ++ ++ ++ 
Nidogen-2 -/+ + ++ ++ ++ 
Clusterin + ++ - + ++ 
Thrombospondin-1 + + - - - 
Thrombospondin-4 - + (focal) + (focal) + (focal) + (focal) 
Proteoglycans      
Perlecan ++ ++ ++ ++ ++ 
Collagen XV + + + + + 
Collagen XVIII ++ ++ ++ ++ ++ 
 Laminins  
Laminins are heterotrimeric molecules composed of one α, one β, and one γ chain, each 
derived from a different gene, which assemble into a disulphide-bonded heterotrimer with 
a cross-shaped structure [353]. The laminins have a central α chain (approximately 400KDa) 
with a varying number of globular regions and a β and γ chains (approximatively 200KDa) 
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with α-helical and globular regions. In higher organisms, 5α (LAMA1–5), 3β (LAMB1–3), and 
3γ (LAMC1–3) chains have been identified [353]. Restrictions in the interaction potential and 
distribution patterns allow only 16 different laminins combinations to be found in vivo, 
despite the 51-possible different αβγ trimers combinations [353]. These proteins are named 
according to their chain composition, as follows: laminin-521 consists of a α5, β2 and γ1 
chains [353]. Laminin trimers assemble and undergo glycosylation intracellularly, prior to 
secretion as intact heterotrimers into the ECM [354, 355]. Once secreted, higher order 
structures are formed, and some are proteolytically processed [356, 357], enabling 
interaction with other proteins. Cells interact with laminins through integrins forming 
complexes that mediate numerous cell functions, including embryonic development, cell 
migration, proliferation and differentiation, and BM assembly [299, 358]. The glutamic acid 
residue in the C-terminal region of the γ chain and the three globular modules in the α chain 
are necessary for binding to integrins [359]. Furthermore, the C-terminal region of the β 
chain possesses a short amino acid sequence to enhance laminin-integrin affinity [360]. 
Laminin γ1 chain is the widest expressed laminin subunit, being present in 10 out 16 known 
laminin isoforms [361, 362]. Laminin isoforms containing α1 and α3 chains are 
predominantly found in epithelia, whereas α2- and α4-containing laminins are mainly found 
in mesenchymal tissues. Additionally, laminins containing α5 chain are expressed in both 
epithelial and mesenchymal cells [361, 363, 364]. Within the cornea the most abundant 
laminin trimer is the laminin -332 with smaller amounts of laminin-111, laminin-311, and 
laminin-511 also being present [351, 352, 365, 366]. The conjunctival BM also contains the 
laminin-332 and laminin-111 [351, 352] but differs from the corneal BM by the expression of 
the α2- and β2-containing laminins, including laminin-211, laminin-221, and laminin-521 [46, 
304].  
Based on observations that laminin-511 contacts the inner cell mass of blastocysts in mice 
[367], this isoform has been used as substrates to enable mouse ESCs self-renewal for a 
period of over 5 months [311]. Others have used fragments of laminin-511, termed laminin 
E8 fragments, as alternatives to Matrigel® or to other feeder layers for culturing hESCs [313]. 
Cells cultured in these laminin fragments maintain high level expression of pluripotency 
markers even after 30 passages and show differentiating capacity into all three germ layers 
[313]. 
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Table 12 - Laminins: its expression, and their receptors. Table adapted from [355, 363, 368-374]. A 
full description can be found at Li et. al [375].  
Laminin 
isoform Main site of expression Integrin receptors 
111 Embryonic and adult epithelium (kidney, liver, testis, ovary) including cornea 
Integrins α1β1, α2β1, 
α6β1, α7β1, α9β1 
121 Placenta  
211 Muscle, heart, peripheral nerve, testis Integrins α1β1, α2β1, α6β1, α7β1 
221 Muscle, heart, peripheral nerve, neuromuscular junction  
332 
Major adhesive component of the epidermal 
BM, including cornea, conjunctiva, and limbal 
BM 
Integrins α3β1 and 
α6β4 
411 Endothelium, smooth muscle, fat, peripheral nerve Integrins α6β1, α7β1 
421 Endothelium, smooth muscle, neuromuscular junction  
511 Developing epithelium, mature epithelium, mature endothelium, smooth muscle 
Integrins α2β1, α3β1, 
α6β1, α6β4, α7β1, 
αvβ3 
521 
Mature epithelium, mature endothelium, 
smooth muscle, neuromuscular junction, 
glomerular basement membrane 
 
 
Laminins are assembled intracellularly through a coiled-coil domain, termed LCC. They are 
then secreted as heterotrimeric molecules composed of one α, one β, and one γ chain [376]. 
The mechanisms by which cells deposit their laminins are not yet fully understood. However, 
two different mechanisms exist for laminin polymerization, these are self and co-
polymerization. Self-polymerization involves the self-assembly of one certain heterotrimer, 
producing a matrix composed of only one laminin isoform. In contrast, co-polymerization 
requires the interaction of two or more laminin heterotrimers, resulting in a complex matrix 
composed by more than one isoform. These two processes exclude the formation of laminins 
containing α4 chain (truncated chain) and occur whilst the laminin chains are still bound to 
the receptors on the cell surface [377, 378].  
 Integrins  
Integrins are a heterodimeric transmembrane molecules composed of an α and β chains non-
covalently associated that facilitate cell-ECM adhesion [379, 380]. Integrins are classified 
according to their ligands, and in mammals at least 22 integrin heterodimers are known 
[327]. Their structure consists of a relatively large ectodomain, membrane-spanning helixes, 
and a relatively short cytoplasmic tail. Their ectodomain binds to ECM glycoproteins, 
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intercellular cell adhesion molecules, and other cellular receptors [379]. When triggered, 
integrins transduce the external signal to the intracellular space, through chemical pathways, 
providing information on its location, environment, adhesive state, and surrounding matrix. 
This information can result in changes of cell cycle, shape, motility, and differentiation [380]. 
They are also involved in the attachment of the cell, through microfilaments, to the ECM. 
The attachment to the substrate is helped by anchorage proteins, such as talin, vinculin, and 
paxillin, which together form a cell adhesion complex [381] whose association/disassociation 
plays a key role in cell migration [382]. For the scope of this study, laminin binding integrins 
include α3β1, α6β1, α6β4, and α7β1 [383]. Critical in the formation of HDs, integrin α6β4 
loss results in a mechanically and functionally defective epithelium [384]. 
 ECM transduction  
Because cells sense the surrounding environment, functionalized substrates have been used 
to modulate cell behaviour, morphology, migration, and differentiation patterns. The cell’s 
response is governed by various processes: 
i. Chemotaxis. Chemotaxis refers to the movement of cells in response to chemical stimuli. 
The movement can be towards the source of the stimuli (chemoattractant) or in the 
opposite direction of the stimuli (chemorepellent) [316]. Chemotaxis is of critical 
importance in early development [317], actin filament rearrangements [318], immune 
response, and cancer metastasis [319, 320].  
ii. Haptotaxis. Haptotaxis is the directional movement of cells in response to a gradient of 
cellular adhesion sites or other substrate-bound chemoattractants. Several biomaterials 
have been functionalized with a wide variety of attractants inducing cell motility, which 
can have a role in enhancing processes as wound healing [321] and immune response 
[322].  
iii. Mechanotaxis. Mechanotaxis refers to the directed cell migration in response to 
mechanical cues, such as stiffness gradients or shear stress. This can be used to modulate 
vascular remodelling, where endothelial cells migration is stimulated in response to shear 
stress [323]. 
iv. Differentiation. Putting together the knowledge that cells actively respond to the 
underlying substrate, several authors have tried, with certain degree of success, to 
promote differentiation of SCs into more-differentiated cell lineages: 
  Chapter 3 
105 
 
a. As mentioned on Chapter 1, the SCs for corneal epithelium reside in a very 
specialized niche, named the limbus. By exposing SCs, isolated from the bulge of hair 
follicles, to limbal specific environment cues (substrates functionalized with laminin-
332) Blazejewska et al. induced these cells to differentiate into corneal epithelial-like 
cells [179].  
b. In the same line of studies, Ahmad et al. induced two different hESC lines to 
differentiate into cornea epithelial-like cells by culturing them on collagen IV (major 
component of limbus) and feeding them with conditioned media obtained from 
limbal fibroblasts [178].  
In both studies SCs lost their “stemness” observed by the decreased expression of SC 
markers, such as α6 integrin and KRT15 [179] and OCT4 and NANOG [178], and increase in 
expression of markers for differentiated corneal ECs, such as KRT3 and KRT12 [178, 179].  
 Intracellular signalling for cell growth and differentiation 
In various non-ocular systems, it is very well documented that the ECM plays crucial roles in 
cell differentiation via integrin-mediated signaling pathways [299, 300]. Protein 
phosphorylation and proteolysis are the two major post-translational modifications for 
controlling cellular functions in response to extracellular stimuli [385]. It is recognized that 
tyrosine phosphorylation is the triggering signal in many signaling pathways. The majority of 
proteins that are downstream targets in these pathways are regulated by phosphorylation, 
not on tyrosine (Tyr) residues but on serine (Ser) and/or threonine (Thr) residues [386]. The 
mitogen-activated protein kinases (MAPKs) are focal points for the extracellular stimuli. Their 
activation is a downstream event of integrin ligation and results in the regulation of crucial 
cellular processes [387]. Three distinct subfamilies of the MAPKs have been described; the 
extracellular signal-regulated kinase (ERK), c-jun N-terminal or stress-activated protein 
kinases (JNK/SAPk), and the p38 group [388], which in resting cells are primarily located in 
the cell cytosol and translocate to the nuclei upon activation [389]. The ERK family has shown 
to be highly responsive to mitogen stimuli (such as growth factors) while JNK and p38 are 
activated by a variety of genotoxic stresses (including DNA repair and apoptosis) [390]. 
Remarkably, Lin et al. have observed that different laminin isoforms activate different 
intracellular signalling pathways, which support the hypothesis that ECM proteins modulate 
cell differentiation via alternate signalling pathways [304]. In this study, a MAPK/ERK 
signalling interactive pathway, whose roles are mainly involved in cell growth and 
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differentiation, was used. This assay allows for the simultaneous detection of the 
phosphorylation and cleavage levels of 18 signalling molecules, Table 13.   
Table 13 - Target map of the PathScan® Intracellular Signalling Array Kit and their key roles in cell 
differentiation. 
Target Role  References  
ERK1/2 Intermediate agent in response to extracellular signals.  
Its activation (phosphorylation) precedes cell growth and 
differentiation. 
[389, 391-
393] 
STAT1 and 
STAT3 
Involved in cell growth, apoptosis, and differentiation.  
STAT3 phosphorylation has a positive effect on EC 
differentiation from the lung. 
[394-399]. 
 
AKT AKT pathway activation (phosphorylation) induces EC 
differentiation and growth, and drives cancer SCs to lose 
their properties. 
Activated AKT results in phosphorylation of important 
downstream proteins involved in cell metabolism, 
proliferation, survival, and growth, such as GSK-3β 
(inhibition), PRAS40 (inhibition), BAD (inhibition), and S6 
ribosomal protein. 
[400-405]. 
mTOR Regulates cell proliferation, metabolism, and survival. 
Dedifferentiation of RPE (retinal pigmented cells) is followed 
by mTOR activation. 
[406, 407]. 
AMPKα Its activation (phosphorylation) promotes epithelial 
differentiation and tight junction formation in gut 
epithelium. 
[408] 
S6 Its phosphorylation reflects mTOR pathway activation and 
predicts cell cycle progression. 
Differentiation agents in embryonic chicken cell lens 
triggered S6 phosphorylation. 
[409] 
P38 MAPK Induces the differentiation of adipocytes, myoblasts, and 
SCs. 
p38δ played a role in regulating keratinocyte differentiation. 
[410] 
GSK-3β Its inhibition (phosphorylation) prevents the epithelial-
mesenchymal transition process, preventing ECs from losing 
their properties. 
[411] 
PRAS40 PRAS40 phosphorylation is increased in cells expressing 
KRT15 (a suggested epithelial SC marker). 
[412] 
 Aims  
i. To identify how the ECM composition drives the differentiation of ECs from the human 
ocular surface. This was investigated by assessing the differences on ECM composition 
produced by the two different cell lines (HCjE-Gi and hTCEpi). 
ii. To determine if the differentiation of human conjunctival and corneal ECs can be 
modulated in response to the laminin composition of the functionalized scaffolds. This 
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was assessed by culturing the two cell lines on functionalized substrates with a range of 
different human recombinant laminins isoforms. 
iii. To identify which proteins are post-translationally modified in response to extracellular 
stimuli. This was assessed by analysing the degree of phosphorylation and cleavage of 18 
proteins upon culture of HCjE-Gi and hTCEpi cells on 4 different substrates. 
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3.2. Materials and Methods 
3.2.1. Extracellular matrix protein extraction for LC-MS analysis 
Basal cell protein proteolysis and extraction was performed according to the method 
described by Todorovic et al. [289] and Gospodarowicz [288] with small modifications. 
Briefly, after 9 days the culture medium was removed (T-25cm2 flasks were used for this 
purpose) and the flask washed with sterile PBS. The cells were then ruptured by treatment 
with 20mM NH4OH in sterile PBS for 5 minutes. The remaining ECM and basal cell 
components were washed several times in sterile PBS followed by ddH2O. A solution of 
50mM NH4HCO3 (cat. number 09830, Sigma-Aldrich) in ddH2O, pH 8.0, containing: 0.02% 
(V/V) ProteaseMax surfactant (cat. number V2071, Promega), 0.33% (W/V) Trypsin Gold 
(Mass Spec grade, cat. number V5280, Promega) was added and the samples digested for 1 
hour at 37°C in a humid chamber. The resulting solution containing the peptides was then 
transferred into tubes specially designed to prevent non-specific adsorption to the surface 
(Eppendorf LoBind cat. number Z666505, Sigma-Aldrich). The enzymatic reaction was 
stopped by adding acetic acid (cat. number 320099, Sigma-Aldrich) setting the pH to 3–4. 1% 
(V/V) of 0.5M 1,4-dithiothreitol (DTT, cat. number D5545, Sigma-Aldrich) was added for 20 
minutes at 56°C to reduce the proteins. 2.5% (V/V) of 0.55M iodoacetamide (cat. number 
I149, Sigma-Aldrich) was added for 15 minutes at RT in the dark to alkylate the proteins. 
0.3125% (W/V) of Trypsin Gold and 0.00625% (V/V) ProteaseMax Surfactant were added and 
the solution heated at 37°C for 3 hours for protein digestion. Trifluoroacetic acid (TFA, cat. 
number 40967, Sigma-Aldrich) was added to a final concentration of 0.5% (V/V) to inactivate 
the trypsin. The samples were frozen at -20°C until further analysis.  
3.2.2. Liquid chromatography–mass spectrometry analysis 
LC-MS analysis was performed using an Ultimate 3000 RSLCnano system (Dionex, Thermo 
Fisher Scientific) coupled to a hybrid linear ion trap/Orbitrap mass spectrometer (LTQ 
Orbitrap XL; Thermo Fisher Scientific). Digested samples were sonicated to ensure an even 
suspension and 1μg of digested proteins was loaded onto a C18 trap column (C18 PepMap, 
300µm i.d. × 5mm, 5µm particle size, 100µm pore size; Dionex) and desalted for 3 minutes 
at a flow rate of 25μL/min using 2% acetonitrile containing 0.1M TFA. The trap column was 
then switched online with the analytical column (PepMap C18, 75µm i.d. × 500mm, 3µm 
particle, and 100µm pore size; Dionex), and peptides were eluted in a 180 minutes gradient 
at a flow rate of 300nL/minute using 2% acetonitrile with 0.1% formic acid (FA) to 50% 
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acetonitrile containing 0.08% FA. Mass Spectrometry Data was acquired with Xcalibur 
software, version 2.0.7 (Thermo Fisher Scientific). The mass spectrometer was operated in 
data-dependent mode and externally calibrated. MS1 survey scan (m/z 400–1200) was set 
at a resolution of 30 000 in the Orbitrap, followed by ten MS2 scans using CID activation 
mode in the ion trap. The dynamic exclusion was enabled with the following settings: repeat 
count, 1; repeat duration, 30 seconds; exclusion list size, 500; and exclusion duration, 40 
seconds. The activation time was 30 milliseconds, with an isolation width of 2 Da for ITMS; 
the normalized activation energy was 32%, and the activation (q) was 0.25. The LC-MS 
analysis was performed at Dublin City University by Dr Finbarr O’Sulllivan and Dr Paula 
Meleady. 
3.2.3. Data analysis – Database Search and Postsearch Filtering Analysis  
Proteome Discoverer (PD) version 2.1.0.81 (Thermo-Scientific) was used to perform the 
database search against the human sequences in the UniProt Swiss-Prot protein database 
(version January 2016 with 20 151 entries) for the Mass Spectrometry raw data files. The 
search engines SEQUEST-HT and Mascot (version 2.4.0) were utilised in PD. The search 
parameters used were as follows: 20ppm tolerance for precursor ion masses, 0.6Da for 
fragment ion masses analysed by ion trap. A total of two missed cleavages were permitted 
for fully tryptic peptides. Carbamidomethylation of cysteines (+57.0215 Da) was set as a fixed 
modification, and variable modifications of methionine oxidation (+15.9949 Da) and N-
terminal acetylation (+42.0106 Da) were allowed. The false discovery rate (FDR) was 
determined by using a target–decoy search strategy using Percolator in PD2.1. The sequence 
database contains each sequence in both forward and reverse orientations, enabling FDR 
estimation. The FDR was set to 0.01 at both the peptide and the protein levels. The LC-MS 
data analysis was performed at Dublin City University by Dr Finbarr O’Sulllivan and Dr Paula 
Meleady. 
3.2.4. Reverse Transcriptase qPCR 
Reverse Transcriptase qPCR and all the previous steps (RNA extraction and cDNA synthesis) 
were done as outlined in sections 2.2.10, 2.2.11, and 2.2.12 respectively. Table 14 shows the 
set of primers used for the studies performed in this chapter. 
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Table 14 –List of primers used for Reverse Transcriptase qPCR studies in Chapter 3. The primer 
sequences and the product size are included. Abbreviations used GAPDH: glyceraldehyde-3-
phosphate dehydrogenase, COL: collagen, LAM: laminin. # Sequences and product size of reference 
genes are not commercially provided by PrimerDesign. 
Primer Gene Sequence Product size (bp) 
GAPDH F - # # R - # 
COLXVIIα1 F - GGAGTACCCTCGGAAGGAATTT 133 R- ACGCTTAACATCATCCAATTCTGT 
LAMα5 F – GGCTTCTACCGCTCTCCCA 114 R – GTAGCATCGACCCGTCAGG 
LAMβ1 F-  GAGAGGAAAGTCAGCGAGATAAA 127 R - GAGCCATCATTTCTGTAACATCTTT 
LAMβ2 F- CCTTGAGCCTGGTATCTCCTAC 117 R - AGATTATTCACCGAGTCAATGAGC 
3.2.5. Flow cytometry 
Flow cytometry was done as outlined in section 2.2.14. Table 15 and Table 16 show the 
antibodies used for the studies performed in this chapter.  
Table 15 – List of primary antibodies used for flow cytometry studies in Chapter 3. Abbreviations 
used COL: collagen, LAM: laminin.  
Antibody Clone Source Isotype Manufacturer Dilution 
COLXVIIα1 EPR18614 Rabbit IgG Abcam 1:500 
LAMα5 2F7 Mouse IgG1 Sigma-Aldrich 1:500 
LAMβ1 Polyclonal Rabbit IgG 
ThermoFisher 
Scientific 
1:500 
LAMβ2 CL2979 Mouse IgG2a Abcam 1:500 
IgG Isotype Control Rabbit --- 
ThermoFisher 
Scientific 
0.49µg/µL 
IgG1 Isotype Control Mouse --- 
ThermoFisher 
Scientific 
0.2µg/µL 
IgG2a Isotype Control Mouse --- 
ThermoFisher 
Scientific 
2µg/µL 
 
Table 16 - List of secondary antibodies used for flow cytometry studies in Chapter 3. Abbreviations 
used FITC: fluorescein isothiocyanate. 
Antibody Host Reactivity Conjugate Manufacturer Dilution 
A-11005 Goat Mouse AlexaFluor 594 Life Technologies 1:400 
F7512 Sheep Rabbit FITC Sigma-Aldrich 1:400 
 
3.2.6. Immunocytochemistry on ECM proteins 
Cells were seeded on a glass coverslip (22x22mm cat. Number 408/0187/33, Thickness No.1, 
BDH) over a desired number of days. The culture medium was removed, and the wells briefly 
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washed once in sterile PBS. The cells were then ruptured using 20mM NH4OH for 5 minutes 
in sterile PBS. The remaining extracellular matrix and basal cell components were washed 
several times in sterile PBS followed by ddH2O. The wells were incubated with ice-cold 
methanol (cat. Number M/4000/PC17, Fisher Scientific UK) for 10 minutes at RT (all steps 
were performed at RT unless otherwise specified), followed by three washing steps with PBS 
for 5 minutes. The wells were then blocked using 2% goat serum (cat. Number G9023, Sigma-
Aldrich) diluted in PBS for one hour, followed by three washing steps with PBS for 5 minutes. 
Primary antibody diluted in PBS was added and incubated overnight at 4°C in the dark, Table 
17. The following day, the primary antibody was removed from the culture well and the well 
washed thrice with PBS for 5 minutes. The well was incubated with conjugated secondary 
antibody diluted in PBS for one hour in the dark, Table 18. After removal of the secondary 
antibody and washing in PBS for 5 minutes, the coverslip was removed from the well and 
mounted in a slide (cat. Number 631-0102, SuperFrost 1mm thick, VWR International) using 
VECTASHIELD (cat. Number H-1000, Vector Laboratories). The coverslips were then viewed 
using an ECLIPSE Ti-E inverted Microscope System (Nikon, USA). 
Table 17 - Table of primary antibodies used for the ICC studies in Chapter 3. Abbreviations used COL: 
collagen, LAM: laminin  
Antibody Clone Source Isotype Manufacturer 
Dilutio
n 
COLXVIIα1 EPR18614 Rabbit IgG Abcam 1:1000 
LAMα5 2F7 Mouse IgG Sigma-Aldrich 1:1000 
LAMβ1 Polyclonal Rabbit IgG ThermoFisher Scientific 1:1000 
LAMβ2 CL2979 Mouse IgG2a Abcam 1:1000 
 
Table 18 - Table of secondary antibodies used for the ICC studies in Chapter 3. Abbreviations used 
FITC: fluorescein isothiocyanate. 
Antibody Host Reactivity Conjugate Manufacturer Dilution 
A-11005 Goat Mouse AlexaFluor 594 Life Technologies 1:400 
F7512 Sheep Rabbit FITC Sigma-Aldrich 1:400 
3.2.7. Coating with human recombinant laminins 
Most laminin isoforms, except for LAM-111, are extremely difficult to extract from tissues 
due to the high degree of cross-linking with other laminins and other molecules. Only 
recently, a few forms of recombinant laminins have successfully been produced [413-415]. 
Solutions containing recombinant LAM-111, -121, -211, -221, -411, -421, -511, and -521 
isoforms were used (cat. Number KT202, BioLamina). All steps were done in accordance with 
the manufacturer’s protocol. Briefly, the stock solutions were thawed on ice prior to use and 
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then diluted in 1xDPBS with Ca2+ and Mg2+ (cat. number 14040091, ThermoFisher) to a final 
concentration of 10µg/mL (9.8µg/cm2) unless otherwise specified. The final solution was 
added to the culture dishes. These were sealed with Parafilm ® and incubated overnight at 
4°C. On the next day cells were seeded accordingly at density of 25000 cells/cm2, the medium 
changed every other day until further experiments. 
3.2.8. PathScan ® Intracellular Signalling Array Kit 
PathScan® Intracellular Signalling Array Kit (Chemiluminescent Readout, cat. Number 7323, 
Cell Signalling Technology) was used for this purpose. All steps were done in accordance with 
the manufacturer’s protocol at RT. Briefly, cells were washed with ice-cold PBS and lysed 
with ice-cold 1X Cell Lysis buffer supplemented with a cocktail of protease and phosphatase 
inhibitors (cOmplete Tablets Mini and PhosSTOP EASYpack, Roche). The Array Blocking 
Buffer was added and incubated for 15 minutes on an orbital shaker. The protein lysate was 
added and incubated for two hours. After washing, the Detection Antibody Cocktail was 
added and incubated for 1 hour on an orbital shaker. HRP-linked streptavidin was added and 
incubated for 30 minutes. LumiGLO®/Peroxidase reagent was added and images captured 
immediately after, using a Chemidoc (chemiDoc ™ XRS+, BioRad) and quantified using 
ImageLab 5.0 Software. 
3.2.9. Statistical analysis 
Kruskal-Wallis test followed by a Dunn’s multiple comparison test (unless otherwise 
specified) were used to determine statistically significant differences (GraphPad Prism 5, 
*p<0.05, **p<0.01, ***p<0.001). Data is expressed as median ± 5-95% percentile (unless 
otherwise specified).  
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3.3. Results 
3.3.1. ECM composition by mass spectrometry analysis 
ECM composition was assessed by mass spectrometry. In total 444 different entries were 
detected: 107 being shown to be found only on HCjE-Gi ECM, 152 exclusively on hTCEpi ECM, 
and 185 found in both matrices preparations, Figure 37.  
Interestingly, amongst the heavy subset of ECM proteins, various growth factors and other 
soluble molecules were detected (data not shown). These include TGF-β, insulin-like growth 
factor binding protein, epidermal growth factor receptor (EGFR), fibroblast growth factor 
(FGF), interleukin enhancer-binding factor 2, and 3, amongst many others. These soluble 
factors produced by cells and trapped within the ECM proteins meshwork provide chemical 
cues, additional to those provided by the ECM proteins, for the differential keratin 
expression [294]. However, additional studies needed to be performed to understand the 
role played by such molecules.  
Very similar results were found for the biological processes associated with the proteins 
derived from either ECM preparations. The majority of the ECM proteins seem to be mainly 
involved in processes of cell adhesion, ECM organization and signal transduction, Figure 38. 
The main cellular components associated with the proteins detected in both ECM proteins 
are shown on Figure 39. Noteworthy is the presence of a large number of proteins associated 
with exosomes.  
Figure 37 - Venn diagram of unique and shared ECM proteome as assessed by mass spectrometry. 
A total of 444 entries were detected: 107 were only found on HCjE-Gi cells-produced ECM, 152 on 
hTCEpi cells-produced ECM, and 185 detected in both ECM preparations. 
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Figure 38 - Biological processes associated with the proteins detected on HCjE-Gi and hTCEpi ECM 
preparations. Inner and outer chart show the percentages relatively to hTCEpi ECM proteins and HCjE-
Gi ECM proteins, respectively. Data analysed using FunRich version 3.0 with Gene Ontology database 
[416]. 
 
 
Figure 39 – Cellular components associated with the proteins detected on HCjE-Gi and hTCEpi ECM 
preparations. Inner and outer chart show the percentages relatively to hTCEpi ECM proteins and HCjE-
Gi ECM proteins, respectively. Data analysed using FunRich version 3.0 with Gene Ontology database 
[416]. 
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Since ECM produced by one cell type induced such an alteration in the other cell type 
behaviour, as shown in Chapter 2, a detailed study was carried on the expression and 
production of proteins that were specifically produced by each cell line and thus more likely 
to be involved in the process of cell differentiation towards a specific cell lineage. Thus, from 
the 107 proteins produced only by HCjE-Gi cells, laminin (LAM)α5 was chosen. Regarding the 
proteins exclusively detected on the hTCEpi ECM, collagen (COL)XVIIα1 and LAMβ1 were 
chosen. Since laminins appear as heterotrimeric proteins, LAMβ2 expression was also a 
subject of study as it trimers with LAMα5 and LAMγ1 to form LAM-521, a protein already 
found on conjunctival BM [417]. 
Collagens are trimeric structures composed of three polypeptide α chains, which account a 
total of 28 collagen members in vertebrates [418]. Unlikely most of the collagen types, 
collagen XVII (also known as BP180) is a transmembrane protein with an intracellular domain 
[419]. It is a homotrimer composed of three α1 chains identified as a structural component 
necessary for the stable attachment of HDs type I to the keratin filaments [420]. It occurs in 
two forms: as a full-length transmembrane protein and as a soluble ectodomain [421]. 
Mutations in the collagen XVII gene are associated with both generalized atrophic benign 
and junctional epidermolysis bullosa [419] and recurrent erosion of the corneal epithelium 
[422, 423]. Due to its role played in the integrity of epithelial tissues, its expression profile 
was subject of this study. Moreover, laminins are known to be involved in many crucial cell 
processes including cell proliferation and differentiation (see section 3.1.3), thus their choice 
as subject of study appeared of understandable interest. 
3.3.2.  mRNA expression levels for ECM proteins show to be different in 
HCjE-Gi and hTCEpi cells - Reverse Transcriptase quantitative PCR 
Reverse Transcriptase qPCR was performed within a certain window of time (Ct values 
obtained at day 0 were used for normalisation). The expression of COLXVIIα1 by HCjE-Gi cells, 
although not detected on mass spectrometry, was detected by Reverse Transcriptase qPCR 
since early time points. However, its abundance levels did not vary significantly through time. 
On the other hand, an increase in its transcript expression levels was observed from day 3 to 
day 6 on hTCEpi cells (126-fold increase, p<0.05), Figure 40. 
  Chapter 3 
116 
 
HCjE-Gi
Day 0 Day 3 Day 6 Day 9
0.001
0.01
0.1
1
10
100
Fo
ld
 C
ha
ng
e
No
rm
al
is
ed
 to
 G
AP
DH
 
hTCEpi
Day 0 Day 3 Day 6 Day 9
0.1
1
10
100
1000
10000
*
Fo
ld
 C
ha
ng
e
No
rm
al
is
ed
 to
 G
AP
DH
 
Figure 40 - The expression of collagen XVII α1 by HCjE-Gi and hTCEpi cells over 9 days as assessed by 
Reverse Transcriptase qPCR. (Data is represented as median ± 5-95 percentile, n≥6, Kruskal-Wallis 
test followed by a Dunn’s Multiple Comparison test, *p<0.05, **p<0.01, ***p<0.001). Dashed line 
represents the basal expression of the gene of interest at day 0. Abbreviations used GAPDH: 
glyceraldehyde 3-phosphate dehydrogenase. 
No significant differences in LAMα5 transcript abundance levels by HCjE-Gi cells were 
detected until day 9 when it drops significantly (p<0.05). In contrast, a continuous increase 
in its expression levels by hTCEpi cells was appreciated from days 0-3 until day 6-9 (p≤0.01), 
Figure 41. 
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Figure 41 - The expression of laminin α5 by HCjE-Gi and hTCEpi cells over 9 days as assessed by 
Reverse Transcriptase qPCR. (Data is represented as median ± 5-95 percentile, n≥6, Kruskal-Wallis 
test followed by a Dunn’s Multiple Comparison test, *p<0.05, **p<0.01, ***p<0.001). Dashed line 
represents the basal expression of the gene of interest at day 0. Abbreviations used GAPDH: 
glyceraldehyde 3-phosphate dehydrogenase. 
As abovementioned, LAMβ1 trimers with LAMα5 and LAMγ1 to form LAM-511 and 
consequently their pattern of expression is expected to be similar. Consistent with this, a 
decrease in its expression levels was observed from day 0 to day 9 by the HCjE-Gi cells (25-
fold decrease, p<0.05). On the other hand, a continuous increase in its expression levels by 
hTCEpi cells was observed from day 0 until day 6 when it peaks (698-fold increase, p≤0.001), 
Figure 42. 
  Chapter 3 
117 
 
HCjE-Gi
Day 0 Day 3 Day 6 Day 9
0.001
0.01
0.1
1
10
*
Fo
ld
 C
ha
ng
e
N
or
m
al
is
ed
 to
 G
AP
D
H
hTCEpi
Day 0 Day 3 Day 6 Day 9
0.1
1
10
100
1000
10000
***
Fo
ld
 C
ha
ng
e
No
rm
al
is
ed
 to
 G
AP
DH
 
Figure 42 - The expression of laminin β1 by HCjE-Gi and hTCEpi cells over 9 days as assessed by 
Reverse Transcriptase qPCR. (Data is represented as median ± 5-95 percentile, n≥6, Kruskal-Wallis 
test followed by a Dunn’s Multiple Comparison test, *p<0.05, **p<0.01, ***p<0.001). Dashed line 
represents the basal expression of the gene of interest at day 0. Abbreviations used GAPDH: 
glyceraldehyde 3-phosphate dehydrogenase. 
LAMβ2 also forms a trimer with LAMα5 and LAMγ1 to form yet a different laminin isoform 
(LAM-521). A continuous decrease in its expression levels was observed for the HCjE-Gi cells 
throughout the course of the experiment (p<0.01). Regarding its expression by hTCEpi cells, 
a peak was observed at day 6 (206-fold increase, p≤0.05) when it plateaus, Figure 43.  
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Figure 43 - The expression of laminin β2 by HCjE-Gi and hTCEpi cells over 9 days as assessed by 
Reverse Transcriptase qPCR. (Data is represented as median ± 5-95 percentile, n≥6, Kruskal-Wallis 
test followed by a Dunn’s Multiple Comparison test, *p<0.05, **p<0.01, ***p<0.001). Dashed line 
represents the basal expression of the gene of interest at day 0. Abbreviations used GAPDH: 
glyceraldehyde 3-phosphate dehydrogenase. 
When the fold change values of the two cell lines are plotted together, additional and 
complementary trends are observed. These include higher COLXVIIα1, LAMα5, LAMβ2 
transcript levels expressed by hTCEpi cells at day 6 and 9 (p≤0.05), and higher LAMβ1 and 
LAMβ2 transcript levels expressed by hTCEpi cells at day 3 (p≤0.05), Figure 44. 
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Figure 44 - The expression of transcripts produced by HCjE-Gi and hTCEpi cells over 9 days as 
assessed by Reverse Transcriptase qPCR. (Data is represented as median ± range, n≥3, Mann Whitney 
test, *p<0.05, **p<0.01, ***p<0.001). Abbreviations used COL: collage, LAM: laminin. 
3.3.2.1. Summary of results 6: 
To summarize these results, the expression levels of: 
i. COLXVIIα1 and LAMα5 in HCjE-Gi cells were relatively constant until day 6, when it 
decreased. 
ii. LAMβ2 by HCjE-Gi cells decreased over time. 
iii. COLXVIIα1, LAMα5, LAMβ1, and LAMβ2 in hTCEpi cells increased over time, plateauing at 
day 6-9. 
iv. COLXVIIα1, LAMα5, LAMβ2 were higher in hTCEpi cells at day 6 and 9 when compared to 
those expressed by HCjE-Gi cells. 
v. LAMβ1 and LAMβ2 were higher in hTCEpi cells at day 3 when compared to those 
expressed by HCjE-Gi cells.  
3.3.3. The percentage of positive events for ECM proteins is shown to be 
different in HCjE-Gi and hTCEpi cells – Flow Cytometry 
Protein expression levels in terms of positive events were assessed by flow cytometry. Here 
BD FACS™ permeabilizing solution 2 was used to detect both membrane and cytosolic 
epitopes.  
A 
C D 
B 
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Consistent with Reverse Transcriptase qPCR results, no appreciable changes in the 
percentage of COLVXIIα1-positive events can be seen on HCjE-Gi cell preparations over time, 
Figure 45A and C. Regarding its expression by hTCEpi cells, significant lower levels of the 
percentage of COLXVIIα1-positive events were shown from day 0 to day 3 (decrease of 70%, 
p<0.01), followed by a steady increase until day 9 (NSS), Figure 45B and D.  
Regarding the expression of LAMα5 by HCjE-Gi cells, and consistent with Reverse 
Transcriptase qPCR results, significant lower levels in the percentage of positive events were 
observed from day 0 to day 9 (p<0.05, corresponding to a decrease of 15% in LAMα5-positive 
events), Figure 46A and C. A decrease in its expression levels was also shown on hTCEpi cells 
although non-significant throughout the course of the experiment, Figure 46B and D.  
The abundance of LAMβ1-positive events in HCjE-Gi cell preparations were shown not to 
significantly vary over the time course analysed, Figure 47A and C. Concerning its expression 
by hTCEpi cells a significant decrease in the percentage of LAMβ1-positive events from day 
0 to day 3 (p<0.01, reduction of 60% in positive events) was observed, Figure 47B and D.  
The levels of LAMβ2-positive events by HCjE-Gi cells was shown to increase over time 
(although not statistically different between time-points), Figure 48A and C. Regarding its 
expression by hTCEpi cells a decrease in the levels of LAMβ2-positive events at day 3 was 
followed by a constant increase in their expression up to day 9 (although not statistically 
different between time-points), Figure 48B and D.  
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Figure 45 –The expression of collagen XVII α1 by HCjE-Gi and hTCEpi over 9 days as assessed by flow 
cytometry. The percentage of positive events normalized against isotype control is shown (Mx). (Data 
is represented as median ± range, n≥3, Kruskal-Wallis test followed by a Dunn’s Multiple Comparison 
test. (Data is represented as median ± range, n=3, Mann-Whitney test) *p<0.05, **p<0.01, 
***p<0.001). Abbreviations used COL: collagen, Ctrl: control, A.U. arbitrary units. 
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Figure 46 - The expression of laminin α5 by HCjE-Gi and hTCEpi over 9 days as assessed by flow 
cytometry. The percentage of positive events normalized against isotype control is shown (Mx). (Data 
is represented as median ± range, n≥3, Kruskal-Wallis test followed by a Dunn’s Multiple Comparison 
test. (Data is represented as median ± range, n=3, Mann-Whitney test) *p<0.05, **p<0.01, 
***p<0.001). Abbreviations used LAM: laminin, Ctrl: control, A.U. arbitrary units. 
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Figure 47 - The expression of laminin β1 by HCjE-Gi and hTCEpi over 9 days as assessed by flow 
cytometry. The percentage of positive events normalized against isotype control is shown (Mx). (Data 
is represented as median ± range, n≥3, Kruskal-Wallis test followed by a Dunn’s Multiple Comparison 
test. (Data is represented as median ± range, n=3, Mann-Whitney test) *p<0.05, **p<0.01, 
***p<0.001). Abbreviations used LAM: laminin, Ctrl: control, A.U. arbitrary units. 
 
C 
A 
B 
D 
hT
CE
pi
          
H
C
jE
-G
i 
     Day 0 
    
    Day 3     Day 6     Day 9 
   LAMβ1  
   IgG control 
  Chapter 3 
123 
 
HCjE-Gi
Day 0 Day 3 Day 6 Day 9
0
20
40
60
80
100
M1
M2 M3
M4
%
 P
os
iti
ve
 C
el
ls
N
or
m
al
is
ed
 to
 Is
ot
yp
e 
C
tr
l
 
hTCEpi
Day 0 Day 3 Day 6 Day 9
50
60
70
80
90
100
M1
M2
M3
M4
%
 P
os
iti
ve
 C
el
ls
N
or
m
al
is
ed
 to
 Is
ot
yp
e 
C
tr
l
 
Figure 48 - The expression of laminin β2 by HCjE-Gi and hTCEpi over 9 days as assessed by flow 
cytometry. (A-D) The percentage of positive events normalized against isotype control is shown (Mx). 
(Data is represented as median ± range, n≥3, Kruskal-Wallis test followed by a Dunn’s Multiple 
Comparison test. (Data is represented as median ± range, n=3, Mann-Whitney test) *p<0.05, 
**p<0.01, ***p<0.001). Abbreviations used LAM: laminin, Ctrl: control, A.U. arbitrary units. 
When the percentage of positive events detected on the two cell lines is plotted together 
additional and complimentary trends are observed. These include a significant higher 
percentage of COLXVIIα1-positive events at day 0 detected on hTCEpi cells (p<0.01, which 
corresponds to a difference in nearly 20% of COLXVIIα1-positive events between the two cell 
lines), Figure 49A; a significant difference at day 3 on percentage of LAMα5-positive events 
(p<0.05) equivalent to a difference in nearly 25% more LAMα5-positive events detected on 
hTCEpi cell preparations, Figure 49B; a higher percentage of LAMβ1-positive events at day 0 
detected on hTCEpi cell preparations (difference in nearly 40% more LAMβ1-positive events 
detected in hTCEpi cells, p<0.05), Figure 49C; and a difference at day 0 on the percentage of 
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LAMβ2-positive events (p<0.05, corresponding to 30% more LAMβ2-positive events being 
detected on hTCEpi cell preparations), Figure 49D.  
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Figure 49 - The expression of ECM proteins produced by HCjE-Gi and hTCEpi cells over 9 days as 
assessed by flow cytometry. The percentage of positive events normalized against isotype control. 
(Data is represented as median ± range, n=3, Mann-Whitney test, *p<0.05, **p<0.01, ***p<0.001). 
Abbreviations used ECM: extracellular matrix, Ctrl: control, COL: collagen, LAM: laminin. 
3.3.3.1. Summary of results 7: 
To summarize these results, the percentage of: 
i. COLXVIIα1-, LAMβ1- , and LAMβ2-positive events was higher in hTCEpi cell preparations 
at day 0 when compared to HCjE-Gi cell preparations. 
ii. LAMα5-positive events was higher in hTCEpi cell preparations at day 3 when compared 
to HCjE-Gi cell preparations. 
3.3.4. ECM characterization by immunocytochemistry 
At desired time points, cell cultures were “de-roofed” and specific ECM proteins 
immunostained and visualized.  
3.3.4.1. Collagen XVIIα1  
Noteworthy is the absence of COLXVIIα1 at day 0 on both HCjE-Gi and hTCEpi ECM. Its 
production appears to increase with time in both matrices, showing a punctate pattern 
(zoomed image). Additionally, on hTCEpi ECM the pattern soon appears to bear a 
A 
C D 
B 
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resemblance to a rosette shape (typical shape of laminin chains with which this protein 
interacts to form HDs), Figure 50. 
 
 
 
hTCEpi 
D
ay
 0
 
D
ay
 3
 
D
ay
 6
 
D
ay
 9
 
    HCjE-Gi 
Figure 50 - The deposition of collagen XVIIα1 by HCjE-Gi and hTCEpi cells over 9 days as assessed by 
immunocytochemistry. Cells plated onto a glass coverslip were de-roofed and analysed by 
immunofluorescence at the showed time-points. Box shows a zoomed typical collagen XVIIα1 
punctuated structure. Yellow arrows show a rosette shape resulting from the interaction of collagen 
XVIIα1 with matrix laminins, (scale bar 50µm). 
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3.3.4.2. Laminin α5 
Regarding LAMα5, its deposition increased over time with incomplete rosette shapes 
observed at day 0 (green arrows) and cloudy appearances at day 9 in both ECMs. The 
production of this laminin chain appeared to be higher by hTCEpi cells, consistent with the 
flow cytometry data. The cloudy appearance is result of the high production and deposition 
of this protein. At intermediate time points, clear rosette shapes can be observed, Figure 51. 
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Figure 51 - The deposition of laminin α5 by HCjE-Gi and hTCEpi cells over 9 days as assessed by 
immunocytochemistry. Cells plated onto a glass coverslip were de-roofed and analysed by
immunofluorescence at the showed time-points. Zoomed box and yellow arrows show a typical 
laminin rosette structure. Green arrows show an incomplete laminin rosette structure, (scale bar 
50µm). 
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3.3.4.3. Laminin β1 and Laminin β2  
Concerning LAMβ1 and LAMβ2 chains, complete rosette shapes can only be observed at day 
3 on HCjE-Gi ECM contrasting with the earlier appearance of these structures on hTCEpi ECM 
at day 0. Consistent with the flow cytometry data, its deposition appeared also to be more 
accentuated at earlier time points by hTCEpi cells when compared to HCjE-Gi cells, Figure 52 
and Figure 53.  
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Figure 52 - The deposition of laminin β1 by HCjE-Gi and hTCEpi cells over 9 days as assessed by 
immunocytochemistry. Cells plated onto a glass coverslip were de-roofed and analysed by 
immunofluorescence at the showed time-points. Zoomed box and arrows show a typical laminin 
rosette structure, (scale bar 50µm).  
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3.3.4.4.  Summary of results 8:  
i. The COLXVIIα1 was only detectable in HCjE-Gi and hTCEpi ECM after 3 days. 
ii. The LAMα5 chain was detectable at day 0 in both cell lines with different shape 
appearances throughout the time window analysed. 
iii. LAMβ1 and LAMβ2 chains were both detected at the earliest time-point with their 
deposition to be more accentuated by hTCEpi cells. 
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Figure 53 - The deposition of laminin β2 by HCjE-Gi and hTCEpi cells over 9 days as assessed by 
immunocytochemistry. Cells plated onto a glass coverslip were de-roofed and analysed by 
immunofluorescence at the showed time-points. Zoomed box and arrows show a zoomed typical 
laminin rosette structure, (scale bar 50µm). 
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3.3.5. Coating plates with recombinant human laminins isoforms 
3.3.5.1. General laminin screening – HCjE-Gi cells show different epithelial 
marker expression when cultured on different human recombinant laminins 
Laminins are, together with collagen fibres, the most abundant components of the BM [347]. 
By binding to integrin receptors and other membrane molecules, they critically regulate cell 
attachment, differentiation, migration and other cell functions [424]. Additionally, specific 
laminins have been robustly demonstrated as regulating agents of the differentiation of 
several cell types, including conjunctival ECs [425]. Moreover, different preparations of 
mixed laminins have previously been shown to modulate ocular surface EC differentiation 
via alternate signalling pathways, however these studies involved crude preparations of 
mixed laminins [304]. Therefore, they are good candidates for contributing to the 
differentiation process. In this study, the cultureware was coated with a single recombinant 
laminin isoform for a better specificity and controlled studies. In this study all the 
commercially available laminin isoforms were tested for a more complete screening of their 
potential on modulating cell differentiation. The expression of six epithelial transcripts by 
HCjE-Gi cells when cultured in 8 human recombinant laminin isoforms was assessed by 
Reverse Transcriptase qPCR and normalised to the GAPDH levels of HCjE-Gi cells cultured on 
TCPS.  
3.3.5.1.1. Expression of corneal epithelial cell markers 
HCjE-Gi cells cultured on LAM-111 and LAM-211 showed higher levels of KRT3 transcript 
levels when compared to those in TCPS (p<0.001); additionally, KRT3 transcript expression 
to be higher in cells cultured on LAM-211 when compared to LAM-121, -221, -411, and -521 
(p≤0.05), Figure 54. HCjE-Gi cells cultured on LAM-121 showed higher levels of KRT12 
expression when compared to those in TCPS, Figure 54.  
3.3.5.1.2. Expression of conjunctival epithelial cell markers 
Regarding the expression of KRT7 and KRT13 transcripts, their levels appeared to be higher 
when HCjE-Gi cells are cultured on LAM-111, -211, and -421 than those cultured in LAM-121, 
-221, -411, -521, and TCPS (p≤0.05), Figure 54.  
3.3.5.1.3. Expression of epithelial stem cell markers 
No significant differences were appreciated on ΔNp63 levels between the various conditions; 
although the expression of ABCB5 was shown to be higher on LAM-421 when compared to 
the other coating proteins (p≤0.05), Figure 54. Noteworthy is the absence of ΔNp63 
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transcript expression by HCjE-Gi cells cultured on LAM-121 and LAM-221 (blue arrows), 
Figure 54.  
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Figure 54 - The expression of epithelial cell markers by HCjE-Gi cells when cultured on top of several 
recombinant laminin isoforms as assessed by Reverse Transcriptase qPCR. (Data is represented as 
median ± 5-95 percentile, n≥6, Kruskal-Wallis test followed by Dunn’s Multiple comparison test, 
*p<0.05, **p<0.01, ***p<0.001). Dashed line represents the basal expression of the markers of 
interests when cells are cultured on TCPS. Arrows represent gene expression not detectable in that 
laminin isoform. Abbreviations used GAPDH: glyceraldehyde 3-phosphate dehydrogenase, LAM: 
laminin, KRT: keratin, ABCB5: ATP-binding cassette sub-family B member 5, TCPS: tissue culture 
polystyrene. 
3.3.5.2. General laminin screening – hTCEpi cells show different epithelial 
marker expression when cultured on different human recombinant laminins 
The expression levels of the same six epithelial transcripts by hTCEpi cells when cultured in 
8 human recombinant laminin isoforms were assessed by Reverse Transcriptase qPCR. Their 
expression was normalised to the GAPDH levels of hTCEpi cells cultured on TCPS.  
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3.3.5.2.1. Expression of corneal epithelial cell markers 
hTCEpi cells cultured on LAM-111, -211, -521 showed higher levels of KRT3 expression than 
those cultured on LAM-411, and those cultured on LAM-511 expressed higher levels of KRT12 
than those cultured on LAM-411 (p<0.05), Figure 55. 
3.3.5.2.2. Expression of conjunctival epithelial cell markers 
hTCEpi cells seeded on LAM-121, -221, and -411 expressed lower levels of KRT7 than those 
cultured on LAM-211, -421, and TCPS (p≤0.05). hTCEpi cells cultured on LAM-411 expressed 
lower levels of KRT13 than those cultured on LAM-421, -511, -521, and TCPS (p≤0.05), Figure 
55.  
3.3.5.2.3. Expression of epithelial stem cell markers 
Cells cultured on LAM-411 showed lower expression of ΔNp63 than those on LAM-421 and 
LAM-511; and lower levels of ABCB5 than those cultured on TCPS, Figure 55. Noteworthy 
was the absence of KRT12, ΔNp63, and ABCB5 transcript expression by hTCEpi cells when 
cultured on LAM-221 (blue arrows), ΔNp63 and ABCB5 when in LAM-521 (red arrows), Figure 
55. 
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Figure 55 - The expression of epithelial cell markers by hTCEpi cells when cultured on top of several 
recombinant laminin isoforms as assessed by Reverse Transcriptase qPCR. (Data is represented as 
median ± 5-95 percentile, n≥6, Kruskal-Wallis test followed by Dunn’s Multiple comparison test, 
*p<0.05, **p<0.01, ***p<0.001). Dashed line represents the basal expression of the markers of 
interests when cells are cultured on TCPS. Arrows represent gene expression not detectable in that 
laminin isoform. Abbreviations used GAPDH: glyceraldehyde 3-phosphate dehydrogenase, LAM: 
laminin, KRT: keratin, ABCB5: ATP-binding cassette sub-family B member 5, TCPS: tissue culture 
polystyrene. 
 
Taken together, the previous observations suggest that cells cultured in LAM-511 did not 
retain fully differentiated characteristics as seen by the high expression of putative SC 
markers. In conjunction with these results and based on others’ investigations related to its 
distribution throughout the surface of human eye [46] and its role in maintaining the 
overlying cells in an undifferentiated state [310, 311, 426, 427], this isoform was chosen to 
further investigate its role on modulating EC differentiation. 
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3.3.6. HCjE-Gi cells respond differently to different concentrations of LAM-
511 
HCjE-Gi cells were cultured on surfaces functionalized with different concentrations of LAM-
511 and the transcript expression of six epithelial markers was normalized to the expression 
of GAPDH of HCjE-Gi cells cultured of TCPS. 
HCjE-Gi cells cultured on surfaces coated with 10µg/mL showed higher levels of expression 
of all keratin transcripts when compared to those seeded on TCPS and on surfaces 
functionalized with lower LAM-511 concentrations (p≤0.05, with some exceptions). 
Noteworthy was the absence of KRT12 expression when HCjE-Gi cells were cultured on 
2.5µg/mL coated cultureware (blue arrow). Regarding the expression of epithelial SC 
markers, HCjE-Gi cells cultured on 2.5µg/mL showed higher expression of ΔNp63 (10-fold 
increase, p≤0.05), and 10µg/mL led to higher levels of ABCB5 expression when compared to 
cells cultured on surfaces coated with 1µg/mL and 5µg/mL of LAM-511 (8.8-fold increase, 
p≤0.01), Figure 56.  
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Figure 56 - The expression of epithelial cell markers by HCjE-Gi cells when cultured on top of surfaces 
coated with various concentrations of human recombinant laminin-511 as assessed by Reverse 
Transcriptase qPCR. (Data is represented as median ± 5-95 percentile, n≥6, Kruskal-Wallis test 
followed by a Dunn’s Multiple Comparison test, *p<0.05, **p<0.01, ***p<0.001). Dashed line 
represents the basal expression of the markers of interests when cells are cultured on TCPS. Arrows 
represent gene expression not detectable in that laminin concentration. Abbreviations used GAPDH: 
glyceraldehyde 3-phosphate dehydrogenase, KRT: keratin, ABCB5:  ATP-binding cassette sub-family B 
member 5, TCPS: tissue culture polystyrene. 
3.3.7. hTCEpi cells respond differently to different concentrations of LAM-
511 
hTCEpi cells were cultured on surfaces functionalized with different concentrations of LAM-
511 and the transcript expression of six epithelial markers was normalized to the expression 
of GAPDH levels of hTCEpi cells cultured on TCPS. 
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hTCEpi cells cultured on 5µg/mL coated surfaces showed changes in keratin expression 
profile. Briefly, significant higher levels of KRT3, KRT12, and KRT13 expression on 5µg/mL 
coated surfaces were observed when compared to cells seeded on others LAM-511 
concentrations. Regarding the expression of epithelial SC markers, hTCEpi cells cultured on 
lower concentrations of LAM-511 (2.5-5µg/mL) appeared to express higher levels of ΔNp63 
and ABCBC5 when compared to those cultured on other LAM-511 concentrations, Figure 57.  
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Figure 57 - The expression of epithelial cell markers by hTCEpi cells when cultured on top of surfaces 
coated with varied concentrations of human recombinant laminin-511 as assessed by Reverse 
Transcriptase qPCR. (Data is represented as median ± 5-95 percentile, n≥6, Kruskal-Wallis test 
followed by a Dunn’s Multiple Comparison test, *p<0.05, **p<0.01, ***p<0.001). Dashed line 
represents the basal expression of the markers of interests when cells are cultured on TCPS. 
Abbreviations used GAPDH: glyceraldehyde 3-phosphate dehydrogenase, KRT: keratin, ABCB5: ATP-
binding cassette sub-family B member 5, TCPS: tissue culture polystyrene. 
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3.3.7.1. Summary of results 9: 
i. HCjE-Gi cells cultured on surfaces coated with 10µg/mL of LAM-511 showed higher levels 
of EC markers transcripts, including corneal (KRT3 and KRT12), conjunctival (KRT7 and 
KRT13), and SC (ABCB5) epithelial markers. 
ii. hTCEPi cells cultured on surfaces coated with 5µg/mL of LAM-511 exhibited higher levels 
of transcripts that encode for corneal (KRT3 and KRT12) and conjunctival (KRT7 and 
KRT13) epithelial markers.  
iii. Cell response to functionalized surfaces is LAM-511-concentration dependent. 
3.3.8. HCjE-Gi cells’ response to LAM-511 functionalized substrates is time-
dependent 
Because cell response showed to be laminin isoform and concentration-dependent, the 
time-dependency was considered and further investigated. For this purpose, HCjE-Gi cells 
were cultured on top of cultureware coated with 10µg/mL of LAM-511, the transcript 
expression of six epithelial markers was then assessed over 5 days and normalised to the 
expression of GAPDH levels of HCjE-Gi cells cultured of TCPS. 
HCjE-Gi cells cultured on LAM-511 for 3 days showed higher expression levels of KRT3 and 
ΔNp63 than those kept in culture for 5 days (24- and 2-fold increase, respectively p<0.001). 
Additionally, the expression levels of KRT3 by HCjE-Gi cells cultured on functionalized 
scaffolds for 3 days were higher than those observed for HCjE-Gi cells cultured on TCPS (24-
fold increase, p<0.05), Figure 58. No KRT12 transcript expression was detected when HCjE-
Gi cells were cultured on TCPS for 3 days, consequently no statistical analysis could be 
performed (blue arrows), Figure 58. 
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Figure 58 - The expression of epithelial cell markers by HCjE-Gi cells when cultured on top of 
recombinant laminin-511 over 5 days as assessed by Reverse Transcriptase qPCR. (Data is 
represented as median ± 5-95 percentile, n≥6, Kruskal-Wallis test followed by a Dunn’s Multiple 
Comparison test, *p<0.05, **p<0.01, ***p<0.001). Dashed line represents the basal expression of the 
markers of interests when cells are cultured on TCPS. Arrows represent gene expression not 
detectable in that time point. Abbreviations used GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase, TCPS: tissue culture polystyrene, KRT: keratin, ABCB5: ATP-binding cassette sub-
family B member 5. 
3.3.9. hTCEpi cells’ response to LAM-511 functionalized substrates is time-
dependent 
In this section, hTCEpi cells were cultured on top of cultureware coated with 5µg/mL of 
recombinant LAM-511, the transcript abundance of six epithelial markers was then assessed 
over 5 days and normalized to the expression of GAPDH levels of hTCEpi cells cultured on 
TCPS. 
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hTCEpi cells cultured on LAM-511 for 3 days showed higher expression levels of KRT3, KRT7, 
and ABCBB5 than those left in culture for 5 days (5.1-, 6.4-, and 2.3-fold increase respectively, 
p≤0.05). Additionally, the transcript abundance of KRT12, KRT7, and KRT13 by hTCEPi cells 
(12-, 6.4-, and 3.8-fold increase respectively, p≤0.01) was also higher for cells kept in culture 
for 3 days when compared to those maintained in culture for 1 day only, Figure 59. 
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Figure 59 - The expression of epithelial cell markers by hTCEpi cells when cultured on top of 
recombinant laminin-511 over 5 days as assessed by Reverse Transcriptase qPCR. (Data is 
represented as median ± 5-95 percentile, n≥6, Kruskal-Wallis test followed by a Dunn’s Multiple 
Comparison test, *p<0.05, **p<0.01, ***p<0.001). Dashed line represents the basal expression of the 
markers of interests when cells are cultured on TCPS. Abbreviations used GAPDH: glyceraldehyde 3-
phosphate dehydrogenase, TCPS: tissue culture polystyrene, KRT: keratin, ABCB5: ATP-binding 
cassette sub-family B member 5.  
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3.3.9.1. Summary of results 10: 
i. HCjE-Gi cells seeded for 3 days on surfaces functionalized with 10µg/mL of LAM-511 
showed significant alterations in their EC markers expression profile. 
ii. hTCEpi cells cultured on surfaces coated with 5µg/mL of LAM-511 for 3 days showed 
significant alterations in their expression profile of EC markers. 
iii. Cell response to functionalized substrates is time-dependent. 
3.3.10. The protein residues’ phosphorylation and cleavage levels are 
reduced when cells are cultured on surfaces coated with ECM proteins 
PathScan® Intracellular Signalling Array Kit was used to monitor the expression of 18 
signalling molecules that are phosphorylated or cleaved in response to signal-transduction 
pathway activation, Figure 60. Different conditions were selected for these studies following 
the modulation observed at keratin profiling: HCjE-Gi and hTCEpi cells cultured on TCPS 
(control), HCjE-Gi and hTCEpi cells cultured on HCjE-Gi ECM proteins and on hTCEpi ECM 
proteins for three days, following “de-roofing”, and HCjE-Gi and hTCEpi cells cultured for 
three days on surfaces coated with 10µg/mL and 5µg/mL of LAM-511, respectively.  
A significant decrease in phosphorylation or cleavage levels of nearly all proteins was 
observed when HCjE-Gi cells were seeded in pre-coated cultureware, regardless the ECM 
proteins preparation. This trend was not observed in the levels of p70 S6 kinase, p53, p38, 
SAP/JNK, and caspase-3 residue phosphorylation. Very similar results were seen for the 
hTCEpi cells. Additionally, no changes in STAT1, S6 ribosomal protein, mTOR and PARP 
residue phosphorylation or cleavage levels were shown when hTCEpi cells were cultured on 
pre-coated cultureware, Figure 61. 
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Figure 60 - PathScan® Intracellular Signalling Array. (A) Target map (B) Chemiluminescent readout (C)
immunoblotting. Abbreviations used: TCPS: tissue culture polystyrene, ECM: extracellular matrix, LAM: 
laminin. 
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Figure 61 (continued) 1/5 - Densitometry quantification of PathScan® Intracellular Signalling Array 
of HCjE-Gi and hTCEpi cells when cultured in different matrices. (Data is represented as median ± 5-
95 percentile, n≥3, One-way ANOVA followed by Tukey’s Multiple Comparison Test, *p<0.05, ** 
p<0.01, *** p<0.001). Abbreviations used A.U. arbitrary units, ECM: extracellular matrix, LAM: 
laminin. Figure 61 - Densitometry quantification of PathScan® Intracellular Signalling Array of HCjE-Gi and hTCEpi cells when cultured in different matrices. 
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Figure 61 (continued) 2/5 - Densitometry quantification of PathScan® Intracellular Signalling Array 
of HCjE-Gi and hTCEpi cells when cultured in different matrices. (Data is represented as median ± 5-
95 percentile, n≥3, One-way ANOVA followed by Tukey’s Multiple Comparison Test, *p<0.05, ** 
p<0.01, *** p<0.001). Abbreviations used A.U. arbitrary units, ECM: extracellular matrix, LAM: 
laminin. 
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Figure 61 (continued) 3/5 - Densitometry quantification of PathScan® Intracellular Signalling Array 
of HCjE-Gi and hTCEpi cells when cultured in different matrices. (Data is represented as median ± 5-
95 percentile, n≥3, One-way ANOVA followed by Tukey’s Multiple Comparison Test, *p<0.05, ** 
p<0.01, *** p<0.001). Abbreviations used A.U. arbitrary units, ECM: extracellular matrix, LAM: 
laminin. 
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Figure 61 (continued) 4/5 - Densitometry quantification of PathScan® Intracellular Signalling Array 
of HCjE-Gi and hTCEpi cells when cultured in different matrices. (Data is represented as median ± 5-
95 percentile, n≥3, One-way ANOVA followed by Tukey’s Multiple Comparison Test, *p<0.05, ** 
p<0.01, *** p<0.001). Abbreviations used A.U. arbitrary units, ECM: extracellular matrix, LAM: 
laminin. 
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Figure 61 (continued) 5/5 - Densitometry quantification of PathScan® Intracellular Signalling Array 
of HCjE-Gi and hTCEpi cells when cultured in different matrices. (Data is represented as median ± 5-
95 percentile, n≥3, One-way ANOVA followed by Tukey’s Multiple Comparison Test, *p<0.05, ** 
p<0.01, *** p<0.001). Abbreviations used A.U. arbitrary units, ECM: extracellular matrix, LAM: 
laminin. 
matrix, LAM: laminin. 
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 Summary of results 11: 
i. A significant decrease in phosphorylation and cleavage levels of nearly all protein residues 
was observed when HCjE-Gi and hTCEpi cells were seeded in pre-coated cultureware, 
regardless the ECM preparation used. 
ii. Similar signalling pathways were activated in the differentation of the two cell lines used. 
3.3.11. Summary of results of Chapter 3: 
i. The “de-roofing” method showed to be reliable as a vast subset of ECM proteins and 
growth factors were found by mass spectrometry in both cell lines lysates. 
ii. The expression of COLXVIIα1, LAMα5, LAMβ1, and LAMβ2 over-time appeared to be cell-
dependent. 
iii. Cells were sensitive to the underlying substrate, i.e. surfaces coated with different laminin 
isoforms induced different keratin profiling expression. 
iv. The cell response to LAM-511 functionalised substrates was concentration and time in 
culture-dependent.  
v. A decrease in residue phosphorylation and cleavage levels was observed for both cell lines 
when cells were cultured on pre-coated cultureware, regardless of the ECM preparation 
used. 
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3.4. Discussion  
The studies in this chapter assessed the composition of ECM produced by the two cell lines 
and the plasticity of two terminally differentiated ECs towards desired epithelial lineages 
upon culture on substrates functionalized with one single laminin isoform.  
3.4.1. Characterization of the ECM produced by the two cell lines 
Mass spectrometry data showed a cell-dependent ECM composition, despite some proteins 
were shown to be present in both matrices. The most abundant proteins found in both 
matrices, and therefore unlikely to be involved in the process of differentiation into specific 
lineage, include fibronectin, the three chains that comprise LAM-332, various integrin chains, 
tenascin, and thrombospondins. Fibronectin [46], LAM-332 [46], and integrin α3β1, α6β1, 
and α6β4 [428] were all also found by others to be present in the conjunctival and corneal 
BM. On the other hand, tenascin-C and thrombospondin-1, here found in both matrices, are 
suggested to be enriched in the limbal and cornea regions, respectively [46].  
Mass spectrometry results showed COLXVIIα1, LAMα5, and LAMβ1 to be specific for one or 
another ECM, and therefore likely to be involved in the process of cell differentiation. For 
this reason, their production and expression was further investigated.  
COLXVIIα1 is a protein involved in the formation of HDs and consequently involved in the 
adhesion of cells to the underlying substrate [420]. Its higher expression levels detected in 
hTCEpi cells (Reverse Transcriptase qPCR and flow cytometry) suggest a stronger and more 
cohesive interaction cell-substrate. These results were expected since conjunctiva is a looser 
structure when compared to cornea [8, 429]. Others have suggested, not only the presence 
of COLXVIIα1 in human corneal tissues, but also a close regulation of mRNA and protein levels 
with increases and decreases in mRNA preceding those of the protein by approximately 2 
days [430].  
LAMα5 isoform trimers with LAMβ1 and LAMγ1 to form LAM-511 or with LAMβ2 and LAMγ1 
to form LAM-521 [353], thus the expression profile of their individual chains should follow 
similar trends. The transcript expression of LAMα5 and LAMβ1 by HCjE-Gi cells showed a 
better match than LAMα5 and LAMβ2, which may suggest that LAM-511 is produced at 
higher levels than LAM-521 by those cells.  
Immunocytochemistry (ICC) results confirmed the production of all four proteins by the two 
cell lines. Others have also localized COLXVIIα1, LAMα5, and LAMβ1 within both the cornea 
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and conjunctival BM [46, 431]. LAMβ2, on the other hand, has been mostly localized in the 
conjunctiva [46, 304, 352] and limbus BM [46]. COLXVIIα1 presence in the ECM appears to 
be delayed in comparison with all other three laminin chains.  
Based on mass spectrometry, Reverse Transcriptase qPCR, flow cytometry, and ICC data, the 
four proteins are produced by the two cell lines. However, their production levels appear to 
be cell and time-dependent. Briefly, the latter three data sets showed higher expression of 
the four proteins by hTCEpi cells over time. The time specificity and differences in protein 
production profiles may be the trigger agent to the different cell responses upon culture in 
the different matrices. Others have yet suggested that even in similar matrices, the 
organizational states of the common ECM molecules and/or the way such components 
interact with each other and/or with other soluble factors may provide tissue specificity [170, 
294]. However, the results in this section not only considered the potential interactions 
between all the proteins present in the ECM but also their interactions with growth factors 
and other soluble factors, as these were shown not to be washed away by the “de-roofing” 
method. 
3.4.2. Cell response to the functionalized substrate is laminin isoform-
dependent 
Functionally, laminin isoforms are known to regulate the differentiation of ECs [432]. 
Differences in the laminin composition of the conjunctival and corneal BM provide 
circumstantial evidences for some external modulation of EC differentiation [30, 425]. 
Consistent with these observations, our experiments showed that different recombinant 
laminins isoforms have different effects on the expression profiles of various EC markers.  
Cells cultured on LAM-411 showed the lowest expression of epithelial markers. One study 
has shown this isoform to have the lowest binding affinity to integrins [433], which may 
impair the formation of adhesion complexes and per se the integrity of overlying cultured 
ECs.  
HCjE-Gi cells cultured on functionalized substrates that contain LAMβ2 showed higher levels 
of corneal EC markers KRT3 and KRT12 and lower levels of conjunctival EC markers KRT7 and 
KRT13 when compared to cells cultured on uncoated substrates. These results are in some 
way contradictory with the work of Kurpakus and Lin, who showed that the lack of LAMβ2 is 
correlated with the loss of expression of KRT4 [425], that dimers with KRT13 to form 
intermediate filaments. Two different reasons may explain these differences; firstly, the time 
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in culture; 5 days in the herein studies versus the 14 days on Kurpakus and Lin’s work; 
secondly, they used a purified LAMβ2 chain whilst here was used a whole laminin isoform 
that contain that specific chain. Interestingly, it is in the substrates that contain both LAMβ2 
and LAMγ1 (LAM-121, -221, and -521) that HCjE-Gi express higher values of the corneal 
markers and lower values of conjunctival markers. Very scarce information is published on 
the effects of LAMγ1 in the ocular cell differentiation. It is present in both cornea and 
conjunctival BM [46] and its knockout is lethal [434] due to the lack of BM formation [435]. 
It was also associated with the differentiation of Schwann cells [436]. The results may suggest 
that HCjE-Gi cells cultured in LAM-111, -211, and -421 are in a less differentiation state as 
they expressed not only the conjunctiva-associated markers, KRT7 and KRT13, but also the 
associated corneal markers KRT3 and KRT12. Similar observations were obtained by Wei et 
al., who by culturing conjunctival ECs on feeder layers observed the expression of KRT5/14, 
hyperproliferative keratins KRT6/16, small amounts of KRT3 and KRT12, and KRT8/18 [30]. 
Suggesting that in appropriate culture conditions conjunctival ECs do not retain fully 
differentiation characteristics [30] and consequently they may either be in a 
hyperproliferative or in a dedifferentiation state. 
On the opposite equivalent direction, hTCEpi cells cultured on LAM-111, and LAM-511 
expressed higher levels of corneal markers and lower levels of conjunctival markers. These 
two laminin isoforms, are together with LAM-332, the most abundant in the cornea BM [352, 
366, 437]. These observations suggested that the mimicry of the corneal environment, by 
using these two isoforms, is correlated with the differentiation of corneal ECs, as shown by 
others using different systems [425]. Moreover, when hTCEpi cells were cultured on the 
suggested conjunctival laminin isoforms (LAM-121, -221, and -521 [46, 438]) the expression 
levels of the conjunctival markers were not statistically different. Despite being observed, 
the expression levels of such markers was lower when compared to the results seen in 
Chapter 2. Two reasons may explain these results; firstly, the cells in Chapter 3 were cultured 
on single laminin isoforms and not in the protein and growth factor meshwork as in Chapter 
2; secondly, the cells were kept in culture for 5 days, whilst others’ studies have cultured 
cells in crude laminin preparations for longer (9-14 days) [425]. Taken together these 
observations suggested that, despite cell responsiveness to the external environment, single 
laminin isoforms are not sufficient to promote complete cell differentiation into specific 
lineages.  
  Chapter 3 
150 
 
To assess the issues related with time and concentration-dependent response, cells were 
cultured in surfaces coated with different LAM-511 concentrations and for variable periods 
of time. LAM-511 was chosen for substrate functionalization because its role in maintaining 
the undifferentiated state of mESCs [311], hESC [313] and to be efficiently used as substrate 
for the ex vivo expansion of human limbal epithelial progenitor cells [439]. 
LAM-511 has been located in conjunctival, corneal and limbal BM, but appears to be enriched 
in the latter [46], which helps to understand why cells cultured in substrates functionalized 
with such laminin isoform start to lose their differentiation characteristics to gain those 
associated with dedifferentiated cells. Indeed, our results showed that both cell lines when 
cultured in LAM-511 express several keratins, including KRT3, KRT12, KRT7, and KRT13 
suggesting that the cultured cells did not retain fully differentiated characteristics. To further 
corroborate these results, the expression of the two epithelial SC markers showed the 
highest levels under the same conditions where the keratin expression levels were also the 
highest. These results suggested an emergence of progenitor ECs. Others have showed an 
optimal concentration of this protein to support the efficient adhesion and expansion of 
human pluripotent SCs ranging from 3-6µg/cm2 (equivalent to roughly 30-60µg/mL) [313], 
considerably higher than the used in the hereby studies.  
The mechanism of differentiation appears to be concentration dependent, with 10 and 
5µg/mL inducing the highest expression of epithelial markers by HCjE-Gi and hTCEpi cells, 
respectively. Additionally, the cell response to LAM-511 seems also to be time-dependent, 
with both cell lines showing higher expression of ECs’ markers at day 3. Some investigators 
have suggested that the process of cell re-differentiation may be preceded by an 
intermediate step of cell de-differentation requiring cell division, however not obligatory in 
all cases [212]. Both cell lines used in this study show a doubling time of around 2 days (see 
section 2.3.1). The cell doubling observations together with the higher expression of SC 
markers within the first 3 days suggest that after the first full cell cycle the cells are in a less 
differentiated state. Interestingly, it has been shown that the process of differentiation and 
proliferation are not mutually exclusive [64]. Being that said, while some cells are 
differentiating and expressing new gene products, others may still be expressing their 
“native” characteristics. Yet again, the differences observed in the gene profiling of cells 
cultured in LAM-511 substrates were not as dramatic as the ones observed in Chapter 2. Lack 
of appropriate structural and biochemical cues for cell differentiation in the LAM-511 culture 
conditions may be a reason for such difference. Only one study has briefly compared two 
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similar culturing systems with very similar findings; the lack of structural and biochemical 
cues on Matrigel coated substrates led cells (mouse mammary ECs) to produce relatively 
large amounts of cytokeratins when compared to those cultured on “de-roofed” ECM 
proteins[440], suggesting a hyperproliferative cell state in the first condition. However, in 
those studies, the expression of SC markers was not addressed. 
Cell interactions with laminins and other ECM proteins are mainly mediated through 
integrins [380]. ECs synthetize various integrin subunits, including integrin α6 and β1 chains, 
both detected by mass spectrometry in either matrices. Integrin α6β1 is the main receptor 
to mediate cell-laminins interactions, including cell-LAM-511 interactions [310, 311]. Integrin 
αVβ1, only detected in hTCEpi ECM, also contributes to cell adhesion [311]. Others have 
shown that by blocking integrin β1 chain the cell adhesion to LAM-511 is completely 
inhibited, whereas integrin αV and α6 chain blocking partially inhibited cell adhesion to LAM-
511 coated surfaces [311]. Others have yet suggested that β1 but not β4 integrin mediated 
the adhesion of conjunctival ECs to LAM-511 and LAM-521 [304]. These observations suggest 
that integrin β1 chain may be the main protein involved in cell-surface cross-talk. By 
assessing the laminin-integrin binding affinity, Nishiuchi et al. have suggested that LAM-511 
and LAM-521 are the preferred ligand for all the laminin-binding integrins, on other hand 
LAM-411 was the poorest ligand, showing the lowest integrin binding affinity [433]. These 
observations may help to understand the lack in keratin expression by cells cultured on LAM-
411 as the cell integrity and adhesion may have been compromised due to the poor cell-
substrate interaction. Additionally, Polisetti et al. have shown that epithelial stem progenitor 
cells cultured on LAM-411 have the lowest covered area, cell adhesion, BrdU proliferation 
and amount of Ki67-positive cells (proliferating cells) when compared to cells cultured on 
other laminin isoforms [439]. Using a different corneal EC line, Kurpakus et al. have shown 
that it is integrin α3 chain (detected by mass spectrometry in both ECM preparations) that 
plays a major role in mediating cellular adhesion to LAM-111 and placental laminin (mainly 
composed of LAM-511 and LAM-521) [438]. However, these results are conflicting with 
others’, who showed that the blocking of this chain does not affect the adhesion of mammary 
ECs to LAM-111 [441] but affects the adhesion of human foreskin keratinocytes [442]. It is 
then reasonable to affirm that integrin specificity for laminin isoforms is cell type-dependent. 
Further investigations should then be performed to characterize cell integrity and 
morphology on the different substrates.  
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The clinical applications of laminin molecules still present technical difficulties as they are 
large proteins that require three different genes, each encoding the α, β, and γ chain [353]. 
Recent studies have reported the successful culture and expansion of hESCs and hiPSCs using 
recombinant laminin E8s isoforms [313]. E8s are truncated proteins consisting of the C-
terminal regions of the α, β, and γ laminin chains. They contain the active integrin-binding 
site composed of the laminin globular domains of the α chain and the glutamate residue of 
the γ chain [443]. These E8 laminin fragments showed robust capacity to be used in 
therapeutic applications as they still retain the α6β1 integrin binding site and do not present 
the risk of contamination with xenogeneic pathogens and immunogens [313]. 
3.4.3. The protein residues’ phosphorylation and cleavage levels are 
reduced when cells are cultured on coated surfaces 
Upon extracellular stimulation, MAPK/ERK signalling module is activated by dual 
phosphorylation of the Thr202 and Tyr204 residues by the dual specificity kinases MEK1 and 
MEK2, which lead to EC differentation [389, 393]. Additionally, growth of undifferentiated 
ESC is enhanced by culture with PD098059, a MEK inhibitor [444], and MEK pathway 
inhibition promotes murine ESC self-renewal [444]. Studies in PC12 cells have shown that 
inhibition of ERK activity results in enhanced STA3-mediated transcription [445], suggesting 
that the antagonism between STAT3 and ERK signalling could account for the effect of 
PD098059 in ESCs. In accordance with these observations, HCjE-Gi and hTCEpi cells when 
cultured on coated substrates showed lower levels of ERK1/2, STAT1, and STAT3 
phosphorylation, suggesting that cells lost their differentiated state, gaining undifferentiated 
characteristics as seen by the high levels of keratin, either corneal and conjunctival, and 
putative SC markers expression.   
AKT and mTOR regulation are intricately linked, with AKT functioning upstream of mTOR 
complex 1 (mTORC1) and mTORC2 regulating AKT activation. mTORC2 phosphorylates the 
AKT serine residues Ser473 and Ser450. Phosphorylation of both serine residues stimulates 
phosphorylation at Thr308 residue by PDK1 (3-phosphoinositide-dependent protein kinase-
1) that leads to full AKT activation, which in turn phosphorylate (activity inhibition) GSK-3β, 
PRAS40, BAD and S6 ribosomal protein [402, 403], consistent with these observations are 
the similar trends followed by the phosphorylation profiles of those five proteins. AKT can 
also activate mTORC1 by phosphorylating PRAS40, thereby relieving the PRAS40-mediated 
inhibition of mTORC1 [446]. mTORC1 phosphorylates p70 S6 kinase leading to cell cycle 
progression. S6 ribosomal protein, found downstream p70 S6 kinase reflects mTOR pathway 
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activation and predicts cell cycle progression. The activation (phosphorylation) of these 
proteins have effects on cell differentiation [404, 405, 447]. Together, and consistent with 
the others’ observations [405, 447], these data support the model that low levels of AKT 
activation (phosphorylation) inhibit cell differentiation, whereas high AKT activation may be 
necessary for cell differentiation.  
GSK-3β inhibitors act as mimetics of Wnt stimulation and consequently support expansion 
of mouse and human ESC keeping their undifferentiated state [448]. Wnt/β-catenin 
signalling has also been correlated with an increase in the proliferation of LSC while 
maintaining the positive LSC markers expression [449].  
The phosphorylation and cleavage levels of all protein residues point all in one single 
direction; cells cultured on coated surfaces exhibit undifferentiated characteristics – high 
levels of keratins and putative SC markers expression. Additionally, the low levels of AMPk, 
HSP27, and PARP phosphorylation also corroborated that hypothesis [408, 450-452]. 
When the three different coating methods are compared, a striking trend is observed; cells 
cultured on “de-roofed” culture systems showed lower levels of protein residue 
phosphorylation and cleavage when compared to LAM-511 coating substrates. These 
observations suggest that cells cultured on ECM proteins appear to be in a less differentiated 
state than those cultured on LAM-511. This may be explained by the lack of structural and 
chemical cues on LAM-511 coating method, whereas “de-roofed” cultures systems not only 
provide morphogenic information resultant from the interaction between all the proteins 
produced, but also provide a pool of soluble factors produced by cells and trapped within 
the ECM. These cues have been shown to regulate central cell processes (reviewed in [299]), 
including cell differentiation, as seen on Chapter 2, in a process that involves an intermediate 
step of cell de-differentiation. On the other hand, LAM-511, despite lack of structural and 
chemical cues, has a differentiation inhibitory potential that allows cells to preserve their 
undifferentiated state [310-312] as seen by the expression of SC markers (ΔNp63 and ABCB5) 
albeit, at lower levels than the cells cultured on the “de-roofed” systems. TCPS, here used as 
control, did not provide any cues, either biochemical or structural, and therefore is the one 
condition showing higher levels of post-translational protein modifications, mostly indicative 
of a fully differentiated cell state. Consistent with this, Wei et al. have shown that 
conjunctival ECs cultured on TCPS are in a hyperproliferative state in contrast to the 
undifferentiated state of those cultured on feeder layers [30]. Taken altogether, these 
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observations have suggested that cells cultured on different ECM proteins meshwork 
(regardless the producing cell) may be in a less differentiated state when compared to those 
on TCPS, however further investigations on the expression of different epithelial SC markers 
should be conducted.  
3.4.4. Potential of differentiating human epithelial cells towards a desired 
cell lineage 
The studies in this chapter addressed the response of ECs upon culture on different laminin 
isoforms regarding their potential for cell differentiation and protein post-translational 
modifications. However, several improvements are needed: 
i. Coating substrates with a combination of several laminin isoforms. The data showed 
that the protein production profiles are cell type-dependent. Useful information would 
arise from culturing cells in substrates functionalized with a combination of laminin 
isoforms that better modulate the keratin expression in accordance with one’s need.  
ii. Specific antibody blocking of certain laminin chains. To better understand the cell 
response to the laminin isoforms, antibody blocking of laminin chains could be performed 
to assess if cell’s phenotype can be recovered after differentiation. 
iii. Blocking of certain signalling pathways. Useful data would result from experiments in 
which certain pathways and/or small branches of these pathways were blocked by 
antibody binding to, therefore, investigate whether the same type of response would be 
given without the interference of the extracellular cues. 
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Chapter 4  
Epithelial cell-derived exosomes trigger the differentiation of two 
epithelial cell lines. 
4.1. Introduction 
Intercellular communication in multicellular organisms is mediated through three different 
mechanisms: (i) direct cell-cell contact, (ii) transfer of secreted molecules, and the recently 
proposed mechanism (iii) the transfer of extracellular vesicles (EVs) [5]. EVs, released by the 
so-called secreting cell, bind to the receptors on the membrane of the recipient cell, 
eventually releasing their cargo and ultimately modifying the recipient’s physiological state 
[453]. Exosomes are a specific subtype of secreted EVs. The term exosome, coined by Trams 
et al., was firstly used to name vesicles ranging from 40 to 1000nm diameter carrying 5’-
nucleotidase [454]. In more recent years, the term exosome has been adapted and adopted 
to designate vesicles whose diameter ranges from 40 to 100nm. Such vesicles have been 
found and isolated from several body fluids, including blood plasma [455], saliva [456], 
semen [457], and tears [458]. Most of these studies referred to these vesicles as exosomes 
because of their exosome-like protein content. However, these populations are likely to be 
composed of a mixture of exosomes and other membrane vesicles, as the isolation and 
purification methods used do not allow to fully discriminate between these two classes of 
vesicles within the same population. 
4.1.1. Exosomes and other secreted vesicles 
EVs are small membrane vesicles released from the surface of many different cell types 
including B lymphocytes, dendritic cells, Schwann cells, intestinal ECs, and many others [459, 
460]. Produced by different mechanisms, three classes of EVs have been identified: (i) 
apoptotic bodies (diameter ranges from 1 to 5µm) released by cells undergoing apoptosis, 
(ii) microvesicles (MVs, whose diameter goes up to 1µm) and (iii) exosomes (40 to 100nm in 
diameter) [461, 462]. MVs are a heterogeneous population of EVs formed by the outward 
budding and shedding from cells’ plasma membrane in a calcium and enzymatic-dependent 
way. Exosomes are a heterogenous population of EVs of endosomal origin. They are formed 
intracellularly by the inward budding on the limiting membrane of endocytic compartments 
leading to the synthesis of vesicles-containing endosomes, the multivesicular bodies (MVBs). 
The MVB will eventually fuse with the plasma membrane of the secreting cell releasing their 
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content, i.e. the exosomes [463]. When viewed under electron microscopy, quickly frozen 
exosomes have a perfectly rounded shape [464] and not the “saucer-like” shape, erroneously 
considered as the typical shape of exosomes [5]. Hereby, the term exosome will exclusively 
refer to EVs of endocytic origin.  
4.1.2. The molecular composition of exosomes 
4.1.2.1. Exosome membrane  
The exosome lipid bilayer is decorated with tetraspanins, a protein superfamily that 
organizes membrane microdomains termed tetraspanin-enriched microdomains (TEM) by 
forming clusters and interacting with a large variety of transmembrane and cytosolic proteins 
[465]. A wide variety of tetraspanins (cluster of differentiation (CD)9, CD63, and CD81) [466], 
and cytosolic proteins, including endosome or membrane-associated proteins are shown to 
be present at the exosome membrane [5]. It is becoming clear that these proteins are not 
exosome-specific markers but rather exosomes-enriched proteins. To describe and 
characterize an exosome-containing solution both transmembrane and cytosolic proteins 
with membrane or receptor binding capacities are required to be found positive. In addition, 
the level of proteins not expected to be enriched in exosome populations of endosomal 
origin should also be determined, these include proteins associated with compartments 
other than plasma membrane or endosomes [467].  
CD63 is a member of the transmembrane 4 superfamily characterized by the presence of 
four hydrophobic domains [468]. Being a tetraspanin, CD63 interacts with different proteins, 
including integrins (α4β1 and α6β1) and has been linked with exosome docking at the 
recipient cell [468]. CD63’s role in exosome function has also been associated with protein 
transporting and sorting [468, 469]. Tumour susceptible gene (TSG)101 is a component of 
the endosomal sorting complexes required for transport (ESCRT)-I complex, being involved 
in the regulation of vesicular trafficking process [470]. It binds to the ubiquitinated cargo 
proteins and is required for sorting of endocytic cargos into MVBs [470, 471]. Glucose-
regulated protein (GRP)94 (also known as endoplasmin and HSP90 β family member 1) is a 
molecule chaperone whose functions are related with the processing and transport of 
secreted proteins [472]. 
In accordance with the gold standards proposed by the International Society for Extracellular 
Vesicles [467], the hereby structures referred to as exosomes are those that demonstrated 
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to be CD63 and TSG101 (endosome-binding and cytosolic protein, respectively) positive and 
GRP94 (endoplasmic reticulum protein) negative.  
Purified exosomes should be completely devoid of serum proteins and other proteins 
associated with intracellular compartments, such as endoplasmic reticulum, mitochondria, 
nuclei, and Golgi-apparatus [473]. In addition to the already mentioned tetraspanins and 
endosome-associated proteins, exosomes are highly enriched in cholesterol, sphingomyelin, 
and hexosylceramides when compared to the plasma membrane [474, 475]. The fatty acids 
in exosomes are mostly saturated or monounsaturated. This high fatty acid concentration 
together with high cholesterol composition has been suggested to be important for their 
segregation into exosomes during their formation at MVBs [5].  
4.1.2.2. Exosome cargo  
Exosomes carry a cargo that appears to be not only cell-type dependent but can even differ 
from parent to daughter cells [476, 477]. The cargo includes mRNA and miRNA molecules, 
often small amounts of DNA, transcription factors, cytokines, and growth factors [453]. More 
recently, deep sequencing approaches have demonstrated that EVs also contain a large 
variety of other small noncoding RNA species, including RNA transcripts overlapping with 
protein coding regions, repeated sequences of structural RNAs, tRNA fragments, and small 
interfering RNA [478, 479]. Many RNA molecules are selectively incorporated into EVs as they 
are found to be enriched relatively to the RNA profiles of the originating cell [479-481].  
How miRNA molecules are selectively incorporated into exosomes is still unknown. However, 
recent studies suggested that miRNAs in EVs share common specific sequence motifs (more 
poly(U) than poly(A)) at the 3’-end of the molecule, which may act as cis-acting elements for 
targeting to EVs [482]. Similarly, Villarroya-Beltri et al. have suggested that this mechanism 
involves the recognition of specific sequence motifs (GGAG) over-represented in miRNAs, 
called EXOmotifs [483]. These motives are recognized by hnRNPA2B1, a heterogenous 
nuclear ribonucleoprotein, and loaded into exosomes [483]. Others have further suggested 
a role of sphingomyelinase 2 on miRNA secretion into exosomes [484]. The cargo can be 
delivered to the recipient cells in remote locations inducing intracellular signalling changes 
and modification of their physiological state [485]. To increase the specificity of cargo 
delivery, MVs are decorated with cellular receptors and transmembrane proteins from the 
secreting cells. Furthermore, after transferring mouse exosomal RNA into human cells, 
mouse proteins were found in the recipient cells, suggesting that the transferred exosomal 
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RNA is translated after entering the recipient cell in the presence of the necessary machinery 
[480, 486]. 
4.1.2.2.1. mRNAs 
Several studies have shown that mRNA molecules are confined inside exosomes and are 
functional and translated into proteins in the presence of the necessary machinery [480, 
486]. These are as follows: 
i. Exosomes treated with RNase showed no difference in RNA degradation when compared 
to non-treated exosomes [480]. 
ii. Exosomes treated with trypsin also showed that exosomal RNA is resistant to the 
treatment [480]. 
4.1.2.2.2. MicroRNAs  
miRNAs are small (20-22 nucleotides long) non-coding RNAs molecules acting as post-
transcriptional repressors by binding to 3’UTR of the target mRNA [1]. They derive from 
transcripts that fold back on themselves to form distinctive hairpin structures [2]. Once 
processed from the hairpin, the miRNAs pair with the mRNAs to direct transcriptional 
modification, Figure 62 [1]. The degree of complementarity (through Watson-Crick base 
pairing) determines the fate of mRNA molecules. Lower rates of miRNA-mRNA sequence 
pairing results in translation repression and mRNA degradation, whereas higher rates of 
complementarity results in mRNA cleavage and degradation [1]. However, in very few cases 
miRNAs also target coding regions upregulating the expression of their target mRNAs [487, 
488]. Each miRNA may bind to several mRNAs targets, and one mRNA may be targeted by 
multiple miRNA molecules [1]. Found in all multicellular eukaryotes species, they regulate 
important biological processes, including cell growth, development, proliferation, and 
differentiation. Nearly 1100 human mature microRNAs have been identified and are 
proposed to regulate more than 30% of human transcriptomes [489].  
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Despite the amount of publications related to miRNA biology and functions over the last two 
decades, the research on miRNA biology in the human eye is still very scarce. An extensive 
list of significant pathways and biological functions potentially affected by differentially 
expressed miRNAs in corneal epithelium can be found at Teng et al. [490] and their roles in 
eye disorders at Raghunath et al. [491]. Others have assessed the miRNA content in human 
corneal [490-495] and conjunctival [496, 497] tissues and/or cells using several techniques. 
Table 19 shows the miRNA signature found in human ocular epithelium. 
The most expressed miRNA molecule in the cornea is miR-184 and it is mainly located at the 
basal and immediately suprabasal cells of the corneal epithelium but not in the superficial 
cells of the cornea, limbus and conjunctiva [493]. Different observations were made by 
Derrick et al. who have shown its expression also in conjunctival clinical samples [497]. It has 
been suggested that miR-184 is involved in the terminal differentiation of the corneal 
epithelium [498] and is down-regulated during corneal re-epithelization in the early stages 
of wound healing, suggesting that its expression is independent of the proliferative status of 
the corneal epithelium [493]. Comparative studies have shown a higher abundance of miR-
184, miR93b, miR-149 and miR-575 at central cornea epithelium when compared to limbal 
Figure 62 - Processing of a typical miRNA. The miRNA is transcribed from its own gene or a host gene 
as a long pri-mRNA transcript. This is processed to pre-miRNA by the protein pair Drosha/Pasha and 
then transported to the cytoplasm by Exportin-5, where it undergoes further modifications to form 
the final miRNA molecule (miRNA* molecule is often degraded). The miRNA can base-pair with any 
target mRNA that contains the complementary sequence. The miRNA prevents gene expression by 
degrading the target mRNA (1) or by blocking its translation (2). Adapted from [1, 2]. 
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epithelial [490], suggesting that those miRNAs may be involved in the terminal 
differentiation processes seen at the central cornea. Because of its similar expression profiles 
in cornea and lens, miR-184 may be involved in some unique common features of these two 
structures, including transparency and avascularity. The limbal regions have been shown to 
be enriched in miR-145, miR-143, miR-126, miR-338, miR-10b, miR142-3p, miR142-5p, miR-
377, and miR-376a [490], which because of their preferred location may be associated with 
undifferentiated cell states. miR-205 and miR-217 are expressed throughout the entire 
corneal, limbal and conjunctival epithelium [493]. In human conjunctival specimens, miR-
1274B has been shown to have the highest overall expression, followed by miR-151-3p, miR-
378, miR-720, and miR-184 [496]. Only two miRNAs have been associated with the regulation 
of adult epidermal SCs: miR-203 as it targets p63, the regulator of epithelial SC maintenance 
and differentiation [499, 500], and miR-125b as it targets Blimp1, responsible for maintaining 
the epithelial SCs in a hair follicle lineage [501]. Only recently, miR-103/107 family has been 
shown to be preferentially expressed in the basal cells of the limbal epithelium, targeting 
p90RSK2 a protein that helps to maintain a slow-cycling phenotype. Other molecules have 
also been identified as targets of this miRNA family, including NEDD9 and m(PTPRM) both 
shown to somehow be involved in SC-enriched epithelia [495]. Others have shown a gradual 
increase in expression of miR-24, mir-27b, and miR-184 during hESCs differentiation toward 
corneal epithelial-like lineages, with the knockdown of miR-184 resulting in reduced levels 
of KRT3 expression and therefore affecting the normal corneal epithelial commitment [494]. 
The same studies have shown miR-450b-5p as a PAX6-repressing miRNA and, accordingly, 
the absence of miR-450b-5p is required for PAX6 expression in the developing eye surface. 
They suggested that PAX6 repression by miR-450b-5p contributed to the pluripotent state of 
SCs and its decrease allows the cells to exit from this undifferentiated state [494].  
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Table 19 – Signature miRNAs in human ocular epithelium. ++++ strong expression, +++ high 
expression, ++ moderate expression, + residual expression, - down-regulated, NA not assessed. 
Adapted from [490-498, 502]. 
miRNA Cornea Limbus Conjunctiva 
miR-145 + +++ NA 
miR-143 -/+ +++ NA 
miR-126 -/+ +++ NA 
miR-338 - ++ NA 
miR-10b -- ++ NA 
miR-142-3p - + NA 
miR-142-5p - + NA 
miR-377 - + NA 
miR-376a -- + NA 
miR-146a -- + NA 
miR-139 -- +/- NA 
miR-211 -- +/- NA 
miR-155 -- +/- NA 
miR-127 -- - NA 
miR-184 ++++ +++ + 
miR-193b +++ ++ NA 
miR-149 + + (+/-) NA 
miR-575 ++ + NA 
miR-1274b NA NA ++++ 
miR-151-3p NA NA +++ 
miR-378 NA NA ++ 
miR-720 NA NA + 
miR-190b NA NA + 
miR-31 ++ - NA 
miR-103 ++ +++ NA 
miR-99a + (-/+) + NA 
miR-21-5p NA NA ++ 
miR-141-3p NA NA + 
miR-26-5p NA NA + 
miR-22-3p NA NA + 
miR-27b-3p NA NA + 
miR-191-5p NA NA + 
  
4.1.2.2.3. Proteins  
Exosome preparations are devoid of any proteins of nuclear, mitochondrial, endoplasmic-
reticulum or Golgi-apparatus origin [503]. All exosomal proteins identified to date have been 
found in the cytosol, in the membrane of endocytic compartments or at the cell membrane 
[473]. Other studies have analysed the protein content of exosomes using Western blotting 
[466, 504, 505] and flow cytometry [506-508]. An extensive table containing proteins present 
in exosome preparations can be found at Thery et al. [473]. Noteworthy is the absence of 
any lysosomal proteases and other soluble endocytic residents [473]. How the cytosolic 
content is recruited into the exosomes is still unclear. However, recent observations indicate 
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that ubiquitination of the cytosolic domain of selected proteins triggers the partitioning of 
some, but not all, membrane proteins into vesicles of endosomal origin [509-511]. It may 
also involve association of exosomal membrane proteins with chaperones, such as Hsc70, 
known to be found in exosomes of most cells [506]. A small subset of other cytosolic proteins, 
together with tetraspanins (a review can be found at Andreu and Yanez-Mo [512]), has been 
suggested to play a role in exosomes sorting. These include the already mentioned Hsc70, 
the Hsc90, and the PKM2 [513].  
4.1.3. Exosome biogenesis 
The endosomal origin is the most accepted hypothesis for the origin of exosomes, several 
studies have solidified this:  
i. Exosome membrane composition. Exosome specific membrane composition lacks some 
abundant cell-surface proteins, such as CD28, CD40L, and CD45 in T-cell derived 
exosomes [514] and transferrin receptor in B-cell-derived exosomes [508, 515]. These 
studies suggested that exosomes are not simply fragments of the cell membrane. 
ii. Exosome cargo. Many of the cytosolic proteins that are found in exosomes have been 
found in the endocytic pathway, these include annexin II, RAB5/RAB7, and TSG101 [516]. 
These observations suggested an endocytic step at some point in the formation of 
exosomes. 
Late endosomes bud off parts of their limiting membrane into their lumen forming 
intraluminal vesicles (ILVs), which can accumulate hundreds of vesicles. This late structure 
termed the MVB will eventually fuse with the cell membrane, in an exocytic manner, 
releasing their content, i.e. the exosomes, Figure 63. Two pathways have been suggested to 
rule MVBs’ fate. The first one, called secretory pathway, leads to the secretion of MVBs to 
the extracellular milieu. The second one, named lysosomal pathway, leads to the fusion of 
the MVBs with lysosomes for degradation of their contents [5]. These two different fates 
arise from distinct populations of MVBs that coexist within the same cell [5, 517]. 
Furthermore, co-localization of cholesterol with the toxin perfringolysin O indicates one 
cholesterol-rich MVB population for exosome secretion, and another, although 
morphologically identical, but cholesterol-poor population for lysosomal targeting [5, 517]. 
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4.1.3.1. ESCRT-dependent pathways 
In exosome biogenesis, well-conserved proteins assemble into four multiprotein complexes, 
known as ESCRT-0, -I, -II, and –III that are associate with various other proteins [518]. ESCRT-
0, -I, and -II complexes recognize and sequester ubiquitinated proteins at the endosomal 
delimiting membrane, the ESCRT- I and -II complexes are, in addition, responsible for 
membrane deformation into buds with sequestered cargo [509, 519, 520]. The ESCRT-III 
complex is responsible for the actual scission of the vesicles [521]. Different members of the 
ESCRT machinery have been involved in exosome biogenesis and secretion in different cell 
types [522]. 
4.1.3.2. ESCRT-independent mechanisms 
It has been demonstrated that in some cells types, such as oligodendroglial cells, the 
depletion of subunits belonging to the four ESCRT complexes does not totally impair the 
formation of MVBs, suggesting that other ESCRT-independent mechanisms can operate for 
exosomes biogenesis. These are known to be dependent on a sphingomyelinase, a ceramide-
producing enzyme [523]. Ceramide is a lipid with a cone-shaped structure that possibly 
Microvesicles 
Exosomes 
Lysosome 
MVB Early endosome 
Golgi 
apparatus 
CCV 
- RNA 
- Clathrin 
- Membrane associated 
proteins 
Figure 63 – Schematic release of MVs and exosomes. MVs bud directly from the cell membrane, whilst 
exosomes are formed by budding into early endosomes and are released by fusion of MVB with the 
cell membrane. Other MVBs can follow the lysosomal pathway for degradation of their contents. 
Abbreviations used CCV: clathrin-coated vesicles, MVB: multivesicular body. Adapted from [5]. 
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facilitates the membrane invagination of ILVs. These observations are consistent with the 
presence of great concentrations of ceramides and its derivatives in exosomes [523]. Other 
have shown that syntenin stimulates the production of exosomes and it is also required for 
the budding of CD63-positve ILVs into the MVB, playing an important role in anchoring 
receptor proteins of the membrane to cytoskeletal components [471]. Syntenin is a protein 
present at great concentrations in exosome populations and its effects on exosome 
production depends on the interaction with an auxiliary component of the ESCRT complexes 
[471]. In addition, syntenin has been shown to bind to membrane receptors, as syndecans 
and CD63 [471], suggesting a direct role on exosomal sorting. Additionally, certain 
mammalian cells have developed pathways for MVBs formation independently of both 
ESCRT complexes [524] and ceramide pathways [469]. Tetraspanins, highly enriched in 
MVBs, have been proposed to function as sorting machines in the formation of exosomes in 
those cells being involved in the organization of large molecular complexes and membrane 
subdomains [459]. Exosome secretion has been shown defective in CD9 knockout mice [525]. 
In contrast, the absence of CD81 in lymphocytes does not have an effect on exosome release 
[526]. 
4.1.4. Exosome secretion 
The release of a vesicle requires its mobilization to the cell periphery, its docking and its 
fusion with the cell membrane. These processes involve cytoskeleton rearrangements 
(mediated by actin and microtubules) associated with molecular motors (regulated by 
kinases and myosin), cell membrane fusion components (regulated by SNAREs and tethering 
factors), and molecular switches [527]. Most of the intracellular transport is controlled by 
well conserved cytosolic proteins, including small GTPases of the Rab family. Rab proteins 
control various steps of vesicular trafficking, including budding, motility, and docking of 
several classes of vesicles with the cell membrane [528]. Proteins of the Rab family are 
suggested to be required for exosome secretion. It is thought that Rab27 is involved directly 
or indirectly in the transportation and tethering of the secretory MVBs at the cell periphery. 
By silencing the two Rab27 effectors, the Slp4 and Slac2b, Ostrowski et al. have shown a 
decrease in exosome secretion, with no modifications in their protein content or morphology 
[529]. In addition, exosomes produced by Rab27a knockdown cells appeared to be larger 
when compared to control but homogenously distributed within the cell. On the other hand, 
exosomes extracted from Rab27b knockdown cells showed asymmetrical perinuclear 
distribution with no changes in their size [529]. These results suggest that these two proteins 
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have different roles in the biogenesis and release of such EVs. In addition, the same group 
has shown that Rab27a is preferentially associated with CD63-positive MVBs, whereas 
Rab27b has a minor co-localization with CD63-positive events. In the same line of studies, 
Hsu et al., by knocking down the Rab GTPase-activating proteins, Rab35, and interfering with 
its effector, showed an inhibition of exosome secretion and an intracellular accumulation on 
endosomal vesicles [530]. Inactivation of Rab11 (although controversial), Rab27, and Rab35, 
is apparently involved in exosome secretion, not causing a complete cessation of exosome 
secretion, albeit reducing it to some extent [529-531]. Since other Rab GTPases (Rab7 and 
Rab11), associated with the endocytic system, have not shown any effect on exosome 
secretion, others have suggested that a particular subset of MVBs participates in the 
generation of exosomes [529]. The role of GTPase-activating proteins can then be 
complimentary or indirectly altered by regulating secretory pathways upstream of those 
involved in exosome secretion.  
Exosome secretion follows the same rules as excretory-lysosome fusion, i.e. they fuse with 
MVB membrane after activation in a Ca2+-dependent manner [5]. The mechanism by which 
MVBs fuse with the plasma membrane of the donor cell is still mostly unknown. The SNARE 
complex involved in Ca2+-regulated exocytosis of conventional lysosomes includes VAMP7 
and Ca2+ binding synaptotagmin VII [532]. Little is known if the exocytic fusion of MVB is 
controlled by the same process and the results are controversial. One study showed that 
exosome secretion by reticulocytes appeared to be VAMP7-dependent [533], whereas in 
kidney ECs (MDCK cells), the expression of the Longin domain of VAMP7 (negatively 
regulating its interaction abilities) selectively impaired the lysosomal secretion but not the 
exosomes release [534]. Release of MVs can be stimulated in response to certain receptors 
in different cell populations. For instance, platelets release more exosomes in response to 
thrombin receptor activation [535] and dendritic cells increase their vesicle release in 
response to lipopolysaccharides [536]. One common signal that triggers the release of EVs is 
the increase of intracellular Ca2+ concentration [504, 531].  
To better understand their biogenesis and release, other groups have reported the secretion 
of vesicles of endocytic origin [537]. Using immunoelectron microscope techniques they 
have observed the destination of an internalized transferrin-receptor antibody - a marker 
used to follow endocytosis and the recycling of cell-surface proteins [463, 538]. At 0 hours, 
the antibody binds to the cell surface. In cells incubated at 37°C for 15 minutes after antibody 
binding, the antibody is found in large empty vesicles, which may correspond to early 
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endosomes. After one hour at 37°C the antibody is then found in endosomes containing 
internal vesicles (likely corresponding to the MVB) and is mainly localized at the surface of 
the internal vesicles. After 3 hours, some of the MVBs fuse with the cell membrane, releasing 
their contents, the exosomes [463]. 
4.1.5. Interactions with recipient cells 
To perform their functions the exosomes must interact with the recipient cells to release 
their cargo, Figure 64. Exosome anchoring to the recipient cell is likely to be determined by 
interactions of different tetraspanins (including CD63, CD81, and CD9) and adhesion 
molecules, such as integrins and ICAMs, present in the EVs membrane [465, 512]. After 
binding to the recipient cell, EVs may follow four different paths: (i) remain stably associated 
with the plasma membrane, (ii) directly fuse with the plasma membrane, (iii) be internalized 
through endocytic or micropinocytic pathways, and (iv) fuse with the delimiting membrane 
of an endocytic compartment [5]. After being endocytosed, the EVs may fuse with the 
endosomal delimiting membrane where their content may be released and translated or 
targeted for lysosomal degradation [5]. Recent studies have shown a more efficient fusion 
of exosomes with the limiting membrane of endocytic organelles in acidic environment due 
to changes in recipient cell membrane rigidity [539]. Of interest is the selective incorporation 
of specific exosomes by some cell types. For example, exosomes extracted from B cells 
selectively bind to follicular dendritic cells in lymphoid follicles [540]; and EVs extracted from 
intestinal ECs bind preferentially to dendritic cells rather than to B or T lymphocytes [541]. 
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4.1.6. Functions of EVs  
Since exosome content varies from one cell type to another, their functions are also likely to 
be different. Firstly, exosomes can facilitate intercellular communication whether locally or 
at a certain distance, without the need for direct cell-cell contact, by exchanging proteins 
and nucleic acids between the exosome-producing and the recipient cell. Secondly, their 
secretion could function as a mechanism of protein and/or obsolete molecules elimination 
alternative to lysosomal degradation [463, 542, 543]. Others have, more recently, 
demonstrated that cancer cells release EVs to increase the tumour progression by promoting 
angiogenesis and tumour cell migration in metastases [544, 545]. The release of EVs by 
intestinal ECs, whether apically or basolaterally, appear to be involved in antigen 
presentation under inflammatory conditions, allowing these static cells to act at distance 
[546]. Studies with Chinese-hamster ovary cells and blood mononuclear cells, cells that 
produce CC-chemokine receptor 5 (CCR5) [547], strongly supported the importance of MV 
transfer between cells. In these studies, large vesicles bearing CCR5 released by hamster 
ovary cells and blood mononuclear cells, transfer CCR5 to monocytes and endothelial cells 
Secreting 
cell 
Recipient 
cell 
A 
B 
C 
MVB 
Microvesicles 
Exosomes 
- RNA 
- Membrane           
aassociated proteins 
D 
Figure 64 - Cargo transfer by EVs and exosomes. RNA molecules and proteins are selectively 
incorporated into MVBs, which will eventually fuse with the plasma membrane to release exosomes 
into the extracellular space. The MVs and exosomes may follow four different paths: (A) remain stably 
associated with the plasma membrane, (B) directly fuse with the plasma membrane, (C) be internalized 
through endocytic or micropinocytic pathways, and (D) fuse with the delimiting membrane of an 
endocytic compartment. Abbreviations used MV: microvesicle, MVB: multivesicular body. 
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(cells that do not express this receptor), rendering them sensitive to infection with 
macrophage-tropic HIV-1 virus [547]. 
4.1.7. Uses of EVs – clinical point of view 
EVs can be used as therapeutic agents with potential advantages over cell therapies. 
Exosome cargo can be tailored for each patient, their lipid composition allows high stability 
(longer than 6 months), they are enriched in major histocompatibility complex (MHC), their 
membrane express ligands for NK receptors (molecules involved in the prevention of nausea 
and vomiting associated with chemotherapy), and they do not respond to 
immunosuppressive molecules [548, 549]. A phase II clinical trial used autologous dendritic 
cell (DC)-derived exosomes for the treatment of cancer. This trial launched in November 
2009 at Gustave Roussy and Curies Institutes used DC-derived exosomes purified from 
autologous maturing monocyte derived-DC. [550]. DC-derived exosomes express high levels 
of functional MHC class-I and -II peptide complexes, that can in theory substitute for DC to 
elicit tumour rejection. Results from phase II studies showed that 32% of the patients had 
stable disease after 4 months and 1 patient had a grade-3 hepatotoxicity [551, 552]. Others 
phase I trials have recently been concluded with promising results [553-556].  
One may ask the reason why exosomes were chosen over other EVs populations, particularly 
MVs. Bruno et al. compared the renal regenerative potential of either exosomes enriched 
populations and MVs enriched populations [557]. They have shown that the exosome 
enriched population not only induce renal regeneration but also showed higher expression 
of pro-proliferative molecules. On the other hand, MVs enriched populations were unable to 
induce renal regeneration [557]. Similar observations were made elsewhere where 
exosome-containing solutions were shown to be more effective than those containing only 
MVs [558-560]. These studies supported the choice of exosomes over MVs. Nevertheless, 
others have yet shown a synergetic effect of exosomes and MVs in reversing the effect of 
radiation in marrow hematopoietic cells [561]. In the latter, preparations containing both 
exosomes and MVs showed to be more effective that either exosomes or MVs alone.  
4.1.8. Aim 
i. To determine if exosomes are produced by cultured ocular surface epithelial cells. 
Exosomes were extracted from the aforementioned cell lines using differential 
ultracentrifugation and characterized in terms of their transmembrane protein content 
and size. 
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ii. To determine if the differentiation of human epithelial cells from the conjunctiva and 
cornea can be modulated in response to different extracellular vesicles populations in 
vitro. Exosomes extracted from the aforementioned cell lines were used to cross-
modulate the differentiation of the two cell lines.  
iii. To characterize the cargo of exosomes extracted from cultured ocular surface epithelial 
cells. Exosomal miRNA cargo was characterized using next generation sequencing 
approaches. 
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4.2. Materials and Methods 
4.2.1.Cell culture  
Human conjunctival ECs (HCjE-Gi) [152] and human corneal ECs (hTCEpi) [562] were cultured 
as described in section 2.2.2 and 2.2.3, respectively. 
4.2.2.Exosome extraction 
The most commonly used protocol for exosome extraction and purification involves several 
centrifugation and ultracentrifugation steps [6, 515, 563], described in Figure 65. Briefly, 
upon 80% confluence cells were cultured in BPE–depleted KSFM (exosomes-free medium) 
for 72 hours. The conditioned medium was then collected and centrifuged at 500xg 
(Centrifuge 5417, Eppendorf) for 5 minutes at 4°C to remove any dead cells, the resulting 
supernatant was collected and centrifuged at 2000xg for 10 minutes at 4°C and the pellet 
discarded to remove cell debris. The resulting supernatant was filtered using a 0.22 µm filter 
(cat. Number SLGP033RS, Merck Millipore). A total of 32mL of conditioned medium per 
condition was collected into OptiSeal ™ tubes (cat. Number 361623, Beckman Coulter) and 
ultracentrifuged at 100000xg (90Ti fixed angle rotor, Beckman Coulter) for 2 hours at 4°C. 
The resulting pellet was re-suspended in PBS and once again ultracentrifuged at 100000xg 
(90Ti fixed angle rotor) for 2 hours at 4°C. The resulting pellet was re-suspended in 200µL of 
PBS and stored at -80°C until further experiments.  
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4.2.3.Exosome characterization by flow cytometry  
The exosome-containing suspension was incubated with 10µL of aldehyde/sulphate latex 
beads (cat. number A37304, Life Technologies) for 15 minutes at RT. PBS was then added to 
a final volume of 1mL and the solution incubated overnight at 4°C on a test tube rotator 
wheel at 20rpm (Stuart® Equipment). To saturate any remaining free-binding sites on beads, 
glycine (cat. Number 67419, Sigma-Aldrich) was added to a final concentration of 100mM 
and the resulting solution incubated at RT for 30 minutes. The solution was then centrifuged 
(all centrifugation steps were performed for 3 minutes at 4,000 rpm at RT). The supernatant 
was then removed, and the remaining pellet was re-suspended in 1ml of 0.5% (W/V) BSA 
 
Obtain conditioned media 
Centrifuge at 500xg for 5 min at 4°C   
Collect supernatant free of dead cells 
Centrifuge at 2000xg for 10 min at 4°C  
Collect supernatant free of cell debris 
Filter the supernatant using 0.22μm filters 
Discard the supernatant and 
re-suspend the pellet in PBS 
  Ultracentrifuge at 100000xg for 2 hours at 4°C 
Re-suspend in 200μl PBS 
 
 
 
 
 
 
To remove any contaminating proteins  
  Ultracentrifuge at 100000xg for 2 hours at 4°C 
To remove any larger vesicles  
Figure 65 - Exosome extraction protocol using differential ultracentrifugation. In differential 
centrifugation exosomes and microvesicles are isolated based on their size upon a sequence of 
centrifugation steps. The resulting solution has been shown to have high purity and high enrichment 
isolation [6]. 
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(cat. Number A9085, Sigma-Aldrich) in PBS, this step was repeated thrice. The resulting pellet 
was then re-suspended in 100µL of primary antibody (Table 20) diluted in 0.5% (W/V) BSA in 
PBS and incubated in the dark for 30 minutes at 4°C. After adding 1ml of 0.5% (W/V) BSA in 
PBS to the suspension, centrifugation was performed. After removal of the supernatant, the 
pellet was re-suspended in 100µL of appropriate secondary antibody (Table 21) diluted in 
0.5% (W/V) BSA in PBS. This suspension was then incubated in the dark for 30 minutes at 
4°C. After the addition of 1ml of 0.5% (W/V) BSA in PBS to the suspension, centrifugation was 
performed. The resulting pellet was re-suspended in 500µl of 0.5% (W/V) BSA in PBS. This 
final suspension was analysed using a BD Accuri C6 flow cytometer (BD Biosciences) and the 
results analysed using BD Accuri C6 (BD Biosciences). 
Table 20 – List of primary antibodies used for exosome characterization using flow cytometry.  
Antibody Clone Host Isotype Manufacturer Dilution 
CD63 Polyclonal Mouse IgG 
Santa Cruz 
Biotechnology 
1:1000 
TSG101 4A10 Mouse IgG1 Abcam 1:1000 
GRP94 9G10 Rat IgG2a Abcam 1:1000 
IgG --- Mouse --- ThermoFisher Scientific 0.2µg/µL 
IgG1  --- Mouse --- ThermoFisher Scientific 1µg/µL 
IgG2a  --- Rat --- ThermoFisher Scientific 1µg/µL 
 
Table 21 - List of secondary antibodies used for exosome characterization using flow cytometry. 
Antibody Clone Host Reactivity Conjugate Manufacturer Dilution 
Anti-mouse A-11005 Goat Mouse FITC 
Life 
Technologies 
1:1000 
Anti-rat F7512 Sheep Rabbit FITC Sigma-Aldrich 1:1000 
 
4.2.4.Quantification and sizing of exosomes by NanoSight® analysis 
750µL of the exosome-containing suspension (dilution factor 1:150) was used for NanoSight® 
analysis following the manufacturer’s protocol (NanoSight NS300 instrument, NanoSight Ltd. 
Minton Park, Amesbury, UK). The camera used was a sCMOS type camera and a red type 
laser. The temperature was kept constant at 22°C and the water viscosity kept at 0.953cP. 
For analysis 1498 frames were used at a rate of 25 frames per second. 
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4.2.5.Reverse Transcriptase qPCR 
Reverse Transcriptase qPCR and all the previous steps (RNA extraction and cDNA synthesis) 
were done as outlined in sections 2.2.10, 2.2.11, and 2.2.12, respectively. Table 22 shows the 
set of primers used for these studies. 
Table 22 – List of primers used for Reverse Transcriptase qPCR studies in Chapter 4. The primer 
sequences and the product size are included. Abbreviations used: GAPDH: glyceraldehyde-3-
phosphate dehydrogenase, KRT: keratin, ABCB5: ATP binding cassette sub-family B member 5. # 
Sequences and product size of reference genes are not commercially provided by PrimerDesign.  
Primer Gene Sequence Product size (bp) 
GAPDH 
F - # 
 
R - # 
KRT3 
F – TTCCATCTCAGGCACAAACAA 
130 
R –CAGGTCCTCCATGTTCTTCAG 
KRT7 
F –CTCCCACCACTCCATCCT 
105 
R - ATCACTTTCCAGACTGTCTCACT 
KRT12 
F –CTCCAAATCACAAGCACAGTCA 
98 
R - CCACCTCACCATTCACCATCT 
KRT13 
F –ATGCTGCTGGACATCAAGAC 
113 
R -TCGTGGTAACAGAGGTGCTA 
ΔNp63α 
F –GGAAGGCGGATGAAGATAGC 
96 
R - CATGTGTGTTCTGACGAAACG 
ABCB5 
F - GGAAAGAATTACCACTACCAAGAAGG 
119 
R - TGGTAGCATCCAAATGGGCAAAC 
4.2.6.Flow cytometry of ocular surface epithelial cells 
Flow cytometry was performed as outlined in 2.2.14. Table 23 and Table 24 show the set of 
primary and secondary antibodies used for these studies, respectively. 
Table 23 – List of primary antibodies used for flow cytometry studies in Chapter 4. # Concentration 
dependent on primary antibody. Abbreviations used KRT: keratin 
Antibody Clone Host Isotype Manufacturer Dilution 
KRT3 AE5 Mouse IgG Abcam ® 1:1000 
KRT7 RCK105 Mouse IgG1 Santa Cruz 1:500 
KRT12 J6 Rabbit IgG  1:1000 
KRT13 Ks13.1 Mouse IgG1 Santa Cruz 1:500 
ΔNp63α Poly6190 Rabbit IgG BioLegend 1:1000 
IgG --- Mouse --- ThermoFisher Scientific # 
IgG --- Rabbit --- ThermoFisher Scientific # 
IgG1 --- Mouse --- ThermoFisher Scientific # 
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Table 24 - List of secondary antibodies used for flow cytometry studies in Chapter 4. Abbreviations 
used FITC: fluorescein isothiocyanate 
Antibody Clone Host Reactivity Conjugate Manufacturer Dilution 
Anti-mouse A-11005 Goat Mouse FITC Life Technologies 1:1000 
Anti-rabbit F7512 Sheep Rabbit FITC Sigma-Aldrich 1:1000 
4.2.7.XenoLight DiR labelling 
After differential ultracentrifugation, the exosome-containing solution was incubated with 
2µM of XenoLigth DiR Fluorescent Dye (cat. Number 125964, PerkinElmer) diluted in diluent 
C (cat. Number CGLDIL, Sigma-Aldrich) for 30 minutes. The resulting solution was then 
washed twice in sterile PBS (100000xg for 2 hours at 4°C). The labelled exosomes were 
diluted in appropriate exosome-free KSFM and used in further investigations. 
4.2.8.End-point PCR 
After differential ultracentrifugation, the exosome-containing solution was used for RNA 
extraction and cDNA synthesis as outlined in 2.2.10 and 2.2.11, respectively. 18ng of cDNA 
(correspondent to 2.5µL) was added to a 200µL PCR tube (Appleton Woods, cat. Number 
BS191) together with 12.5µL of REDTaq® ReadyMix ™ (cat. Number R2523, Sigma-Aldrich), 
5µL of primer pair and 5µL of nuclease-free ddH2O (cat. Number AM9937, Ambion). End-
point PCR temperatures were in accordance to section 2.2.12.  
4.2.9.Agarose gel 
5µL of HyperLadder 100bp (cat. Number BIO-33056, Bioline) and 10µL of end-point PCR 
products were loaded into different lanes of a 2% TAE agarose gel (cat. Number A9639, 
Sigma-Aldrich) supplemented with 0.0036% (V/V) ethidium bromide (cat. Number E1510, 
Sigma-Aldrich) and run for approximately 1 hour at 100V (PowerPac Basic ™, BioRad). TAE 
buffer was prepared as follows: 40mM Tris (cat. Number 93362, Sigma-Aldrich), 20mM acetic 
acid (cat. Number 320099, Sigma-Aldrich), and 1mM EDTA (cat. Number EDS, Sigma-Aldrich), 
pH adjusted to 8.6. 
4.2.10. Next Generation Sequencing - Exosomal RNA sequencing 
10 mL of cell culture media was centrifuged at 1500xg for 5 minutes to remove residual cells 
and debris. The supernatant was transferred to a new 50mL conical tube for exosome 
isolation. ExoQuick-TC (System Biosciences, Palo Alto, CA) was added to the supernatant at 
1:5 ratio (ExoQuick:Supernatant), mixed gently, and allowed to incubate overnight at 4°C. On 
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the next day, the admixture was centrifugated at 1500xg for 30 minutes to recover exosomes 
for total RNA isolation. 
Please refer to page 5 of the SeraMir Exosome RNA Amplification User Manual 
(https://www.systembio.com/downloads/Manual_SeraMir_web_ver12.pdf) for detailed 
information on isolation of exo-RNA from exosomes. The key information is presented on 
Steps 7-22. 1µL of total exo-RNA was utilized for measurement of small RNA concentration 
by Agilent Bioanalyzer Small RNA Assay using Bioanalyzer 2100 Expert instrument (Agilent 
Technologies, Santa Clara, CA). 
Next generation sequencing libraries were generated with the TailorMix Micro RNA Sample 
Preparation version 2 protocol (SeqMatic LLC, Fremont, CA). Briefly, 3’-adapter was ligated 
to the RNA sample and excess 3’-adapters were removed subsequently. 5’-adapter was then 
ligated to the 3’-adapter ligated samples, followed by first strand cDNA synthesis. cDNA 
library was amplified and barcoded via enrichment PCR. Final RNA library was size-selected 
on an 8% TBE polyacrylamide gel. Sequencing was performed on the Illumina NextSeq 500 
platform at a readlength of 1x75bp single-end at SR50. 
The isolation method used for this analysis (performed by the manufacturer) was different 
from the method used in the remaining studies of this thesis.  
4.2.11. Statistical analysis  
A Mann-Whitney analysis followed by Dunn’s multiple comparison test (unless otherwise 
specified) were used to determine statistically significant differences (GraphPad Prism 5, 
*p<0.05, **p<0.01, ***p<0.001). Data is expressed as median ± 5-95% percentile (unless 
otherwise specified). 
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4.3. Results  
4.3.1. Exosome characterization by flow cytometry  
To ensure that the feeding medium is per se exosome-free, flow cytometry was performed 
on the solution resultant of ultracentrifugation of fresh medium depleted from BPE. Both 
conjunctival and corneal KSFM (BPE-depleted) showed to be negative for the exosome-
enriched solution markers CD63 and TSG101, and negative for GRP94, Figure 66A and B 
respectively. These results suggested that the feeding media is then exosome-free and any 
vesicle thereafter detected resulted from cell production and release.  
 
 HCjE-Gi cells-derived exosomes are CD63 and TSG101 positive and 
GRP94 negative 
Upon 80% of confluence, cells were cultured in BPE–depleted KSFM (exosome-free medium). 
The conditioned medium was then collected at day 1, 2, and 3 and the exosomes extracted 
using differential ultracentrifugation. Flow cytometry was performed to characterize the 
resulting solution. 
Figure 66 - Characterization of particles extracted from fresh (A) HCjE-Gi and (B) hTCEpi BPE- 
depleted KSFM assessed by flow cytometry. Abbreviations used BPE: bovine pituitary extract. 
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The percentage of CD63-positive events in the HCjE-Gi cells-derived population increased 
over time, ranging from 9.84% at day 1 to 65.33% at day 3 (p<0.05). Regarding TSG101, its 
expression peaks at day 3, with 24.64% of vesicles shown to be TSG101-positive (p<0.05). 
The expression of GRP94 was shown to be negative throughout the entire course of the 
experiment, Figure 67.  
0
20
40
60
80
Day 1
Day 2
Day 3
CD63 TSG101 GRP94
*
*
%
 P
os
iti
ve
 E
ve
nt
s
N
or
m
al
is
ed
 to
 Is
ot
yp
e 
C
tr
l
 
 hTCEpi cells-derived exosomes are CD63 and TSG101 positive and 
GRP94 negative 
Concerning the hTCEpi-derived exosomes, an increase in the percentage of CD63-positive 
events can be appreciated over time, ranging from 8.18% at day 1 to 45.55% at day 3 
(p<0.05). Regarding TSG101, its expression increased within the time window analysed, 
peaking at day 3, with 12.27% of vesicles shown to be TSG101-positive (p<0.05). The 
expression of GRP94 was shown to be negative throughout the whole-time course, Figure 
68. 
Figure 67 - Characterization of HCjE-Gi-derived exosomes extracted from conditioned medium over 
3 days as assessed by flow cytometry. The percentage of positive events normalised against isotype 
control is shown. (Data is represented as median ± 5-95 percentile, n=3, Kruskal-Wallis test followed 
by Dunn’s Multiple comparison test, *p<0.05, **p<0.01, ***p<0.001).  
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 Summary of results 12: 
i. The percentage of CD63- and TSG101-positive events (markers for exosome-enriched 
solutions) peaked in the exosome populations extracted from cells kept in culture for 3 
days.  
ii. The percentage of GRP94-positive events showed to be zero throughout the whole 
experiment. 
4.3.2. Exosome characterization by NanoSight 
To further characterize the exosome population in terms of size distribution and 
concentration, the conditioned medium was collected at day 1, 2, and 3. After extraction, 
the exosome-enriched solutions were viewed under NanoSight®.  
4.3.2.1. HCjE-Gi derived exosomes’ size ranges from 81 to 96nm 
Regarding the HCjE-Gi-derived exosome population, the particles concentration seemed not 
to differ much from day 1 to day 2. However, an increase in particle concentration is 
observed at day 3, Figure 69C. In terms of size distribution, 10% of the particles (D10) had a 
diameter that ranges from 81 to 96nm (or smaller), within the expected size range of 
exosomes, Figure 69. A snapshot captured during the collection of the data is shown in Figure 
69D. As expected, since the solution under visualization has a certain “tridimensionality”, 
some vesicles appeared out of focus (red arrowhead) which may have biased the expected 
size of exosomes.  
Figure 68 - Characterization of hTCEPi exosomes extracted from conditioned medium over 3 days 
as assessed by flow cytometry. The percentage of positive events normalised against isotype control 
is shown. (Data is represented as median ± 5-95 percentile, n=3, Kruskal-Wallis test followed by 
Dunn’s Multiple comparison test, *p<0.05, **p<0.01, ***p<0.001).   
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4.3.2.2. hTCEpi exosomes derived exosomes’ size ranges from 97 to 124nm 
The hTCEpi-derived exosomes populations showed little differences in particle concentration 
observed from day 1 to day 3. In terms of size distribution, 10% of the particles had a 
diameter that ranges from 97 to 124.7nm (or smaller), within the expected size range of 
exosomes, Figure 70 
Figure 69 - Characterization of HCjE-Gi cells-derived exosomes extracted from conditioned medium 
as assessed by NanoSight. (A-C) The size distribution and concentration of particles extracted from 
conditioned medium kept in culture for 1, 2, and 3 days is shown, respectively (merged mean of 3 
individual samples). (D) Snapshot captured whilst sample was being analysed. Red arrowhead shows 
the particles “off-focus”. D10, D50, and D90 indicates the percentage undersize, i.e. for example if 
D50 is 100nm that means that 50% of analysed vesicles are 100nm or smaller.  
Mean: 149 ± 6 nm 
D10: 85.6 ± 6.7 nm 
D50: 134.5 ± 7.6 nm 
D90: 225.9 ± 9.8 nm 
Concentration:  
6.2*10
7
 ± 6.33*10
6
 
particles/mL 
Mean: 162.1 ± 10.3 nm 
D10: 81.1 ± 3.6 nm 
D50: 144.5 ± 12.7 nm 
D90: 267.5 ± 17.5 nm 
Concentration:  
1.02*10
8
 ± 7.99 10
6
 
particles/mL 
Mean: 165.4 ± 2.6 nm 
D10: 96.1 ± 4.1 nm 
D50: 148 ± 3.1 nm 
D90: 262.4 ± 7 nm 
Concentration:  
3.22*10
8
 ± 2.7*10
7
 
particles/mL 
A B 
C D 
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Putting together this information, the exosomes used in the downstream experiments were 
the ones extracted from the conditioned medium collected after 3 days of cell culture. 
4.3.2.3. Summary of results 13: 
i. Higher concentrations of exosomes were obtained from conditioned medium collected 
from cells kept in culture for 3 days.  
ii. The diameter of vesicles falls within the range of the expected size for exosomes. 
4.3.3. Exosome internalization studies- XenoLight DiR-labelled exosomes  
To better understand the internalization of exosomes through time, a dye used for lipid 
bilayer staining was used. The labelled exosomes, diluted accordingly in KSFM, were 
incubated in culture for a desired period and the percentage of positive events assessed 
using flow cytometry.  
A B 
C D 
Mean: 204.4 ± 8.2 nm 
D10: 124.7 ± 4.5 nm 
D50: 182 ± 8.6 nm 
D90: 321.4 ± 17.8 nm 
Concentration:  
4.12*10
8
 ± 3.41*10
7
 
particles/mL 
Mean: 199.4 ± 2.4 nm 
D10: 124.4 ± 2.9 nm 
D50: 178.7 ± 1.7 nm 
D90: 294.2 ± 8.2 nm 
Concentration:  
3.16*10
8
 ± 1.12*10
7
 
particles/mL 
Mean: 169.2 ± 3.6 nm 
D10: 97 ± 3.3 nm 
D50: 144.6 ± 4.6 nm 
D90: 274.4 ± 14.7 nm 
Concentration:  
2.65*10
8
 ± 1.81*10
7
 
particles/mL 
Figure 70 - Characterization of hTCEpi cells derived exosomes extracted from conditioned medium 
as assessed by NanoSight. (A-C) The size distribution and concentration of particles extracted from 
conditioned medium kept in culture for 1, 2, and 3 days is shown, respectively (merged mean of 3 
individual samples). (D) Snapshot captured whilst sample was being analysed. D10, D50, and D90 
indicates the percentage undersize, i.e. for example if D50 is 100nm that means that 50% of analysed 
vesicles are 100nm or smaller. 
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A B 
The percentage of DiR-labelled hTCEpi-derived exosomes internalized and/or docked to the 
cell membrane of HCjE-Gi cells increased over-time peaking at 24 hours (p<0.05), Figure 71A. 
Very similar results were obtained when hTCEpi cells were cultured with labelled HCjE-Gi 
derived exosomes, Figure 71B. 
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Figure 71 – Internalization and/or docking profiles of XenoLight DiR labelled exosomes. (A) hTCEpi-
derived exosomes by HCjE-Gi cells. (B) HCjE-Gi-derived exosomes by hTCEpi cells. Results are 
normalised against non-labelled exosomes (Data is represented as median ± range, n=3, Kruskal-Wallis 
test followed by Dunn’s Multiple Comparison Test, *p<0.05, **p<0.01, ***p<0.001). 
 
Another membrane labelling dye (PKH26) was used elsewhere to assess the time-response 
to exosome uptake by bladder cancer cells [564]. Very similar results were there shown, with 
a peak in number of spots (supposedly exosomes) detected inside the cells after 14 hours of 
incubation with PKH26-labelled exosomes. The same study showed a dose-dependency in 
exosome uptake, with more vesicles being detected as its concentration increases. The 
decrease in the percentage of internalized vesicles can be explained by the incorporation of 
the exosomes by the cell which will eventually result in the release of their cargo. 
4.3.4.  Culturing HCjE-Gi cells with hTCEpi-derived exosomes drives higher 
expression of corneal epithelial markers than the HCjE-Gi-derived exosomes.  
This section addresses the results obtained when HCjE-Gi cells were cultured in hTCEpi-
derived exosomes containing medium. 3.22x108 particles per 25000 cells were used. The 
extent of differentiation was assessed by studying the expression of a wide range of well-
accepted markers for ECs; KRT3 and KRT12 were used as markers for terminally 
differentiated corneal ECs [107, 108] while KRT7 and KRT13 were used as markers for 
terminally differentiated conjunctival ECs [106]. As markers for epithelial SCs ΔNp63 and 
ABCB5 were used. 
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4.3.4.1. Reverse Transcriptase qPCR 
4.3.4.1.1. Expression of corneal epithelial cell markers 
hTCEpi-derived exosomes appeared not to induce significant changes in the levels of 
expression of KRT3 and KRT12 when compared to HCjE-Gi cell-derived exosomes (dashed 
line), exception is made for the significant lower levels of KRT3 expressed at 36 hours (25-
fold decrease, p≤0.05). However, an increase in the levels of KRT12 appeared to be occurring 
at later time-points (NSS). Remarkably, no KRT12 expression was detected at 6 hours when 
medium containing HCjE-Gi-derived exosomes was used (blue arrow), Figure 72.  
4.3.4.1.2. Expression of conjunctival epithelial cell markers 
Regarding the expression of KRT7, two different outcomes can be observed. In the first one, 
up to 12 hours, an increase in its expression levels was observed when medium containing 
hTCEpi cells-derived exosomes was used compared to HCjE-Gi-derived exosomes containing 
medium (NSS). This is followed by a significant decrease in KRT7 expression at 24 and 96 
hours when hTCEpi-derived exosomes were used and compared to HCjE-Gi derived 
exosomes (7.7- and 2.6- fold decrease respectively, p≤0.05). Similarly, the expression of 
KRT13 was significantly lower at 12 and 48 hours when hTCEpi-derived exosomes were used 
(1.8- and 2.8- fold decrease respectively, p≤0.001), Figure 72. 
4.3.4.1.3. Expression of epithelial stem cell markers 
Several peaks in ΔNp63 expression were appreciated at 6 and 48 hours when hTCEpi cells-
derived exosomes were used (4.1- and 12-fold increase respectively, NSS). The expression of 
ABCB5 peaked at 36 hours, being significantly increased when hTCEpi-derived exosomes 
were used and compared to HCjE-Gi-derived exosomes (329-fold increase respectively, 
p<0.01), Figure 72.  
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Figure 72 - The expression of epithelial cell markers by HCjE-Gi cells when cultured in medium 
containing hTCEpi-derived exosomes compared to medium containing HCjE-Gi-derived exosomes 
over 96 hours as assessed by Reverse Transcriptase qPCR. (Data is represented as median ± 5-95 
percentile, n≥6, Mann-Whitney test, Bonferroni corrected p-value, *p<0.05, **p<0.01, ***p<0.001). 
Dashed line represents the basal expression of the markers of interests when cells are cultured on 
their own exosomes-containing medium. Abbreviations used GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase, KRT: keratin, ABCB5: ATP-binding cassette sub-family B member 5. 
 
4.3.4.2. Flow cytometry 
4.3.4.2.1. Expression of corneal epithelial cell markers 
By culturing HCjE-Gi cells in hTCEpi-derived exosomes containing medium an increase in 
expression of KRT3 was induced after 36 hours (translated in an increase in 35% of KRT3-
positive events, p<0.001) and 96 hours (increase in nearly 10% of KRT3-positive events, 
p<0.001). A continuous diminution in the expression levels of KRT3 is observed from 6 hours 
to 96 hours, regardless the exosome population, with no expression detected at 48 and 72 
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hours. Regarding the expression of KRT12, a continuous increase in its expression was 
observed over time when hTCEpi-derived exosomes were used. Remarkably, the hTCEpi-
derived exosomes induced HCjE-Gi cells to significantly increase the percentage of KRT12-
positive cells at 36 hours (p<0.05), Figure 73.  
4.3.4.2.2. Expression of conjunctival epithelial cell markers 
In terms of KRT7 overall expression, a relative plateau in the percentage of positive events is 
seen throughout the time-window analysed until 48 hours when a drop in its levels is 
observed. Moreover, the only significant differences between the two exosome populations 
arrived at 12 hours when the hTCEpi-derived exosomes induced a decrease in KRT7 
expression levels (nearly 30% of positive events, p<0.001). Regarding the percentage of 
KRT13-positive events, a drop in its levels was already observed at 6 hours and 24 hours 
(decrease in nearly 40% and 10% of KRT13-positive cells, respectively, p≤0.05) when hTCEpi-
derived exosomes were used, Figure 73.  
4.3.4.2.3. Expression of epithelial stem cell markers 
At 24 hours a significant increase in the levels of ΔNp63-positive events (5%, p<0.05) was 
observed when hTCEpi-derived exosomes were used. This increase came to a halt between 
24 and 48 hours followed by a significant increase in the levels of expression at 72 hours 
(increase in 10% of ΔNp63-positive events, p<0.01) when hTCEpi-derived exosomes were 
used, Figure 73. 
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Figure 73 - The expression of epithelial cell markers by HCjE-Gi cells when cultured in medium 
containing hTCEpi-derived exosomes compared to medium containing HCjE-Gi-derived exosomes 
over 96 hours as assessed by flow cytometry. The percentage of positive events normalised against 
isotype control is shown. (Data is represented as median ± interquartile range, n≥3, Mann-Whitney 
test, Bonferroni corrected p-value, *p<0.05, **p<0.01, ***p<0.001). Abbreviations used Ctrl: control, 
KRT: keratin. 
 
4.3.4.3. Summary of results 14: 
HCjE-Gi cells cultured in medium containing exosomes extracted from hTCEpi cells showed: 
i. An increase in expression of corneal EC markers. 
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ii. A decrease in expression of conjunctival EC markers. 
iii. An increase in expression of epithelial SC markers. 
4.3.5. Culturing hTCEpi cells with HCjE-Gi cells-derived exosomes drives 
higher expression of conjunctival epithelial markers than the hTCEpi-derived 
exosomes 
The results in this section were obtained by culturing hTCEpi cells with medium containing 
HCjE-Gi-derived exosomes and compared to hTCEpi cells cultured with hTCEpi-derived 
exosomes over a desired period. 3.22x108 particles per 25000 cells were used.  
4.3.5.1. Reverse Transcriptase qPCR 
4.3.5.1.1. Expression of corneal epithelial cell markers 
Little changes on KRT3 and KRT12 expression were appreciated until 48 hours, when a peak 
in their expression was observed (18- and 40-fold increase respectively). This was followed 
by a significant decrease in their expression to negligible values (100-fold decrease for both 
markers, p≤0.01), Figure 74.  
4.3.5.1.2. Expression of conjunctival epithelial cell markers 
The HCjE-Gi-derived exosomes appeared to significantly induce an increase in KRT7 and 
KRT13 expression over time, peaking at 48 hours (8.1- and 17-fold increase respectively, 
p≤0.05), followed by a significant decrease in their expression to negligible values (nearly 
100-fold decrease for both markers, p≤0.001), Figure 74. 
4.3.5.1.3. Expression of epithelial stem cell markers 
Regarding ΔNp63 expression, a significant peak in its levels was appreciated at 12 and 48 
hours when hTCEpi cells were cultured with HCjE-Gi-derived exosomes (7.8- and 66-fold 
increase respectively, p<0.005). Very similar results were found for the other SC marker, 
ABCB5, Figure 74. 
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Figure 74 - The expression of epithelial cell markers by hTCEpi cells when cultured in medium 
containing HCjE-Gi-derived exosomes compared to medium containing hTCEpi-derived exosomes 
over 96 hours as assessed by Reverse Transcriptase qPCR. (Data is represented as median ± 5-95 
percentile, n≥6, Mann-Whitney test, Bonferroni corrected p-value, *p<0.05, **p<0.01, ***p<0.001). 
Dashed line represents the basal expression of the markers of interests when cells are cultured on 
their own exosomes-containing medium. Abbreviations used GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase, KRT: keratin, ABCB5: ATP-binding cassette sub-family B member 5. 
 
4.3.5.2. Flow cytometry  
4.3.5.2.1. Expression of corneal epithelial cell markers 
By culturing hTCEpi cells with medium containing HCjE-Gi cells-derived exosomes a decrease 
in the percentage of KRT3-positive events was seen after 6 hours (decrease of 20% in KRT3-
positive cells, p<0.05). This decrease was also appreciated after 96 hours (diminution of 10% 
in positive events, p<0.05). The only appreciable changes in KRT12 expression induced by 
HCjE-Gi-derived exosomes were observed after 96 hours (decrease of 10% in KRT12-positive 
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cells, p<0.001). Interestingly, a negligible percentage of KRT12-positive events was observed 
at 96 hours when the hTCEpi cells were seeded with HCjE-Gi-derived exosomes containing 
medium (blue arrow). Moreover, the percentage of KRT12-positive events appeared to 
increase throughout the time-window analysed until 72 hours, Figure 75.  
4.3.5.2.2. Expression of conjunctival epithelial cell markers 
Regarding the percentage of KRT7-positive events no significant changes could be 
appreciated until 72 hours where a significant increase in its percentage was seen 
(corresponding to an increase of 10% in positive events, p<0.01). In respect to KRT13, a 
significant increase in its expression levels is observed after 24, 48, and 96 hours when HCjE-
Gi cells-derived exosomes were used (corresponding to an increase of nearly 15% in KRT13-
positive cells, p≤0.05). Remarkably, negligible percentages of KRT13-positive events were 
detected at 48 hours when medium containing hTCEpi-derived exosomes was used (green 
arrow), Figure 75. 
4.3.5.2.3. Expression of epithelial stem cell markers 
Concerning the expression of ΔNp63 a cyclic trend could be observed, i.e. a decrease in its 
expression levels was followed by an increase for either exosomes-containing medium used. 
At 96 hours the HCjE-Gi-derived exosomes induced a significant increase in its expression 
levels by hTCEPi cells (equivalent to an increase in 20% of positive events, p<0.001), Figure 
75. 
  Chapter 4 
189 
 
KRT3
6 12 24 36 48 72 96
0
20
40
60
80
*
*
HCjE-Gi exosomes
hTCEpi exosomes
Time (hours)
%
 P
os
iti
ve
 C
el
ls
N
or
m
al
is
ed
 to
 Is
ot
yp
e 
C
tr
l
 
KRT12
6 12 24 36 48 72 96
0
20
40
60
80
100
HCjE-Gi exosomes
hTCEpi exosomes
***
Time (hours)
%
 P
os
iti
ve
 C
el
ls
N
or
m
al
is
ed
 to
 Is
ot
yp
e 
C
tr
l
 
KRT7
6 12 24 36 48 72 96
0
20
40
60
80
100
**
HCjE-Gi exosomes
hTCEpi exosomes
Time (hours)
%
 P
os
iti
ve
 C
el
ls
N
or
m
al
is
ed
 to
 Is
ot
yp
e 
C
tr
l
 
KRT13
6 12 24 36 48 72 96
0
20
40
60
80
HCjE-Gi exosomes
hTCEpi exosomes
*
*** *
Time (hours)
%
 P
os
iti
ve
 C
el
ls
N
or
m
al
is
ed
 to
 Is
ot
yp
e 
C
tr
l
 
Np63
6 12 24 36 48 72 96
0
20
40
60
80
100
HCjE-Gi exosomes
hTCEpi exosomes
***
***
Time (hours)
%
 P
os
iti
ve
 C
el
ls
N
or
m
al
is
ed
 to
 Is
ot
yp
e 
C
tr
l
 
Figure 75 - The expression of epithelial cell markers by hTCEpi cells when cultured in medium 
containing HCjE-Gi cells-derived exosomes compared to medium containing hTCEpi cells-derived 
exosomes over 96 hours as assessed by flow cytometry. The percentage of positive events 
normalised against isotype control is shown. (Data is represented as median ± range, n≥3, Mann-
Whitney test, Bonferroni corrected p-value, *p<0.05, **p<0.01, ***p<0.001). Abbreviations used Ctrl: 
control, KRT: keratin. 
 
4.3.5.3. Summary of results 15:  
hTCEpi cells cultured in medium containing exosomes extracted from HCjE-Gi cells showed: 
i. A decrease in expression of corneal EC markers. 
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ii. An increase in expression of conjunctival EC markers. 
iii. An increase in expression of epithelial SC markers. 
4.3.6. Exosome cargo - End-point PCR 
Several studies have shown that mRNA molecules are confined inside the exosomes and can 
be translated into proteins in the presence of the necessary machinery [480]. In this section, 
PCR products were probed for the encoding genes for the EC markers used throughout this 
study. 
4.3.6.1. HCjE-Gi-derived exosomes contain mRNA molecules 
Exosomes produced by HCjE-Gi cells contain mRNA from all studied genes with exception for 
KRT12 and KRT13 (blue arrows), Figure 76. 
 
 
 
4.3.6.2. hTCEpi-derived exosomes contain mRNA molecules 
Exosomes produced by hTCEpi cells showed to contain mRNA from all studied genes with 
exception for KRT12 and KRT13 (green arrows), Figure 77. 
4.3.6.3. Negative control 
The presence of the mRNA for the transcripts of interest was not detected, Figure 78. 
Figure 77 - Polymerase chain reaction products extracted from exosomes produced by hTCEpi cells. 
First lane shows a 100bp ladder. Abbreviations used bp: base pairs, KRT: keratin, ABCB5: ATP-binding 
cassette sub-family B member 5, GAPDH: glyceraldehyde 3-phosphate dehydrogenase. 
100 bp 
200 bp 
300 bp 
100 bp 
200 bp 
300 bp 
Figure 76 - Polymerase chain reaction products extracted from exosomes produced by HCjE-Gi cells. 
First lane shows a 100bp ladder. Abbreviations used bp: base pairs, KRT: keratin, ABCB5: ATP-binding 
cassette sub-family B member 5, GAPDH: glyceraldehyde 3-phosphate dehydrogenase. 
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4.3.7. Exosome cargo - Exo-NGS Exosomal miRNA Sequencing 
NGS sequencing results showed the presence of 22 different RNA types in both exosome 
populations, being the miRNA (mild blue) a small percentage of the total molecules detected, 
Figure 79. 
100 bp 
200 bp 
300 bp 
Figure 78 – Negative control for polymerase chain reaction products. First lane shows a 100bp ladder.
Abbreviations used bp: base pairs, KRT: keratin, ABCB5: ATP-binding cassette sub-family B member 5, 
GAPDH: glyceraldehyde 3-phosphate dehydrogenase. 
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Figure 79 - Pie chart summarizing the number of reads mapping to each annotation type in each 
sample. Sample1 and Sample2 indicate HCjE-Gi and hTCEpi-derived exosomes, respectively. 
  
The relative abundance in miRNA content of the two exosome populations was assessed by 
NGS exosomal miRNA sequencing. A total of 1668 different miRNA molecules (precursor and 
mature) were detected: 337 showed to be present only on HCjE-Gi-derived exosomes, 282 
on hTCEpi -derived exosomes, and 1049 to be shared by both populations, Figure 80. Table 
25 shows the presence of 11 miRNA molecules (precursor and mature), with significant 
  Chapter 4 
193 
 
differences in their relative abundance between the two populations (p<0.05). The 
abundance of mir-146a, miR-146a-5p, mir-155, miR-155-5p, mir-9-5p, mir-9-1, mir-9-3, and 
mir-9-2 was significantly higher on the HCjE-Gi-derived exosome populations (p<0.05). On 
the other hand, the abundance of mir-598, miR-598, miR-34c-3p, and mir-34c was shown to 
be significantly higher on hTCEpi- derived exosomes population (p<0.05).  
Table 25 - miRNA content of the two exosome populations as assessed by NGS. mir denotes 
precursor miRNA molecules, miR denotes mature miRNA molecules. 
miRNA Abundance HCjE-Gi 
Abundance 
hTCEpi 
p-
value 
Log
2 
fold 
change 
Role 
miR-598 Residual  111.74 0.048 infinity Down-regulated in cancer tissues  
miR-34c-3p 46.56 1548.96 0.011 5.1 Up-regulated in cell differentation 
mir-34c 116.39 2713.78 0.029 4.5 Up-regulated in cell differentation 
mir-146a 10080.83 510.48 0.048 -4.3 Upregulated in stem cell maintenance homeostasis  
miR-146a-
5p 10080.83 510.48 0.048 -4.3 
Upregulated in stem cell 
maintenance homeostasis  
mir-155 703.82 4.38 0.0001 -7.3 Upregulation represses cell differentiation 
miR-155-5p 703.82 4.38 0.0001 -7.3 Upregulation represses cell differentiation 
miR-9-5p 86.27 Residual  0.03 infinity Probably involved in cell differentiation  
mir-9-1 98.59 Residual  0.018 infinity Probably involved in cell differentiation  
mir-9-3 98.59 Residual  0.018 infinity Probably involved in cell differentiation  
mir-9-2 98.59 Residual  0.018 infinity Probably involved in cell differentiation  
337 2821049 
HCjE-Gi-derived 
exosomes 
hTCEpi-derived 
exosomes 
Figure 80 - Venn diagram presentation of miRNAs content detected in both exosome populations. 
337 molecules were only detected on HCjE-Gi-derived exosomes (blue), 282 molecules detected only 
on hTCEpi-derived exosomes (green), and 1049 molecules were shown to be shared by both exosome 
populations (dark green). 
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4.3.8. Summary of results of Chapter 4: 
i. An optimized percentage of CD63- and TSG101-positive events (markers for exosome-
enriched solutions) was obtained from vesicles extracted from conditioned medium 
collected after 3 days in culture.  
ii. The percentage of GRP94 -positive events showed to zero throughout the whole 
experiment. 
iii. The internalization of DiR-labelled exosomes by both cell lines peaked after 24 hours. 
iv. By seeding HCjE-Gi cells with medium containing exosomes extracted from hTCEpi cells: 
a. An increase in expression of corneal EC markers was observed. 
b. A decrease in expression of conjunctival EC markers was seen. 
c. An increase in expression of epithelial SC markers was appreciated. 
v. By seeding hTCEpi cells with medium containing exosomes extracted from HCjE-Gi cells: 
a. A decrease in expression of corneal EC markers was seen. 
b. An increase in expression of conjunctival EC markers was appreciated. 
c. An increase in expression of epithelial SC markers was observed. 
vi. Exosomes extracted from the two cells lines contained mRNA to encode for KRT3, KRT7, 
ΔNp63, and ABCB5. 
vii. The miRNA content carried by the two exosomes populations showed to be different. 
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4.4. Discussion 
Countless studies have already suggested EVs, and particularly exosomes, as agents to 
transfer bioactive molecules between different cells to play important roles in angiogenesis 
[565], wound healing [566], cancer metastasis [567, 568], amongst many other processes. 
The studies outlined in this chapter addressed for the first time the role played by the 
exosomes to induce the differentiation of two EC populations from the human ocular 
surface. The extent of differentiation and the characterization of exosomes cargo was 
assessed by a range of different techniques. 
The mass spectrometry results, addressed in Chapter 3 (section 3.3.1), showed the presence 
of exosome-associated proteins present in the HCjE-Gi and hTCEpi ECM preparations. These 
observations were the first indicative of the production and release of exosomes by the two 
cell lines.  
4.4.1. Exosomes were successfully extracted from the conditioned media 
obtained from the two cell lines 
Flow cytometry results revealed a successful extraction of EVs with the properties of 
exosomes-enriched populations: (i) presence of CD63- and TSG101-positive events and (ii) 
absence of GRP94-positive events [503]. The percentage of CD63 and TSG101-positive events 
was shown to increase with the time that cells are kept in culture, which may be a result of 
more exosome-like vesicles being produced over time. Co-localization of CD63 and TSG101, 
to address the double-positivity, would give better insights regarding the real percentage of 
exosomes that can be extracted from conditioned medium and therefore a better approach 
to distinguish them from other EVs. NanoSight® data showed that the extracted EVs have 
diameters that fall within the expected size of an exosome (40-100nm) [473, 569]. However, 
bigger events are detected which are likely the result of off-focus particles detected and 
analysed by the NanoSight® software. Based on these two sets of data, exosomes-containing 
populations can be extracted from conditioned medium, collected as early as day one, 
obtained from the two cell lines (HCjE-Gi and hTCEpi).  
Thery et al. have shown that clathrin coated vesicles, which will later mature into MVBs, are 
internalized by cells in 15 minutes [473] and PKH26-labelled exosomes are detected within 
different cell types just one hour after incubation [570]. In accordance with these studies, 
the herein internalization studies have shown an increase in DiR-labelled vesicles from, as 
early as 6 hours until 24 hours, when the percentage of positive events dropped significantly. 
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This reduction may be attributed to degradation of exosome membrane due to their fusion 
with the cell membrane or other intracellular compartments, resulting in exosome cargo 
release. Because of their content and rapid internalization by cells, exosomes are powerful 
agents to induce changes in cell physiological state very quickly. 
4.4.2. hTCEpi-derived exosomes drive higher expression of corneal epithelial 
markers by HCjE-Gi cells than HCjE-Gi-derived exosomes 
The results outlined in this section highlight the role of hTCEpi-derived exosomes for inducing 
the differentiation of HCjE-Gi cells into the corneal epithelial-like lineage, as assessed by 
various methods. The internalization studies showed a peak in exosome intake and/or cell 
membrane docking at 24 hours which may suggest that the major changes in cell behaviour 
would occur within that time-frame or shortly after. This is shown to be verified mainly for 
the decreased in the levels of expression of the conjunctival markers that occurs at significant 
levels within the first 24 hours. On the other hand, the changes in the corneal markers 
expression are mainly occurring at later time periods. The Reverse Transcriptase qPCR data 
shows an early peak (6 hours) in expression of epithelial SC markers ΔNp63 and ABCB5, 
despite being non-significant this increase is likely to indicate an emergence of early 
epithelial progenitor cells resulting from the de-differentiation of terminally differentiated 
HCjE-Gi cells. This is followed by a decrease in expression of conjunctival ECs markers KRT7 
and KRT13 at 24 and 12 hours, respectively, and a later moderate increase in expression 
terminally differentiated corneal ECs markers KRT3 and KRT12. Flow cytometry data show 
even greater differences when the two different exosomes populations are used, 
noteworthy is the steady decrease in the percentage of KRT3-positive events over time, 
however at slower rates when hTCEpi-derived exosomes are used. When the two data sets 
are analysed together some discrepancies are observed, meaning that additional agents are 
affecting the changes in protein translation. This may be result of miRNAs molecules shown 
to be present in the exosome cargo that may play a role in increase/decrease the protein 
abundance without the need of mRNA levels to change. Taken together, these results 
suggested an early emergence of progenitor ECs, accompanied by a loss of conjunctival-like 
phenotype and by a differentiation toward a corneal epithelial-like lineage of HCjE-Gi cells in 
response to hTCEpi-derived exosomes. 
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4.4.3. HCjE-Gi-derived exosomes drive higher expression of conjunctival 
epithelial markers by hTCEpi cells than hTCEpi-derived exosomes 
This section addresses the role played by HCjE-Gi-derived exosomes on inducing the 
differentiation of hTCEpi cells into a conjunctival epithelial-like lineage. Similar to the 
previous section, the internalization studies showed a peak in exosome intake and/or 
membrane docking after 24 hours. The Reverse Transcriptase qPCR data shows one peak in 
expression of epithelial SC markers ΔNp63 and ABCB5 at 12 hours (6 hours delayed when 
compared to previous section) which may indicate the emergence of early epithelial 
progenitor cells. This is indeed followed by an increase in expression of conjunctival markers 
KRT7 and KRT13 (the latter at lower magnitude) and a decrease in expression of terminally 
differentiated corneal ECs markers KRT3 and KRT12. Flow cytometry data show similar 
results with even greater differences when two different exosomes populations are used, 
suggesting that the changes observed at transcript levels may then be translated at protein 
levels. Yet again the role played by the miRNA molecules contained in the exosomes should 
not be downplayed in its effects on changing the protein abundance without the need in 
changing the mRNA levels. Based on both data sets, it is suggested that the hTCEpi cells, a 
corneal cell line, started to show conjunctival epithelial like-characteristics, losing its corneal 
epithelial-like phenotype in a process that involves an intermediate step of cell de-
differentiation. 
4.4.4. Exosome cargo characterization shows the presence of mRNA and 
miRNA molecules 
mRNA and miRNA are two families of molecules showed to be part of exosome cargo [571-
573] playing important roles in processes as diverse as biomarkers for schizophrenia [574] 
and cancer progression and metastasis [575]. Others have already shown that mRNA [576, 
577] and miRNA molecules [577] can be delivered by exosomes and translated in the 
presence of the necessary machinery [577].  
Exosome cargo was characterized by end-point PCR and Next Generation Sequencing for 
mRNA and miRNA content, respectively. End-point PCR data shows the presence of mRNA 
for the markers on interest, exception is made for KRT12 and KRT13 (presence not detected). 
The presence of these mRNA molecules and the notion that they can be translated [576, 577] 
aids to understand the rapid cell response in terms of protein turn-over observed.  
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The information regarding miRNA expression, function and location in the human ocular 
surface is still very scarce. The most common miRNA molecules, their location within the 
ocular surface and function, are shown on Table 26. 
Table 26 – Most common miRNAs, their location within the ocular surface and function. Adapted 
from [490, 491, 493, 502, 578-583]. Abbreviations used NA: not assessed, NGS: next generation 
sequencing, * results obtained from murine studies. 
miRNA Cornea Limbus Conjunctiva Role NGS results 
     HCjE-Gi  hTCEpi 
Up-
regulated     
  
miR-24 NA NA NA Associated with differentiated ECs 
++ +++ 
miR-103 -,-/+ ++ NA 
Promote 
epithelial SCs 
characteristics 
NA NA 
miR-107 -,-/+ ++ NA 
Promote 
epithelial SCs 
characteristics 
+ + (++) 
miR-125 
family + ++ NA 
Maintenance of 
the adult 
epidermal SCs 
+ -/+ 
miR-127 + ++ NA Tumorigenesis -/+ - 
miR-139 + ++ NA Tumorigenesis -/+ + 
miR-143 + ++ NA 
Tumour 
suppressor, ESC 
pluripotency 
-/+ -/+ 
miR-145 + ++ NA 
Tumour 
suppressor, ESC 
pluripotency 
+ - 
miR-146a -,-/+ + NA Tumour suppressor 
++ + 
miR-203 NA NA NA 
Maintenance of 
the adult 
epidermal SCs 
+++ + 
miR-205 + + + 
Corneal 
keratinocyte 
migration 
(inhibition), 
highly expressed 
in mammary 
progenitor cells 
++++ ++++ 
miR-211 + ++ NA Tumorigenesis NA NA 
miR-338 + ++ NA Tumour suppressor 
NA NA 
miR-
450b-5p NA NA NA 
Contribute to the 
pluripotent state 
of SCs 
-/+ -/+ 
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Down-
regulated     
NA NA 
miR-184 ++ + -* 
Oncogenic, neural 
stem-cell specific 
(induces 
proliferation and 
inhibits 
differentiation), 
cornea-specific 
-/+ - 
miR-193 ++ + ND Tumour suppressor 
- -/+ 
 
NGS results showed the expression of a total of 1668 different miRNA molecules (precursor 
and mature), of which 337 showed to be expressed only by HCjE-Gi-derived exosomes, 282 
by hTCEpi-derived exosomes, and 1049 to be shared by both exosome populations.  
Despite the non-significant differences in the abundance of miR-145, miR-143, miR-205, mir-
126, and miR-193 between the two exosomes populations, the higher expression of the first 
four and the lower expression of the latter observed in HCjE-Gi-derived exosomes suggested 
a less differentiated state of such cells, as these miRNAs have been found to be involved in 
corneal epithelial differentiation [502], enriched in limbal regions [490], progenitor cells 
homeostasis [583], and tumour suppression [582]. Additionally, miR-203 and miR-125b 
(enriched in the HCjE-Gi-derived exosomes) have been linked with the maintenance of adult 
epidermal SCs [499-501] and miR-450b-5p to contribute to the pluripotent state of SCs. On 
the other hand, miR-24 (enriched in the hTCEpi-derived exosomes) functions are mainly 
related with EC differentiation [494]. NGS results suggested that exosomes released by the 
HCjE-Gi cells contain miRNAs molecules mainly involved in keeping cells in undifferentiated 
states while exosomes released by hTCEpi cells contain higher abundances of miRNAs 
associated with EC differentiation.  
From the wide panel of the detected molecules, only 11 showed significant differences in 
their relative abundance between the two populations, these include miR-598, miR-34c 
family, miR-146a, miR-155 family, and miR-9 family.  
4.4.4.1. miR-598 is downregulated in cancer tissues 
The information on miR-598 biology is still very scarce, with no reports yet showing its 
expression by human ocular ECs. However, Chen et al. have shown that miR-598 is highly 
downregulated in colorectal cancer tissues and it inhibits metastasis in colorectal cancer by 
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suppressing JAG1/Notch2 pathways, stimulating epithelial mesenchymal transition (EMT) 
[584]. These observations suggest that its high expression is involved in cell differentiation. 
4.4.4.2. miR-34c is involved in cell differentiation 
The miR-34 family consists of three members: miR-34a, miR-34b, and miR-34c. The miR-34 
family show the highest induction by p53, a tumour suppressor protein, which prompted the 
investigation of their role in cancer biology [585]. All members of miR-34 were shown to 
suppress tumour growth by inhibiting cancer development, metastasis and stemness, a 
process regulated through the downregulation of their target mRNAs [586, 587]. Others have 
yet shown an increased expression of miR-34c expression from new-born to sexually mature 
mouse testes, suggesting its involvement in germ cell differentiation and sperm production, 
promoting cell differentiation of mouse spermatogonial SCs [578, 588]. Additionally, miR-34c 
was shown to regulate the differentiation of mouse ESCs into germ cells [578] and all 
members of the miR-34 family are induced during osteoblast differentiation in bone 
development [589]. An extensive report on the role played by miR-34 family in modulating 
EMT has shown that the overexpression of miR-34c attenuated EMT via suppression of 
Notch/Jag1 pathway [590]. To date no reports have been published showing any role played 
by this miRNA family in the development of the eye nor epithelial differentiation, however 
in light of this knowledge it may be deduced that their higher abundance in hTCEpi cells-
derived exosomes are an indicative of a more differentiated cell state.  
4.4.4.3. miR-146a is involved in the maintenance of LSCs homeostasis 
miR-146a overexpression has been associated with delayed wound healing properties in 
human diabetic corneas, probably due to its putative role in inhibiting cell migration through 
phosphorylated EGFR and p38 signalling pathways [492]. Winkler et al. have, more recently, 
shown that miR-146a is overexpressed in limbus versus central cornea suggesting its possible 
role in LSCs homeostasis [580], therefore playing a role in maintenance and early 
differentiation state of LSCs. Additionally, its expression in the healthy cornea (central and 
peripheral) yielded a diffuse and weak expression, whereas the diabetic cornea showed 
stronger expression, specially at limbal locations [492]. Xu et al. have shown that miR-146a 
negatively regulated EGFR expression and inhibited tumour growth through the MAPK 
pathway in a pERK-dependent manner to control migration and proliferation [579]. It has 
been associated with several diseases, including diabetic nephropathy-associated 
inflammation [591] and diabetic retinopathy [581]. It also inhibits migration and proliferation 
of lung cancer cells due to its targeting of EGFR and NF-κB signalling [592]. Putting together, 
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all these observations, and particularly its higher expression at limbus locations, suggest that 
its higher abundance in HCjE-Gi-derived exosomes is an indicative of an overall less 
differentiated cell state.  
4.4.4.4. miR-155 represses cell proliferation and differentiation and is highly 
expressed at limbal locations 
TCF4, a target of miR-155, is a crucial transcription factor of Wnt signalling and has been 
shown to regulate p63/surviving and p57 expression by maintaining the proliferation and 
migratory properties of human corneal epithelial progenitor cells [593]. Other predicted 
targets of miR-155 are involved in MAPK, insulin, and mTOR signalling, suggesting potential 
suppressive effect on cell proliferation, differentiation , and migration [490]. As it has been 
shown to be enriched in limbal ECs, it antagonizes transcription factors that regulate cell 
proliferation, differentiation, and apoptosis. Therefore, its higher expression in HCjE-Gi cells-
derived exosomes suggest an overall less differentiated cell state.  
4.4.4.5. miR-9 is involved in cell differentiation 
Very little has been published on the functions of miR-9 on human ocular cell biology. Only 
two manuscripts have shown an increase in its expression associated with cell apoptosis and 
differentiation of retinal pigmented ECs [594] and retinal progenitor cells [595]. Other 
reports pointed in the same direction, with the expression of miR-9 being associated with 
the differentiation of neural SC [596] and bone marrow mesenchymal SCs into neuronal cells 
[597].  
The significant differences in miRNA content from the two exosomes populations are mainly 
related with miRNA molecules involved in maintaining and/or promoting an undifferentiated 
cell state, being their expression higher in exosomes derived from HCjE-Gi cells. The higher 
abundance of these miRNA molecules in the exosomes released by such cell line suggest 
three different, but correlated, outcomes. Firstly, it is indicative that HCjE-Gi cells may be in 
an overall less differentiated state when compared to hTCEpi cells. Secondly, the cargo 
carried by HCjE-Gi-derived exosomes promoted a delayed intermediate step of cell 
dedifferentiation as observed by the higher expression of epithelial SC markers ΔNp63 and 
ABCB5 by hTCEpi cells at later time-points when cultured with HCjE-Gi-derived (12-48 hours, 
Figure 74 and 36 hours, Figure 75) and compared to the high expression by HCjE-Gi cells 
when cultured on hTCEpi-derived exosomes at 6-12 hours (Figure 72 and Figure 73). Thirdly, 
the hTCEpi differentiation toward a conjunctival epithelial-like lineage in response to HCjE-
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Gi-derived exosomes appeared to be delayed and more incomplete. Supporting this 
hypothesis is the relatively constant transcript levels of keratins (KRT3, KRT12, KRT7, and 
KRT13) up to 48 hours (Figure 74) upon which an up-regulation of epithelial SC markers is 
seen, suggesting an emergence of progenitor cells. On the other hand, hTCEpi-derived 
exosomes promoted an early down-regulation in keratin expression on HCjE-Gi cells (24-48 
hours for KRT7 and 6-12 hours for KRT13, Figure 72) preceded by an increase in expression 
of epithelial SC markers ΔNp63 and ABCB5. Taken altogether, these results suggested that 
HCjE-Gi-derived exosomes have restricted potential for differentiation.  
4.4.5. Potential of transdifferentiating human ocular epithelial cells using 
cell-derived exosomes 
The studies outlined in this chapter provide a step towards refinement of protocols to use 
EVs, and particularly exosomes, for potential therapeutic purposes. However, several 
improvements to the technique need to be carried out before these potential therapeutic 
agents can be understood: 
i. Validate the expression of miRNA molecules by Reverse Transcriptase qPCR, mRNA 
target assessment, and antagomirs experiments to silence endogenous miRNA to better 
understand their effects on ECs from human ocular surface. These results should also be 
verified using primary ECs from the human ocular surface. 
ii. Presence of potential dangerous mRNAs and/or miRNAs. The presence for 
undifferentiated cell molecules such as NANOG, OCT4 may be addressed and selectively 
eradicated to prevent tumour formation upon administration.  
iii. Selectively change their cargo to enhance their properties. Remarkably, a study using 
exosomes extracted from cells genetically modified to express CD34+ sonic hedgehog 
protein, showed infarct size reduction and improvement of cardiac function after 4 
weeks, when those exosomes were injected into the infarcted border zone [598]. 
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Chapter 5 – Discussion and Future work 
In this chapter, the main results and conclusions obtained in each chapter will be discussed 
in context with the original aims, the research of others, and the future research work 
resulting from this thesis. Research related to conjunctival transdifferentiation had its 
pinnacle in the 1980s and early 1990s with the work of Friedrich Kruse, Scheffer Tseng, and 
Winston Kao [29, 166-169, 184, 233-242], with very few research articles been published 
ever since. On the other hand, the field of exosome biogenesis, release, and mechanisms of 
action, despite being poorly understood, has gained a lot of new insights with the number of 
publications dramatically increasing over the last decade (over 6200 “exosomes” entries on 
PubMed on January 2018). 
Until recently, tissue-specific SCs were considered to have limited potency, and their derived 
TACs to be irreversibly committed. This paradigm has been challenged with the recent work 
of Takahashi and Yamanaka that led to the discovery that mature cells can be reprogrammed 
to become pluripotent [203]. The idea of adult somatic cell reprogramming has gained new 
knowledge more recently, with the extracellular environment being one of the triggering 
agents for such process [599]. One of the best studied models on cell-ECM interactions arises 
from the skin, where integrin-ECM interactions regulate cell fate [600]. 
Adult mammalian central corneal cells, which are widely accepted to be differentiated cells, 
are shown to differentiate into pilosebaceous units when confronted with trichogenic 
embryonic dermis, or sweat glands when cultured in plantar dermis [601]. The corneal cells 
lose their high levels of KRT12 expression gaining granular and cornified features, associated 
with pilosebaceous units, or show the formation of footpads and sweat glands when in 
plantar dermis [601]. To understand the process of cell reprogramming, the same group of 
investigators have shown that the first stage of the transformation may be the restoration 
of a more SC-like phenotype [601]. This is in accordance with the work of Potten and Loeffler, 
who showed that TACs that left their SC niche are not irreversibly committed to a terminal 
differentiation pathway but are able to revert to being SCs [64]. Interesting observations 
have shown that proliferation and differentiation processes are not mutually exclusive, i.e. 
the expression of a new gene product is not necessarily linked to functional irreversibility 
[64]. In the same line of studies, Ferraris et al. have induced corneal epithelium from rabbit 
embryos (23 and 24-day embryos and new-born animals) to form hair follicles when 
associated with dorsal embryonic dermis. These corneal cells failed to express KRT12 and 
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then stratified into structures containing hair buds [602]. Many studies have extensively 
addressed the effect of the external environment stimuli on cell’s fate with certain degree of 
success. These include chondrocyte differentiation and morphogenesis of mammary ECs 
when cultured in 3D environments [603], and differentiation of dermal cells into neural-like 
cells when grown on laminin substrates and fed with FGF2-containing medium [604]. Besides 
ECM physical/mechanical cues, conditioned medium has also been used to differentiate cells 
toward specific lineages. One study showed that dermal papilla cells cultured with 
conditioned medium from an endothelial cell line start to express endothelial markers and 
to exhibit functional activities (formation of capillary-like structures in Matrigel®) [605].  
KRT10, an acidic type of keratin filament, is commonly associated with the terminally 
differentiated suprabasal cells of the stratified epidermis of skin [606]. In rat embryos it also 
has been shown to be expressed at the limbus of late gestation embryos, persisting after 
birth and progressively being lost from limbus as the rats age [606]. However, when corneal 
ECs are cultured under high calcium concentrations they express KRT10 [607], additionally 
hESCs differentiated into corneal epithelial like cells also express this keratin [178]. These 
two studies show that corneal ECs when cultured under atypical conditions can express 
KRT10, suggesting that extracellular cues can promote changes in cell phenotype and 
possibly reverting them into a more progenitor phenotype, however further investigations 
are needed to address this point. 
Taken together, all these observations suggest that cells cultured in appropriate conditions 
and given the adequate cues can differentiate towards specific lineages, changing their 
characteristics to those in accordance to the new environment in which they are placed 
regardless their differentiation state. 
The aim on Chapter 2 was two-fold; firstly, to develop a protocol to promote the alternate 
differentiation of ECs from the human ocular surface in response to the extracellular protein 
meshwork, whose morphogenic tissue-specific properties where kept intact. Secondly, to 
drive the differentiation of hESCs in response to the ECM preparations derived from two 
different cell lines. The first goal was fulfilled using a derivation of a method firstly 
established by Gospodarowicz [288] and later utilized by Todorovic et al. to assess the 
proteins expressed by basal cells using mass spectrometry [289]. The main hurdle faced in 
these investigations was to efficiently remove all cells and cell debris leaving only ECM 
proteins on the culture system, as their expression and presence was impossible to detect 
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until performing the mass spectrometry and immunostaining assays carried out in Chapter 
3. However, two main conclusions can be drawn from the studies here outlined: (i) there is 
a process of EC differentiation in response to the ECM proteins and (ii) this process involves 
a mechanism of cell dedifferentiation as intermediate step. The first conclusion arises from 
the higher expression of corneal markers by HCjE-Gi cells upon culture in corneal 
environment (and vice-versa); and the second conclusion from the higher expression of 
putative SC markers during the experiments course. Several other studies have shown similar 
mechanisms of transdifferentiation that involve a first step of cell dedifferentiation that 
precede the full re-differentiation into the “new” cell type. These include, for example, the 
transdifferentiation of pancreatic cells to hepatocytes [217] and the vascular endothelium to 
smooth muscle [218]. In the process of dedifferentiation the cell undergoes reversion from 
a differentiated gene expression to a progenitor gene expression profile, accompanied by 
the repression of the development-related gene, and the activation of the genes that keep 
the cell in the undifferentiated state [608]. The dedifferentiated cells are usually smaller, 
have fewer organelles, and have higher nucleus/cytoplasm ratio when compared to the more 
mature cells [608]. At a functional level, the cell eventually regains the ability to proliferate, 
which means that a differentiated cell can re-enter the cell cycle. A very interesting example 
of dedifferentiation arises from the work of Pearton et al. who dedifferentiated and reverted 
mice differentiated corneal ECs into a limbal basal phenotype by triggering them with dermal 
development signals, a process that involves the activation of Wnt and BMP/Noggin 
signalling pathways [609, 610]. 
Further studies must then be performed to firstly, fully characterize the functional potential 
of the differentiating cells, as some authors have suggested that they may differ from the 
targeted cell in glycogen metabolism, keratin profiling, and tensile strength [166, 167, 169]. 
Secondly, the expression of SC markers need to be refined to prevent the risk of formation 
of tumours upon transplantation. Thirdly, “function-rescue” experiments should also be 
carried out to confirm if the phenotype of the differentiating cell can be reverted as to the 
parental cell, because despite being defined as an irreversible switch of one differentiated 
cell type into another [611], several studies have shown examples of reversible 
transdifferentiation between cell types, such as the reversible transdifferentiation between 
two different types of alveolar ECs [612] and blood vascular endothelial cells to a lymphatic-
like phenotype [613].  
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Clinically one of the best-studied examples of metaplasia in response to the extracellular 
stimuli is the Barrett’s oesophagus. This disease is characterized by the replacement of the 
normal stratified squamous epithelium by simple columnar epithelium with interspaced 
goblet cells in response to changes in environment acidity due to reflux [614].  
The second goal of the Chapter 2 was partially achieved by culturing undifferentiated hESCs 
in “de-roofed” cultures containing conjunctival or corneal ECM proteins and growth factors 
trapped within the protein meshwork. While many others investigations have promoted 
such differentiation using coated surfaces with one single protein [179] and/or using 
conditioned medium from other cell cultures [178, 314], the studies in this chapter showed 
that hESCs can be partially differentiated into epithelial-like cells by mimicking the 
conjunctival and corneal microenvironments. The future potential of this model of hESC 
differentiation needs, however, to be further improved. Firstly, studies at protein levels (flow 
cytometry and Western blotting) are essential to evaluate the expression of epithelial 
markers by the cells undergoing differentiation as great variability is observed on Reverse 
Transcriptase qPCR results. Secondly, functional studies are required to assess the 
differences between the functionality of the differentiating cells and the native conjunctival 
or corneal ECs. Thirdly, the expression of undifferentiated hESC markers needs to be refined 
and selectively silenced to eliminate the risk of tumour formation upon transplantation. 
Fourthly, the possible potential of this culture system to provide a novel source for 
conjunctival cells or LSCs for clinical applications certainly needs to be determined. 
Three main achievements were reached in Chapter 3, firstly the reliability of the “de-roofing” 
method; secondly, the acquaintance of the set of ECM proteins that are responsible for the 
process of cell differentiation; and thirdly, the intracellular mechanisms that triggered such 
process. Regarding the first aim, the “de-roofing” method showed to be reliable and, more 
importantly, replicable. The studies outlined in Chapter 2 and Chapter 3 showed that cells 
can be driven to differentiate towards a desired lineage in response to the morphogenic 
properties of the extracellular environment, resultant from the interactions of the different 
proteins with each other and with other soluble factors [299]. The effect of ECM, and 
particularly BM, composition on cell behaviour has been extensively addressed elsewhere 
[178, 179]. However, in most of these studies the morphogenic properties of the 
extracellular environment are ruled out as simple crude coatings with one single protein are 
usually performed. Indeed, in vivo studies have shown that when conjunctival ECs are 
cultured on intact corneal BM they express KRT12, suggesting that a more complete 
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transdifferentiation of these cells can be achieved upon culture with appropriate stimuli 
(corneal microenvironment mimicry) [175]. Further immunocytochemistry studies should 
here be carried out not only to visually confirm the presence of more proteins detected by 
mass spectrometry (in addition to COLXVIIα1, LAMα5, β1, and β2 chains), but also to co-
localize some of them. Laminin-integrin co-localization would be of very useful potential to 
better understand the role of these proteins cross-talk in the process of epithelial 
differentiation, since integrins in the cell membrane bind to the extracellular laminins to 
transduce information regarding the ECM to the cell [615].  
Regarding the second goal of the Chapter 3, differential cellular response is shown for 
different laminin isoforms. In addition to protein-dependency, cell response showed also to 
be concentration and time-dependent. The amount of protein that truly attaches to the 
cultureware should be determined, as the concentration used in our studies was in 
accordance with the manufacturer’s instructions and others’ methods [438]. LAM-511, here 
used as one of the proteins for substrate functionalization, has extensively been studied due 
its inhibitory differentiation properties [312, 427, 439], however other laminin isoforms have 
been tested for the same purpose. Domogatskaya et al. showed that LAM-332 enables ESCs 
proliferation but not pluripotency, LAM-111 caused ESCs differentiation within 2 weeks, and 
LAM-411 was not capable of supporting ESC survival [311]. In the same studies, that group 
have suggested that different integrins chains have different roles in mediating cell adhesion; 
by blocking β1 integrin they completely inhibited ESCs adhesion to LAM-511 whereas α6 and 
αν integrin blocking only partially inhibited cell adhesion; α2β1, α3, α4, α5β1, αV, β2, β3, and 
β4 integrin blocking had no effect on ESCs adhesion [311]. In addition to their potential role 
in maintaining cells in undifferentiated states, LAM-511 and LAM-521 have been used as 
substrates to successfully culture corneal endothelial cells, which upon culture in either 
isoform formed a monolayer with a hexagonal morphology and increased percentage of 
Ki67-positive cells (proliferative cells). In contrast, the same cell type cultured on LAM-211 
functionalized scaffolds showed patchy colonies with fewer cells in proliferative states [427]. 
Additionally, the levels of phosphorylated (activated) FAK is increased when cells are 
cultured on LAM-511 when compared to those on LAM-211, suggesting enhanced adhesion 
to LAM-511 through a mechanism mediated by α3β1 and α6β1 integrin [427]. These studies 
acknowledge the differential response of cells to laminin isoforms. LAM-511 also functions 
as a better adhesive substrate for intestinal ECs than LAM-111, LAM-211, and LAM-332 [616], 
once again showing that different laminin isoforms have differential effects on cells’ 
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behaviour. The ability of corneal ECs to readily adhere, spread, and migrate on preparations 
of amniotic membrane (mainly composed of LAM-511 and LAM-521) [304, 438, 617-619], 
may explain its high success in human corneal surface reconstruction. Taken together these 
observations suggest different cell adhesion affinities to different laminin isoforms [433] and 
cell type-dependent mechanisms of integrin-laminin interaction [620]. Further studies by 
Kurpakus-Wheater and colleagues have suggested that human corneal ECs adhere to LAM-
511 and LAM-521 mainly through integrin α3β1 and not integrin α6β1 [304, 438]. On the 
other hand, adhesion to EHS laminin (mainly composed of LAM-111) has been reported to 
be primarily modulated by integrin α6β1 [621, 622]. Very little is still known about the role 
of different laminin isoforms in conjunctival EC behaviour. Dowgiert et al. have shown that 
LAM-211 regulates conjunctival EC adhesion to ECM via α3β1 integrin in a process that 
activates both Erk1/2 and Akt-1 signalling pathways, enhancing conjunctival EC proliferation 
[623]. In this regard, our mass spectrometry results showed that integrin α3, α6, β1, and β4 
chains are produced by both cell lines, whilst α2, αν, and β6 chains to be produced only by 
hTCEpi cells. The expression of such variety of integrins suggest that these cells can interact 
with various laminin isoforms, including with those that are not normally localized on 
conjunctival or corneal BM. By using function-blocking antibodies to several integrin chains, 
interesting information would arise from the identification of which integrins mediate 
conjunctival and corneal EC adhesion to the different laminin isoforms. Amongst the non-
integrin receptors, dystroglycan and Lutheran glycoproteins and heparan sulphate 
glycosaminoglycan have also been shown to mediate the adhesion of conjunctival and 
corneal ECs to laminins [624-626]. 
Thirdly, the signalling pathway results enlightened the mechanisms behind the process of 
cell differentiation. MAPK activation is a downstream event of integrin ligation resulting in 
the regulation of important cellular processes [387]. Three different subfamilies of the 
MAPkinases pathway have been described; including the ERK, p38, and JNK/SPK [627]. The 
phosphorylation levels of the first two were addressed in this study, with no significant 
differences observed in the residue phosphorylation of the proteins related with p38 
pathway, which suggested that the process of epithelial cell differentiation is mainly 
mediated by the ERK1/2 pathways activated upon Thr202 and Tyr204 phosphorylation. 
Interesting and useful data would result from experiments in which certain pathways and/or 
small branches of these pathways were blocked by antibody binding to, therefore, 
investigate whether the same type of response would be given without the interference of 
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the extracellular cues. Certainly, the results outlined in Chapter 2 and Chapter 3 together 
open the door to further studies of cell differentiation with different cell lineages using the 
hereby developed “de-roofing” method.  
Clinically, the advantage of using laminin isoforms to promote the undifferentiated state of 
ESCs over fibroblast feeder layers arises from the elimination of any animal products that are 
likely to contaminate cells with pathogens and other immunogenic molecules [628]. Recent 
observations have reported the utilization of truncated sequences of LAM-511, the so called 
E8 fragments, in therapeutic applications as they do not present the risk of contamination 
and, as smaller molecules, they overcame the issues related with the stability and mass 
production of full laminin isoforms [313]. Additionally, hESCs supportive feeder layers have 
been shown to produce LAM-511 and express the laminin binding integrins α3β1, α6β1, α7β1 
[310], supporting the positive role of such proteins in hESC maintenance. 
The aim in Chapter 4 was threefold; firstly, the protocols for exosome extraction and 
characterization needed to be optimised as, besides the dramatic impact that this field has 
had recently, little has been done using exosomes derived from cultures of human ocular 
ECs. In this regard, exosomes were isolated using a method based on differential 
centrifugation described by Thery et al. [563] with few modifications. The resulting solutions 
from this isolation/purification method were shown elsewhere to have high purity and to be 
highly enriched in exosomes [6], consistent with the results herein presented. Secondly, cell 
response to exogenous exosomes populations was evaluated. Concerning this, only one work 
has been published to date where exosomes from corneal ECs culture were extracted and 
used [566]. In the work from Han et al. corneal EC-derived exosomes were shown to mediate 
communication between corneal ECs and corneal keratocytes and vascular endothelial cells 
and therefore to be involved in corneal wound healing and neovascularization [566]. On the 
other hand, countless manuscripts have reported the role played by exosomes extracted 
from other systems in cell differentiation with high rates of success. These include exosomes 
derived from lymphoma cell lines to induce the differentiation and proliferation of B cells 
[629], the differentiation of mesenchymal SC into myofibroblasts using cancer-derived 
exosomes [630], amongst many others. Thirdly, the characterization of the cargo that would 
eventually be transferred from the secreting to the recipient cell was assessed. In this regard, 
an astonishing number of manuscripts have been published, with the majority suggesting an 
enriched content in mRNA and miRNA molecules. Moreover, exosomal miRNAs have been 
shown to be involved in many biological processes including cardiovascular protection and 
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repair [631], differentation and reprogramming [632], neural cells differentiation and 
glutamate transporter expression [633] and neurite outgrowth [634]. Exosomal cargo has 
shown considerable differences in the miRNA signature between the limbal and corneal 
regions, with miRNAs encountered to be enriched at the limbal regions likely to be involved 
in the maintenance of the undifferentiated cell state. These include miR-145, miR-143, miR-
126, miR-338, and miR-10b [490-498, 502]. On the other hand, miR-184, miR-193, miR-149, 
and miR-575 have been preferentially located in the corneal regions [490-498, 502] and 
therefore associated with the terminally differentiated phenotype of their constituent cells. 
Yet again, Han and colleagues have also characterized the cargo carried by corneal epithelial-
derived exosomes [566], although regarding its protein content only. Altogether, the studies 
in this chapter have shown that EVs populations can be extracted from cultures of ECs from 
the ocular surface. The extracted vesicles showed properties that are in accordance to those 
of exosome-enriched populations [503], namely CD63 and TSG101-positive content, GRP94 
absence, and diameters that range from 80 to 120 nm. Additionally, the exosomal cargo 
derived from conjunctival and cornea ECs showed to contain various mRNA and miRNA 
molecules that may be involved in the triggering of events that led to cell differentiation. The 
cargo characterization showed significant differences in the relative abundance of 11 
miRNAs molecules between the two populations. However, as no information is available 
regarding the effect of such molecules on the cells from the ocular surface, their role was 
mainly extrapolated from other systems. The significant differences are mainly related to 
molecules involved in maintaining and/or promoting an undifferentiated cell state, being 
their expression higher in exosomes derived from HCjE-Gi cells. Further investigations should 
be then performed in terms of exosomes characterization, namely transmission electron 
microscope to assess their morphology and Western blotting to evaluate their content in 
terms of CD63, TSG101, GRP94, and protein cargo assessment. Another exciting set of 
experiments would be to use miRNA knock-out approaches to investigate which miRNA 
molecule(s) (detected in Next Generation Sequencing results) is/(are) involved in the process 
of cell differentiation. Exosome cargo may also be selectively modified not only to eliminate 
the potential dangerous mRNAs and miRNAs, such as OCT4 and NANOG which would 
represent a risk of tumour formation, but also to enhance certain properties as has already 
been shown elsewhere [598, 635, 636]. Finally, “rescue” experiments should also be carried 
out to confirm if the phenotype of the differentiating cell can be reverted to that of the 
parental cell in response to endogenous exosomes populations.  
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When the results from all the previous chapters are interpreted together a few iterations can 
be made. Firstly, ECs from the ocular surface dedifferentiate prior to fully re-differentiation 
upon extracellular stimuli. Secondly, differences exist in the differentiation potential 
between the two cell lines. Regarding this, results in chapter 2 showed that HCjE-Gi ECM has 
a more accentuated effect on hTCEpi cells differentiation than hTCEpi ECM on HCjE-Gi cells 
differentiation. Thirdly, primary cells respond similarly to extracellular cues when compared 
to the immortalized cell lines. Fourthly, Chapter 3 showed that, consistent with the 
observations made in Chapter 2, hTCEpi cells are more responsive to extracellular stimuli 
than HCjE-Gi cells upon culture in HCjE-Gi ECM and hTCEpi ECM proteins, respectively. 
Fifthly, Chapter 4 has shown that the HCjE-Gi and hTCEpi cells-derived exosomes have the 
potential to trigger the process of EC differentiation. Sixthly, HCjE-Gi cells-derived exosomes 
contain higher amounts of miRNAs molecules involved in the maintenance of 
undifferentiated cell states. Taken together these results suggested that the HCjE-Gi cell line 
is less resilient to differentiation upon external stimuli. 
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Appendix A – Results analysis 
A.1 Reverse Transcriptase qPCR and Melt curves analysis  
Housekeeping genes should have stable mRNA expression and the amount of reference gene 
(given by Ct value) must not vary with the experimental conditions [637]. Amongst a wide 
library of available house-keeping genes, GAPDH was chosen. One study in human ocular 
surface epithelium has shown that GAPDH has the second highest stability amongst nine 
different control genes used [638]. Therefore, GAPDH was chosen as housekeeping genes in 
this study. Prior utilization, primer-BLAST was conducted using NCBI Primer-BLAST tool. 
Melt curve analysis is widely used to evaluate the specificity of the amplified products when 
intercalating dyes (such as SYBR green) are used. Since many of these dyes bind to any 
double-stranded DNA products and are not sequence specific, the specificity of amplification 
is of crucial concern. 
The single peak observed in the resulting melt curves is usually interpreted as a pure, single 
amplicon. In contrast, melt curves that exhibit two or more peaks are indicative of two or 
more different amplicons.  
At the end of the qPCR run, the thermal cycler measures the fluorescence intensity at a 
certain temperature. The temperature is then increased at a desired rate as the instrument 
keeps measuring the fluorescence of the sample. At a certain temperature, amplicon-
dependent, the double stranded DNA product starts to denature becoming single-stranded, 
the dye dissociates and the fluorescence decreases. The reduction on fluorescence is 
measured and plotted as a function of temperature, obtaining the melt curve. Two melting 
phases can often be observed however, this does not imply the presence of two different 
amplicons. These two fashion curves may indicate regions of higher stability within the 
amplicon (such as G/C rich regions) that do not melt immediately. Agarose gel analysis can 
then be performed to visualize the qPCR products, where the presence of a single band 
indicates the presence of a single product.  
Reverse Transcriptase quantitative PCR using SYBR green as intercalating dye was used in 
this study to assess the transcript expression. Figure A 1, Figure A 3, Figure A 5 show the 
resultant melt curve for each amplicon used. All curves exhibit a single peak suggesting a 
single and pure qPCR product.  
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Primer efficiency calculated as in Equation 3 and ranging from 80 to 110% is considered 
acceptable. Figure A 2, Figure A 4, and Figure A 6 show the primer efficiency curves and 
slopes used for primer efficiency calculation. 
𝑝𝑟𝑖𝑚𝑒𝑟 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 = −1 + 10ି(
ଵ
௦௟ ) 
Equation 3 – Formulae for primer efficiency calculation. For primer efficiency to approach 1 (100%) 
the value of slope should be -3.334. 
Other important information that can be obtained from the efficiency curves is the 
parallelism of the gene of interest when compared to the housekeeping genes. Ideally, the 
slope of the line should be -3.334 and the gene of interest and housekeeping gene lines 
should be parallel, avoiding any line cross-over. This would result not only in perfect primer 
efficiency but would also avoid any biased results arising from the gene of interest being 
detected prior its housekeeping gene.  
All primers used in these studies exhibit the aforementioned characteristics, exception is 
made for primers shown in Figure A 4. The primer efficiency for the genes shown in Figure A 
4 appear to be out of the acceptable range which may be result of the low level of fit (r2), 
and KRT10 transcript was not detected.  
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Figure A 1 - Melt curves for each individual amplicon used in chapter 2. All amplicons showed a single 
peak following melt curve analysis representing a pure and single amplicon. Abbreviations used KRT: 
Keratin, ABCB5: ATP-binding cassette sub-family B member 5, GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase.  
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 KRT3 KRT7 KRT12 KRT13 MUC5AC ΔNp63 ABCB5 GAPDH 
Slope -3.472 -3.673 -3.563 -2.985 -2.963 -3.76 -3.228 -3.928 
SD 0.63 0.24 0.87 0.20 0.51  0.13 0.20 
Efficiency (%) 94.1 87.2 90.8 116.3 1.18 84.5 104.1 79.7 
r
2 0.94 0.99 0.94 0.99 0.92  0.99 0.99 
Figure A 2 - Primer efficiency analysis for each individual primer used in chapter 2. (A) Graphics 
showing the efficiency curve. (B) Table containing the slopes used for primer efficiency calculation, 
efficiency, and goodness of fit. Abbreviations used KRT: keratin, MUC: mucin, GAPDH: glyceraldehyde 
3-phosphate dehydrogenase, ABCB5: ATP-binding cassette sub-family B member 5. 
A 
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Figure A 3 - Melt curves for each individual amplicon used in chapter 2. All amplicons showed a single 
peak following melt curve analysis representing a pure and single amplicon. Abbreviations used KRT: 
keratin, GAPDH: glyceraldehyde 3-phosphate dehydrogenase.  
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Figure A 4 - Primer efficiency analysis for each individual primer used in chapter 2. (A) Graphics 
showing the efficiency curve. (B) Table containing the slopes used for primer efficiency calculation, 
efficiency, and goodness of fit. Abbreviations used KRT: Keratin, GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase. 
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Figure A 5 - Melt curves for each individual amplicon used in chapter 3. All amplicons showed a single 
peak following melt curve analysis representing a pure, single amplicon. Abbreviations used 
Abbreviations used COL: collagen, LAM: laminin, GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase.  
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Figure A 6 - Primer efficiency analysis for each individual primer used in chapter 3. (A) Graphics 
showing the efficiency curve. (B) Table containing the slopes used for primer efficiency calculation, 
efficiency, and goodness of fit. Abbreviations used COL: collagen, GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase, LAM: laminin.  
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A.2 Flow cytometry analysis 
The percentage of positive events detected by flow cytometry was calculated as shown on 
Figure A 7. Briefly, the debris and dead cells are discarded by gating out the smallest events 
detected (Rx). This detection is based on its size distribution given by FSC-A (SSC-A is an 
indicative of granularity of the event). This results in a new plot where only the true events 
(cells) will be analysed, Figure A 7. C and F. By overlaying the resultant graphs, a percentage 
of ‘true positive’ events can be assessed by subtracting the percentage of positive events on 
sample (ABCB5 in the example) to the one on isotype control, using as starting point the 
moment where those two curves cross-over, resulting in the percentage M1, Figure A 7. 
AB
CB
5  
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yp
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rl  
      No Gating        No Gating        R1 Gating A B C 
       R2 Gating        No Gating        No Gating D E F 
R1 and R2 Gating G 
Figure A 7- Flow cytometry example of analysis. Scattered plot A and D show the distribution of size 
(FSC-A) and granularity (SSC-A) of the non-gated samples. Graphs B and E show the fluorescence 
distribution (FL1-A) of all events detected of the non-gated samples. Graphs C and F show the 
fluorescence distribution (FL1-A) of all events detected after gating, excluding the debris and dead 
cells based on their size distribution (R1 and R2). Graph G shows the resulting difference of true 
positives between sample (red) and isotype control (purple) (M1) after gating for debris and dead 
cells. Abbreviations used Ctrl: control, ABCB5: ATP-binding cassette sub-family B, member 5. 
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Appendix B– human limbal and conjunctival epithelial cultures 
B.1 Introduction  
To successfully culture primary limbal and conjunctival ECs, a replication of the culture 
conditions firstly used for skin ECs was used [639]. These conditions included the use of 
murine feeder layers and supplemented hormonal medium shown to be successful for the 
culture of limbal and conjunctival ECs. 
 The murine 3T3 fibroblast feeder layer 
Two main reasons have been suggested for the little success on culturing skin and corneal 
ECs: 
i. Fibroblast contamination. Due to the proximity of fibroblasts and ECs in both tissues, the 
isolation of these two types of cell from each other has been shown to be difficult. 
Another reason that leads to the low success of the culture of primary ECs is the higher 
proliferative rate of fibroblasts, which may outgrow the ECs, overtaking the culture [640, 
641]. 
ii. Limited growth. Successfully established epithelial cultures have been shown to 
demonstrate a short lifespan with any attempt of sub-culturing being unsuccessful [640, 
641].   
Until the co-culture of skin ECs with murine 3T3 fibroblasts by Rheinwald and Green, the 
success rate of epithelial cultures was very limited [639]. 3T3 is a fibroblast cell line 
established from disaggregated random-bred Swiss mouse embryos [642]. Prior co-culture, 
the 3T3 fibroblasts are mitotically inactivated by irradiation or upon treatment with 
mitomycin-C, which is of crucial importance to prevent outgrowth over the primary ECs. 
Primary ECs have then been reported to grow successfully on a feeder layer of mitotically 
inactive 3T3 fibroblasts [643]. Moreover, Sun and Green showed that this co-culture model 
could also be used to sub-culture primary corneal ECs [644]. In the present study, ECs from 
human cornea and conjunctiva were grown successfully in a 3T3 fibroblasts feeder layer 
mitotically inactivated with mitomycin-C. 
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 The medium requirements 
Primary epithelial cultures grow optimally in humidified atmosphere with 5% CO2 at 37°C fed 
with a supplemented hormonal epithelial medium (SHEM) [643, 645]. This media consists of 
a 3:1 (V/V) ratio of DMEM: Ham F12 supplemented with the following nutritional 
requirements: 
i. Foetal calf serum (FCS). FCS is an essential requirement for successful primary EC culture 
as it contains a mixture of cytokines, growth factors, and hormones (most of them 
unknown) [646]. In the most recent years, several attempts to eliminate FCS from culture 
conditions have been tried. These attempts have result in poor maintenance of LSCs with 
rapid differentiation towards TACs [647].  
ii. Hydrocortisone. The addition of cortisone is known to improve both the growth and 
morphology of primary ECs in culture [639]. Others have suggested that hydrocortisone 
also prevents the deterioration of the 3T3 fibroblasts feeder layer [648].  
iii. Insulin. The addition of insulin to the medium has been suggested to reduce the 
requirement of FCS [649, 650]. It stimulates glucose transport into cells and is crucial in 
the synthesis of glycogen by those cells [649]. 
iv. Tri-iodothyronine (T3). Similar to insulin, the addition of T3 to the culture medium 
reduces the requirement of FCS [649]. Others have yet suggested that the addition of T3 
combined with insulin reduces the requirement of FCS in 50% [643]. T3 is a hormone 
required in essential cellular metabolic processes, such as growth and development.  
v. Adenine. Adenine improves the ability of primary ECs to form colonies [651]. As the 
proliferation of a single primary cell relies upon the formation of colonies of epithelium 
around this cell, the addition of adenine played a central role on the success of cultured 
primary ECs. 
vi. Epidermal growth factor (EGF). EGF promotes the migration of growing ECs preventing 
the accumulation and subsequent senescence of cells at the centre of the colony. It also 
prevents the differentiation of progenitor cells promoting a undifferentiated cell stage 
[652].  
 Properties of epithelial cells in culture 
By studying cultures of limbal and corneal ECs, several authors have suggested the following: 
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i. Variations between the limbal regions. It has been shown that ECs from different areas 
of the limbus have different ability to generate colonies, with cells from the superior 
limbus having higher CFE [80]. This finding, alongside with the higher density of palisades 
of Vogt at this region, which provide higher contact area and protection, suggested these 
limbal areas as the preferred for LSCs location.  
ii. Variations between the conjunctiva regions. It has been demonstrated that ECs from 
different regions of the conjunctiva have similar CFE [80] although slightly higher CFE has 
been observed in colonies from the superior bulbar and superior fornix of the conjunctiva. 
Stewart et al. suggested however, an increased CFE at the inferior fornix and medial 
canthal proposing these areas as the preferred location for the conjunctiva SCs. Higher 
expression of putative SC markers, ΔNp63α and ABCG2, was also found by Stewart et al. 
in the inferior forniceal and medial canthal regions of conjunctiva [61]. They suggested 
that these areas offer higher protection and vascularization, features shared with many 
others SCs niches [61]. 
iii. Ability to sub-culture. ECs from the limbus, whole bulbar conjunctiva and superior and 
inferior fornix can be cultured up to 14 passages (ranging from 2 to 3 months) before 
reaching senescence. Within this period the number of cell doublings range from 80-100 
[80].  
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